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Foreword
The last decade has witnessed an unprecedented increase in funding for malaria control efforts, 
which has resulted in a massive scale up of malaria prevention efforts, primarily through the use 
of long lasting insecticide treated bednets and indoor residual spraying with insecticides. These 
measures (along with intermittent preventive treatment in pregnancy) are estimated to have 
saved more than 735,000 lives in 34 African countries over the past 10 years. Yet malaria remains 
an enormous public health problem, responsible for 781,000 deaths a year, most of those among 
African children less than five years of age. Given that malaria is now an entirely preventable and 
treatable disease, this represents a senseless tragedy.
One of the reasons for this continued burden is that improvements in access to prompt diagnostic 
testing and effective treatment of confirmed malaria have lagged behind prevention efforts. Last 
year, the WHO Global Malaria Programme issued revised guidelines for the treatment of malaria 
in which it was recommended that all suspected cases of malaria receive a diagnostic test prior 
to treatment.
In many settings, especially in Africa, this represents a real paradigm change. For far too long, 
fever has been equated with malaria throughout most of the continent. Now, for the first time, 
that is changing in many places. With effective and widely deployed prevention measures, the 
proportion of fevers due to malaria is falling rapidly. The availability of inexpensive, quality-
assured rapid diagnostic tests for malaria means that parasite-based diagnosis is now not only 
achievable at peripheral health care facilities, but also at the community level.
Despite scattered data (and innumerable anecdotes) to suggest that health workers (and patients) 
will not pay attention to the results of such tests, and that they want antimalarial treatment for 
every fever, the truth is that most people do want to know what is wrong with them, and that 
health workers want to provide the best care they can for their patients. Ultimately, providing an 
antimalarial medicine to someone who has pneumonia, or a urinary tract infection as the source 
of their fever, is both bad medicine, and bad public health. The indiscriminate use of artemisinin-
based combination therapies risks fostering the spread of Plasmodium resistance, especially to 
medicines partnered with the artemisinins. 
The scale up of diagnostic testing offers unprecedented opportunities to strengthen health sys-
tems in several ways. First, timely and accurate surveillance based on confirmed, rather than 
suspected cases, is now possible. As malaria transmission continues to fall, such local data are 
essential to appropriate and effective malaria programme management. Second, the introduction 
of diagnostic testing allows for improved treatment of the many non-malarial febrile illnesses 
that are consequently “unmasked” at both facility and community level. For this reason, close 
collaboration with Maternal and Child Health services in the scale up of malaria diagnostic test-
ing is essential, especially through integrated management of childhood illnesses (at the facility 
level) as well as integrated community case management. 
While achieving universal access to malaria diagnostic testing will not be easy, some countries 
have already shown that is can be done. In Senegal, following the introduction of malaria RDTs 
in 2007, malaria diagnostic testing rates rose rapidly from 4% to 86% (by 2009); the prescription 
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of ACT dropped throughout this period from 73% of malaria-like febrile illness to 32%, reach-
ing close equivalence to confirmed malaria (30% of 585,000 suspected fever cases). More than 
500,000 courses of inappropriate ACT prescription were averted.
This operational manual is the result of the work of many people across diverse agencies and 
organization, a testimony to the importance of diagnostic testing in overall malaria control 
efforts. We hope that this manual will provide critically useful information to National Malaria 
Control Programmes and their partners as we work together to reach the health-related Millen-
nium Development Goals, as well as our ambitious goal of near-zero deaths from malaria by the 
end of 2015.
Robert D. Newman, MD, MPH
Director, Global Malaria Programme
World Health Organization
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glossary
Accreditation: Procedure by which an authoritative body formally recognizes that a body or 
person is competent to carry out specific tasks.
Certification: Procedure by which a third party gives written assurance that a product, process 
or service conforms to specific requirements.
Competence: Knowledge, skills, abilities and attitudes at a level of expertise sufficient to perform 
in an appropriate work setting; this should be a measurable standard.1
Combination rapid diagnostic test: Malaria rapid diagnostic test with more than one test line, 
detecting P. falciparum as well as other malaria species (in different combinations). 
Diagnosis: The process of establishing the cause of an illness (for example, a febrile episode), 
including clinical assessment and diagnostic tests.
Diagnostic test: Diagnostic tool (technique) used to confirm or exclude the presence of a disease
Diagnostic test performance: Capacity of a test to confirm or exclude a disease; a combination of 
the sensitivity and the specificity of a test that by definition does not depend on the prevalence of 
the disease in the population tested.
Internal audits: Set of activities organized by a laboratory or health facility staff to effectively and 
systematically monitor work carried out internally.
External quality assessment: Set of activities organized outside a laboratory or health facility 
(by external supervisors or an external quality provider) to effectively and systematically moni-
tor work carried out, including not only proficiency testing but also validation of the results of 
routine blood slide and on-site supervision.
Laboratory: A place where technicians are equipped to perform medical tests on clinical speci-
mens, not including health workers in a health facility or community health workers performing 
rapid diagnostic tests only.
Level of health-care system: Level of administrative decision-making in a health-care system, 
not the hierarchical organization of health facilities (primary, secondary or tertiary) or the geo-
graphical distribution (central, peripheral).
The central level generally corresponds to the national level; however, in some (often big) coun-
tries with a federal system, many central decisions are taken at state level rather than at federal 
level. 
The subnational level is any level between the central and the point-of-care level; countries may 
have multiple administrative structures at this level (governorates, regions, provinces, districts, 
counties).
1 Adapted from Harvey L. Analytic Quality Glossary, Quality Research International, 2011. Available at: 
 http://www.qualityresearchinternational.com/glossary/competence.htm
xiii
The point-of-care level corresponds to the places at which medical care is delivered to patients; it 
includes all health facilities (from referral hospitals to the smallest peripheral health facilities) as 
well as community health workers.
Lot (of rapid diagnostic tests): A lot (or batch) is defined as a production run in which particular 
batches of monoclonal antibodies and nitrocellulose were used. Each lot is usually identified by a 
number by the manufacturer and usually consists of 40 000–80 000 tests.
Lot testing: Quality control testing of a product lot (batch) after release from the manufacturing site.
Malaria: Disease caused by infection of red blood cells with Plasmodium parasites, with fever as 
the commonest presenting sign.
Malaria infection: Presence of Plasmodium parasites in blood or tissues, confirmed by the pres-
ence of parasites in peripheral blood by microscopy, malaria antigenaemia by rapid diagnostic 
testing or parasite DNA or RNA by polymerase chain reaction (PCR). 
Malaria test: For the purposes of this manual, a rapid diagnostic test (RDT) for malaria or micro-
scopic examination of a blood slide (thick or thin smear) for malaria parasites; PCR is not includ-
ed, as this manual focuses on tests used for the management of patients.
Panel detection score: Main measure (score between 0 and 100) of performance used in WHO 
product testing of malaria RDTs, corresponding to the percentage of times a malaria RDT gives 
a positive result on all tests from both lots tested against samples of parasite panels at a specific 
parasite density (i.e. four tests at 200 parasites per microlitre, two at 2000 parasites per microlitre). 
It is not a direct measure of RDT sensitivity or specificity.
Parasite density: Number of asexual parasites per microlitre of blood, detected by microscopic 
examination of peripheral blood films. Any level of parasite density can lead to clinical illness.
Plasmodium antigens: Antigens produced by malaria parasites and detected with RDTs; the 
antigen concentration depends on the parasite density in peripheral blood and the total parasite 
load (including sequestered parasites); may also vary with parasite species, stage of parasite life 
cycle, duration of infection, host immunity and other factors.
Proficiency testing: Inter-laboratory comparisons organized regularly to assess the performance 
of analytical laboratories and the competence of the personnel. In such programmes, multiple 
samples are periodically sent to laboratories for analysis or identification, and each laboratory’s 
results are compared with those of other laboratories, with an assigned value and reported to the 
participating laboratories and others.
Quality assurance: All processes involved in ensuring that results obtained with a tool are as 
accurate as the tool is designed to be (all diagnostic tools have limitations). Addresses all factors 
that affect diagnostic performance, including test performance by health staff, internal audits, 
external quality assessment, microscopy equipment and reagent quality, quality of RDT devices, 
storage and transport of RDTs, use of test results by clinicians, workload, workplace conditions, 
training and staff support and community perception.
Quality management system: System to direct and control an organization with regard to quality.
Quality monitoring: All activities involved in ensuring that the diagnostic tests continue to con-
form with established specifications during storage, distribution and use; part of quality assurance.
Quantification: Estimation of the quantities and frequencies of supplies necessary to meet 
demand in a specific area, avoiding stock-outs and over-stocking.
Sensitivity: For diagnostic tests, proportion of patients with the disease who have a positive result 
in the test being evaluated, determined from the results of the reference or ‘gold standard’ test; 
ranges from 0% (bad performance) to 100% (optimal performance).
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Specificity: For diagnostic tests, proportion of patients without the disease who have a negative 
result in the test being evaluated, determined from the results of the reference or ‘gold standard’ 
test; ranges from 0% (bad performance) to 100% (optimal performance).
Testing site: Any place in which malaria tests (RDTs or microscopy) are performed in the context 
of the clinical management of patients.
Test performer: Health worker or laboratory technician performing and interpreting an RDT or 
preparing, staining and examining a blood slide by microscopy.
Universal access: For malaria diagnostic tests, all sick people who fulfil the definition of a sus-
pected malaria case have access to a reliable malaria test, administered by a trained health worker 
at a health facility or community health centre. Does not include asymptomatic people in the 
context of strategies for eliminating malaria.
1preamble
preAmble
The aim of this interagency manual is to provide policy, strategy, technical and operational guid-
ance to countries wishing to strengthen or set up routine malaria diagnostic services. These ser-
vices include the use of both microscopy and rapid diagnostic tests (RDTs) at all levels for the 
management of febrile patients by health workers and are integrated within other national pro-
grammes for strengthening laboratory services.
This operational guide is primarily for national, provincial and district health and laboratory 
managers in ministries of health and malaria control programme and for the managers of other 
health agencies, nongovernmental organizations and faith-based organizations working with 
national health authorities to strengthen malaria diagnostic services.
The manual starts with a section on programme aspects (section 1), followed by descriptions of 
the policies and guidelines that are needed in a programme to strengthen malaria diagnostic test-
ing (section 2). The various activities are then described (sections 3–7), with the different aspects 
of monitoring and surveillance (sections 8 and 9). Strategies for particular settings are briefly 
proposed in section 10. 
Although the general approach is directed to programme management, some sections and tools 
might be useful for designing training materials and standard operating procedures for health 
professionals (doctors, nurses and health officers) and laboratory staff (scientists, technicians and 
microscopists) working in programmes for the diagnosis and treatment of patients with malaria. 
Most of the tools are described in the annexes to this manual.
This manual is a synthesis of important issues published previously, presented in an accessible 
format, and is intended to give a practical approach to establishing a reliable system for malaria 
diagnostic testing. References to WHO publications available online, which provide more detailed 
information, are listed throughout this manual and in the annexes. The manual is intended to 
provide general guidance, which may help countries to prepare or revise their operational manu-
als by involving national health authorities and technical partners active in this area of work. For 
example, the manual makes reference to health facility support to community health workers in 
conducting malaria diagnostic testing at community level. These sections might not be relevant 
to all countries. 
The aim of the manual is to stimulate the development of malaria diagnostic testing and manage-
ment, not as a vertical programme but integrated with activities at various levels of the health 
system. A key condition for its success is that malaria diagnostic testing not be practised on its 
own but as one component of the management of febrile patients, including causes of fever other 
than malaria.
Experience in several countries (Burkina Faso, Ghana, Nigeria, Papua New Guinea, Uganda, the 
United Republic of Tanzania (including Zanzibar) and Zambia) has shown that, with good train-
ing and support, health workers adhere to the results of malaria tests and treat only positive 
patients. This manual provides technical guidance on who should be tested for malaria and how. 
This is a major shift from other criteria for deciding who should be treated for malaria. It aligns 
the management of malaria with that of any other disease for which a reliable diagnostic test is 
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available. When the terms ‘RDT’ and ‘microscopy’ are used in a recommendation, it is considered 
as implicit that the tests are quality assured and therefore that they provide reliable, reproducible 
results in line with their technical characteristics. 
When not explicitly mentioned, the statements in the manual apply to all Plasmodium species 
(falciparum and non-falciparum).
This manual is intended to be read comprehensively, although some sections and tools given in 
the annexes can stand alone.
3introduction
introdUCtion
Why is parasitological diagnosis of malaria necessary?
An essential component of malaria control and elimination strategies is prompt, 
accurate diagnosis and treatment (within 24 hours of onset of illness) of patients 
with an effective medicine. The process of diagnosis is initiated by a suspicion of 
malaria on the basis of a defined set of clinical criteria, which may vary with the 
level of malaria endemicity and the types of non-malaria fevers in the area. Diag-
nosis is then confirmed by a laboratory test: either a blood film for microscopy or 
a rapid diagnostic test (RDT).1 
The clinical presentation of malaria is one of the least specific of all the major diseases. The causes 
of fever can range from non-serious viral infections to serious, life-threatening conditions that 
require immediate, appropriate treatment. Malaria infection can coexist with other life-threaten-
ing conditions, such as pneumonia, which also require urgent, appropriate treatment, especially 
in young children. When managing a febrile patient, it is therefore impossible to know if the 
condition is due to malaria or another disease solely on the basis of the clinical presentation. For 
optimal treatment and to save lives, an accurate diagnosis is therefore essential. Confirmatory 
malaria diagnosis is even more vital in areas with successful malaria control programmes, where 
the malaria incidence is declining and the likelihood that malaria is the cause of fever is reduced, 
to make sure that antimalarial medicines are not used inappropriately and that other conditions 
receive the correct management.
Parasitological testing is the only way to diagnose malaria accurately in febrile patients. Treat-
ment based on diagnostic testing is good clinical practice and has many advantages over pre-
sumptive treatment of all fever episodes:
• improved care of parasite-positive patients because of confirmation of infection;
• identification of parasite-negative patients, in whom another diagnosis must be sought and 
treated accordingly;
• avoidance of antimalarial medicine use in parasite-negative patients, which reduces side-
effects, drug interactions and selection pressure for drug resistance, potentially resulting in 
financial savings;
• better public trust in the efficacy of artemisinin-based combination therapy (ACT) when it is 
used only to treat confirmed malaria cases; and
• better public trust in diagnosis and treatment of non-malaria causes of febrile illness.
Since early 2010, WHO has recommended prompt parasitological confirmation by microscopy or 
an RDT for all patients suspected of having malaria, before treatment is started. Treatment solely 
on the basis of clinical suspicion should be considered only where parasitological diagnosis is 
not accessible.2 
1 Guidelines for the treatment of malaria, second edition. Geneva, World Health Organization, 2010. Available at: 
http://whqlibdoc.who.int/publications/2010/9789241547925_eng.pdf
2 Not available within 2 hours of the patient presenting at a point of care.
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The prevalence of malaria in a wide range of settings, its aspecific clinical presentation, which 
overlaps with that of many other diseases, and the acute and life-threatening nature of the disease 
require universal access to parasitological diagnosis, i.e. extension of malaria diagnostic services 
to all levels, up to the community. The aim of testing a sick person for malaria is not just to con-
firm the presence of an infection with Plasmodium but to decide on the appropriate treatment: 
a positive result indicates that an antimalarial medicine should be given, and a negative result 
indicates that no antimalarial medicine should be given. As a general principle (valid for any 
laboratory diagnostic test), the benefit of testing is lost if clinicians decide not to use a test result 
as a basis for treatment. 
Accurate malaria diagnosis can also greatly improve the reliability of surveillance data. With the 
progressive deployment of diagnostic testing, the number of recorded malaria cases is changing 
dramatically: in places where the majority of reported malaria cases had been diagnosed only on 
the basis of clinical suspicion, there is an apparent decrease in the number of cases because an 
increasing proportion of reported cases are accurately diagnosed. In many places, these trends are 
combined with a real decrease in malaria incidence due to effective control efforts, as in Senegal.1
New momentum in malaria diagnosis with the availability of RDTs
High-quality microscopy services for the diagnosis of malaria are not widely available, especially 
at the community level, where access to malaria diagnosis and treatment is needed. Microscopy 
requires trained staff, well-maintained equipment, a regular supply of reliable reagents, clean 
water and electricity, and a well-executed quality management system. Where the training of 
microscopists, equipment and reagents are substandard, the microscopy services are almost 
always of poor quality. In many countries, ensuring quality management of microscopy at all 
levels of the health-care system has not been feasible.
For these reasons, the development, in the early 1990s, of a simple immunochromatographic test 
to detect malaria parasite antigens in a fingerprick blood sample was a major advance. RDTs do 
not require water, electricity or laboratory facilities and can easily be performed in remote rural 
settings. Although training and regular supervision is as essential for RDT as it is for microscopy, 
the performance of RDTs and interpretation of their results require less training and experience 
than microscopy, and diagnostic performance does not depend on the availability of trained lab-
oratory technicians. This new tool allows widescale access to diagnostic testing, which could not 
be done with microscopy alone. The use of RDTs, with treatment given only to parasite-positive 
patients, has shown to be safe in recent studies, including for febrile children under 5 years of age 
living in remote, highly endemic areas.2 RDTs thus provide an opportunity for accurately diag-
nosing malaria even in this vulnerable group.
When well-trained and supervised health workers use RDTs of high quality, clinicians can 
be confident about the reliability of the test result and the safety of withholding antimalarial 
treatment in test-negative patients,2,3 thus reducing unnecessary consumption of antimalarial 
medicines. Health authorities must therefore select RDTs with high diagnostic performance, as 
assessed in product testing by WHO and the Foundation for Innovative New Diagnostics, which 
are appropriate for local conditions. Health authorities must also ensure correct management of 
the supply chain, including transport and storage, effective training of health workers and regular 
on-site supervision of both clinical and laboratory staff. 
1 World malaria report 2010. Geneva, World Health Organization, 2010. Available at: 
 http://www.who.int/malaria/world_malaria_report_2010/worldmalariareport2010.pdf
2 D’Acremont V et al. Withholding antimalarials in febrile Children who have a negative result for a Rapid Diagnos-
tic Test. Clinical Infectious Diseases, 2010, 51:506–11.
3 Njama-Meya D et al. Treatment of malaria restricted to laboratory-confirmed cases: a prospective cohort study in 
Ugandan children. Malaria Journal, 2007, 6:7.
5The availability of RDTs should also be used as an opportunity to improve the quality and avail-
ability, where needed, of microscopy; they should not replace microscopy. It is therefore essential 
that both decision-makers and health workers clearly understand the indications for use of each 
type of test.
Integration of diagnostic testing for malaria with laboratory services
In most malaria-endemic countries, malaria diagnostic services are part of the general health-
care system. Therefore, strengthening parasitological diagnosis of malaria is an opportunity for 
strengthening the national laboratory services, in close cooperation with the national coordinat-
ing body for all laboratory services in the country. 
Integration of diagnostic testing for malaria into the general  
management of fever 
A diagnosis of malaria is only one possibility in the management of a patient presenting with fever. 
To really improve the quality of care of these patients, WHO promotes an integrated approach.
One of the greatest challenges for a clinician working in a malaria-endemic area is managing 
a febrile patient who does not have malaria. Clinicians are more likely to adhere to the results 
of a malaria test when they can perform a comprehensive assessment of the patient to identify 
and treat other diseases. For this to be effective, additional diagnostic tools must be available to 
health workers, which are appropriate to the setting, including clinical diagnostic equipment and 
additional laboratory tests such as urine dipsticks. The appropriate medicines for treating com-
mon causes of fever (e.g. antibiotics for pneumonia, oral rehydration salts and zinc for diarrhoea) 
should also be available.
The training of health workers should include not only malaria diagnosis but also the overall 
management of fevers on the basis of the range and frequency of other causes of fever in the area. 
When available, training should include all nationally approved clinical and laboratory decision 
algorithms for the management of diseases other than malaria. As universal access to parasito-
logical diagnosis of malaria is scaled-up, close coordination with programmes for patient man-
agement, such as Integrated Management of Childhood Illness (IMCI), Integrated Management 
of Adolescent and Adult Illness (IMAI) and integrated Community Case Management, are essen-
tial, so that algorithms are appropriately modified for quantification of medicines and supplies. 
Training health workers in non-malaria febrile illnesses is especially important to avoid unneces-
sary prescription of antibiotics, which leads to the development of bacterial resistance. 
Use of RDTs or microscopy should therefore not be planned as a separate activity run by the 
national malaria control programme but should be fully integrated into case management pro-
grammes, as part of overall efforts to strengthen laboratory services. At central level, the national 
malaria control programme and the general laboratory services should work in close collaboration, 
as many activities, such as quantification, procurement, training, supervision, quality manage-
ment, monitoring and maintenance, require close coordination. Communication and coordina-
tion between different focal points are also important at subnational and point-of-care levels.
Types of tests appropriate for parasitological diagnosis of malaria
Routine parasitological confirmation of malaria is based on either identification of parasites in 
blood films examined by light microscopy or detection of parasite antigens with RDTs. Other 
diagnostic tests, such as polymerase chain reaction (PCR), may be used in certain situations, 
such as for identifying morphologically similar species (Plasmodium malariae and P. knowlesi), 
introdUCtion
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for efficacy testing to distinguish new infections from relapses and recrudescences and in specific 
elimination and containment projects, but these tests are presently not indicated for the case man-
agement of fever. Serological tests for malaria have no place in the management of febrile patients.
Microscopy and RDTs both show adequate performance in the diagnosis of malaria in febrile 
patients.1,2 Each test has characteristics that make it useful in particular clinical situations or set-
tings. Therefore, in most countries, both are needed. In all circumstances, setting up an effective 
quality management system for both microscopy and RDTs should be considered indispensable 
to ensure the accuracy and reliability of the programme. The introduction of RDTs is thus an 
opportunity to review and strengthen the entire system for managing the quality of general labo-
ratory services, of which malaria diagnosis is a significant part.
1 Ochola L.B et al. The reliability of diagnostic techniques in the diagnosis and management of malaria in the absence 
of a gold standard. The Lancet Infectious Diseases, 2006, 6:582–588. 
2 WHO technical consultation: Parasitological confirmation of malaria diagnosis, 6–8 October 2009. Geneva, World 
Health Organization, 2009. Available at: 
 http://whqlibdoc.who.int/publications/2010/9789241599412_eng.pdf
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1
The ultimate goal of a national malaria control programme is to provide universal access to accu-
rate malaria diagnostic testing for all patients suspected of having malaria. In most countries, this 
will not be possible in a single step, and a careful plan should be established, with strategies and 
timelines to reach full coverage and priorities set by region, health-care level (e.g. health facility, 
then community level) and sector (e.g. public sector, then private sector). The plan must subse-
quently be adapted to the results of monitoring and evaluation.
Strengthening parasitological diagnosis of malaria might be an opportunity to strengthen the 
existing national laboratory services. An integrated approach should be encouraged, and both 
the national malaria control programme and other relevant public health programmes should 
contribute to strengthening the health-care delivery system, coordinated through the structure 
for coordinating laboratory services in the ministry of health. 
1.1 Terms of reference for the national coordination group  
 on malaria diagnosis
The role of the national programme is to coordinate the planning, implementation, monitoring 
and evaluation of malaria diagnostic services. This should ideally be done by a national diagnos-
tic committee, led by the national laboratory services. The programme should therefore establish 
such a committee and prepare its terms of reference.
The national diagnostic committee (or an already established group or committee could be 
used) should comprise the main groups involved in strengthening malaria laboratory diagnosis, 
including the national reference laboratory, relevant disease control programmes (e.g. national 
programmes for malaria, tuberculosis and HIV/AIDS), the relevant public health programmes 
(e.g. Integrated Management of Childhood Illness (IMCI), Integrated Management of Adolescent 
and Adult Illness (IMAI), integrated Community Case Management), local health authorities, 
academic and research institutions with expertise in malaria diagnosis, funding, procurement 
and implementing agencies involved in malaria diagnosis, and the national regulatory authority 
for assessing diagnostic devices. This committee should ensure the coordination of all malaria 
diagnostic activities, including both strengthening malaria microscopy and introducing and 
deploying RDTs.
Terms of reference for the national diagnostic committee should be prepared, for defining the 
roles and responsibilities of each stakeholder in: 
• reviewing and updating policies and guidelines;
• preparing and overseeing implementation plans; 
• coordinating the activities of multiple partners;
• regularly reviewing progress and monitoring activities; and
• resource mobilization, partner coordination and preparation of a budget. 
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1.2 Situation analysis and gap identification
One of the first steps is to conduct a situation analysis, focusing on the status of malaria diagnos-
tic testing and existing barriers to setting up a diagnosis programme and implementing activities. 
This step is useful not only for gathering information but also for promoting interactions and 
exchange of information among different stakeholders. The analysis should address the following:
Epidemiology and infrastructure
• malaria mapping and stratification: type of parasite species present in the country, level of 
endemicity by province or district, epidemic-prone zones, non-endemic areas and areas at risk 
for reintroduction of malaria;
• health system organization and mapping, including the number and level of laboratories in the 
public and private sectors;
• laboratory infrastructure, staffing and management;1
• number and type of reference laboratories (including research institutions);
• health facility infrastructure, staffing and management; 
• community health workers: organization of work, activities, referral and 
supervisory structures, resources and other support systems;
• common practices of use of diagnostic tests: recent data on diagnostic use in the public and 
private sectors and community level, if available; and
• access to care: cost, distance, availability, access, vulnerable groups, cultural and religious fac-
tors
Policies and regulations
• current policies, regulations and practices, with specific attention to blood-testing devices;
• malaria case definitions, clinical algorithms and treatment guidelines;
• laboratory quality management system status;
• medical equipment management practices and policies: equipment and equipment mainte-
nance, spare parts, maintenance tools; and
• health technology assessment practices and procedures
Training and supervision
• levels of training and career structure of clinical and laboratory staff; numbers of staff trained; 
training resources;
• quality of pre-service training curricula for health workers and community health workers;
• supervision of clinical and laboratory staff: ongoing activities and available resources; and 
• in-service training programmes for health workers and community health workers
Logistics and documentation
• supply chain management and logistics information system;
• safety and waste management; 
1 Malaria microscopy quality assurance manual, version 1. World Health Organization, Regional Office for the West-
ern Pacific, 2009. Table 3, page 21. Available at: 
 http://www.who.int/malaria/publications/malaria_microscopy_QA_manual.pdf
9• health management information system;
• malaria surveillance system, reporting and data management;
• health system communication and networking;
• health development partners and focus of activities; and
• available resources, including all health development partners, and resource mobilization plans.
Information collected during the situation analysis and the gaps that are identi-
fied should be compiled into a report that can be referred to when evaluating the 
outputs of the diagnosis strengthening programme.1 
• Identify gaps and constraints in all the above aspects of malaria diagnostic 
services and the need for strategic and policy changes and new regulations.
• Identify national targets and priorities, in particular regarding malaria diag-
nostic testing.
• Map resources and time requirements for addressing all priority gaps and bottlenecks in scal-
ing-up. If relevant activities such as malaria programme reviews have been completed recently, 
the information can be used to identify resource requirements. 
• Use all this information to prepare a plan of action (see section 2.4).
1.3 Roles and responsibilities
This section defines roles and responsibilities at different levels in a country (as defined in the 
glossary): central (national), subnational (provincial or district) and point-of-care (health facili-
ties or community). Issues relating to the private sector are discussed under the subnational level. 
The focal points for malaria diagnosis at each level should oversee both microscopy and RDT 
activities. They should work closely with the person in charge of managing the laboratory services 
and coordinate their activities with the people responsible for training clinicians in the manage-
ment of malaria and of fever in general. 
Table 1 gives general indications of areas of responsibility. These may vary in some countries. As 
part of the rapid assessment of roles and responsibilities in the situation analysis, it is important 
to identify those that are specific for the context of each country. 
1.3.1 Central level (national)
The activities described below are generally under the responsibility of departments or agencies 
at national level and should be coordinated through the national laboratory services. Depending 
on the health system of the country, however, some of these roles will be filled partially by entities 
at provincial or even district level. 
A focal person responsible for malaria diagnosis should be identified within the national malaria 
control programme, in close coordination with the national laboratory services. The roles and 
responsibilities of the focal person should be clearly defined. He or she should facilitate a fund-
ed national coordinating mechanism through the national committee on malaria diagnosis to 
promote integration of activities, including those conducted by the national malaria control 
programme, the national reference laboratory and key stakeholders, and to facilitate information-
sharing and overseeing of the activities of the different partners. 
1. progrAmme plAnning And mAnAgement
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1 Malaria programme reviews: a manual for reviewing the performance of malaria control and elimination pro-
grammes, trial edition, March 2010. Geneva, World Health Organization, 2010; Annex 5.6. Available at: 
 http://www.who.int/malaria/publications/atoz/whomprmalariaprogramperformancemanual.pdf
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Table 1. Areas of responsibility by level of the health system
Area of 
responsibility Central (national) Subnational
Point-of-care:  
health facilities
Point-of-care: 
community
planning Annual national operational 
plan of activities
regional plan of 
activities
plan for internal 
quality assurance and 
community health 
worker supervision
policy 
development and 
dissemination
Updating and harmonizing 
policies
product selection 
and procurement
selection of rdts, 
microscopes, stains 
and related supplies; 
quantification
Compilation 
of requests for 
supplies from local 
quantification
Quantification and 
requests for supplies 
Quantification and 
requests for supplies 
transport From central store to regional 
warehouses
From regional 
warehouse to health 
facility
From health facility  
to community  
health workers
storage and stock 
management
Central warehouse regional warehouse At health facility Appropriate storage 
place
maintenance medical equipment 
management policy and 
maintenance tools
medical equipment 
maintenance
medical equipment 
maintenance
Quality 
management 
system
national reference 
laboratory, training in quality 
management, monitoring 
of subnational reference 
laboratories, accreditation 
schemes for microscopists, 
proficiency testing and/or 
slide validation, request for  
lot-testing of rdts
regional reference 
laboratory, slide 
validation, visits to 
malaria testing sites, 
direct observation 
of microscopists 
and health workers 
performing rdts 
internal audits of 
laboratories
internal audits of rdt 
performance
training (pre- 
and in-service)
national standards, 
training curricula, training 
materials, planning, funding, 
coordination and facilitation 
of courses
Facilitation of training 
courses
selection of health 
workers, community 
health workers 
and other staff for 
microscopy and/or rdt 
training
testing performance of rdts 
and/or microscopy
performance of rdts
Advocacy, 
communication 
and social 
mobilization
strategy development, 
production of materials and 
messages adapted to local 
context
planning and 
implementation 
of community 
sensitization activities 
at district level 
sensitization 
of patients in 
health facility and 
dissemination of health 
education materials 
for use by community 
health workers
sensitization of 
patients and community 
members
supervision standard tools and reporting 
format, evaluation of 
supervisory system and 
overall performance
planning and 
implementation of 
on-site supervisory 
visits of health facility 
and community health 
workers and feed-back
supervision of 
community health 
workers (when 
relevant)
private sector licensing and monitoring of 
private health facilities and 
private laboratories, quality 
control of private suppliers 
inspection, supervision 
and training of private 
health facilities and 
laboratories, quality 
control of private 
suppliers
procurement, testing, 
storage of commodities 
and internal quality 
control
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Policy development 
The role of the national level is to devise malaria diagnostic policies that are integrated into 
national and treatment policy and regulations, as the basis for practical guidelines for health 
workers. The malaria diagnostic policy should be reviewed and updated regularly in the light of 
new developments and changing malaria endemicity, harmonized with other relevant, approved 
policies and regulations related to malaria control, integrated case management, community 
health care, laboratory services, private health care and disease surveillance systems. 
The review and elaboration of a malaria diagnosis and treatment policy will reveal issues requir-
ing harmonization and updating in different policy documents. It must therefore be conducted in 
an inclusive national coordinating mechanism. The role of the national or central level is there-
fore to ensure that policies and guidelines are up to date, available and followed. The full aspects 
of policy, regulation and technical guidelines are addressed in section 2.
Planning 
At national level, annual plans of action should be prepared, with clear objectives for activities 
based on policy direction and the national strategic plan, responsible partners, timelines, budg-
ets, staff resources, sources of funding and monitoring indicators. The national strategic plan for 
malaria control should include the components needed to achieve universal access to diagnostic 
testing. If the strategic plan already exists and does not include these components, a working 
group or task force should be identified to prepare this component.
Strengthening of malaria diagnostic capacity must be linked to the health sector development 
plan, especially regarding health infrastructure and distribution of laboratory services, human 
resources and systems for quality management of laboratories. The national plan of action will 
be strongly influenced by the availability of human, material and financial resources. A phased 
approach, depending on the priorities of the government and the availability of resources, is rec-
ommended. The phases should be defined and articulated; for example, first, all health facilities in 
priority districts; then, all health facilities in the remaining districts; then, the community level. 
Phased implementation will also allow expansion of activities on the basis of local experience and 
identified solutions. 
For elaboration of the national plan for strengthening malaria diagnosis, one or more workshops 
should be held. In some countries, the national malaria control programme has strengthened the 
involvement of various partners through technical working groups by including some of the fol-
lowing technical areas within the plan of action:
• regulatory requirements and diagnostic services;
• resource mobilization, partner coordination and budget;
1. progrAmme plAnning And mAnAgement
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Table 1. Continued
Area of 
responsibility Central (national) Subnational
Point-of-care:  
health facilities
Point-of-care: 
community
monitoring and 
evaluation
Choice of indicators, tools 
for data collection, data 
management, analysis 
and use for programme 
implementation 
data management, 
analysis, feed-back and 
use for remedial action 
at health facility level
data recording, 
feed-back and use 
for remedial action 
at community health 
worker level (when 
relevant)
data recording, action 
on feed-back
budgeting 
and resource 
mobilization
resource mobilization and 
preparation of full national 
budget to cover all activities
resource mobilization, 
compilation of regional 
or district budget 
requirements for all 
activities
Compilation of budget 
requirements for health 
facility activities
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• procurement and supply; 
• malaria diagnosis in the context of the management of fever;
• promotion of good diagnostic practices in the private sector;
• training, supervision and a quality management system;
• safe disposal of waste and sharps;
• advocacy, communication and social mobilization;
• monitoring and evaluation; and
• operational research for updating country-specific regulations, policies and practices, e.g. use 
of RDTs by medicine vendors, incentives or user fees and waste disposal at community level. 
However, local field studies to specifically assess the sensitivity and specificity of RDTs should 
be discouraged (see section 3.1.1).
Once these components have been elaborated in detail, a plan of action, timelines and budget 
requirements can be prepared. An example of an implementation plan with detailed activities is 
given in section 2.4.1.
1.3.2 Subnational level 
Depending on the country, the subnational level will correspond to provincial and district levels, 
or, in some countries, further administrative units. The role of the subnational level may be simi-
lar to that of the national level, except for policy updating and procurement, which, for the public 
sector, are generally centralized.
The specific role of the subnational level is to provide:
• regional reference laboratory services to laboratories and RDT testing sites in a designated 
area;
• supervision and external quality assessment of public and private health institutions and pro-
viders in the designated provinces or districts;
• training and remedial action in the designated provinces or districts;
• laboratory support services for outbreak investigation; and
• advocacy to the central level for budget support.
Although responsibilities vary from country to country, the subnational level should also provide:
• appropriate storage facilities for laboratory and RDT supplies and supply chain management;
• transport, handling and distribution of the supplies;
• cool chain distribution of temperature-sensitive products (RDTs);
• contingency response to stock-outs; 
• maintenance of laboratory equipment and replacement of spare parts; 
• a regional or district plan for safe disposal of waste and sharps;
• coordination with national-level staff to schedule training, such as workshops, for health workers;
• a locally appropriate advocacy, communication and social mobilization plan for community 
sensitization and education;
• data management for monitoring and evaluation for the designated province or district; and
• financial planning and management for the designated province or district.
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The subnational level should also ensure that private hospitals and clinics, faith-based organiza-
tions, nongovermental organizations and private medicine vendors:
• are trained according to national requirements and guidelines;
• adhere to national guidelines (in particular, treatment based on the malaria test result);
• procure and use approved equipment, reagents and RDTs according to national regulations;
• monitor that consumers have access to affordable, appropriate RDTs, ACT and medicines to 
treat non-malaria fevers;
• are regularly inspected by the appropriate health authorities;
• complete and submit data for malaria surveillance according to procedures recommended by 
the health authorities;
• participate in national external quality assessment programmes for malaria testing; and
• safely dispose of infectious waste and sharps.
1.3.3 Point-of-care level: health facilities
The role of health facilities is to:
• provide malaria microscopy and RDT diagnostic services; 
• provide supplies and support supervision and monitoring of lower-level facilities; and
• ensure disease surveillance and participate in outbreak investigations. 
In health facilities with a significant number of health workers but no functioning laboratory ser-
vice, it may be appropriate to nominate a focal point for RDTs (who could for example be also the 
focal point for other rapid diagnostic tests, such as for pregnancy, HIV and syphilis) to ensure good 
follow-up and continuous internal monitoring of staff performing RDTs or using RDT results.
The role of the point-of-care level is to: 
• ensure that malaria testing, patient management and follow-up adhere to national guidelines 
(in particular that results are used to guide patient treatment); 
• ensure that malaria test results and treatment are recorded in patient registers and reported to 
a higher level as part of an appropriate surveillance system;
• keep laboratory supplies in appropriate storage conditions with temperature monitoring 
(where possible) and recording;
• maintain all medical equipment according to national guidelines;
• quantify the supply needs for the health facility to cover a specified period (including safety 
stock requirements) and for community health workers served by the health facility; 
• if microscopy is done, keep a predetermined number of blood slides for quality management 
(validation of routine slide results);
• ensure self-monitoring of laboratory and clinical performance through internal audits;
• ensure that clinicians and laboratory personnel are encouraged to work as a team, with mutual 
benefit for the patient and professional respect;
• ensure adherence to biosafety guidelines and proper disposal of sharps and waste; and
• ensure that locally appropriate health education messages on the need for and benefits of a 
malaria test before treatment are widely disseminated to community members. 
1. progrAmme plAnning And mAnAgement
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In countries where community case management is available, health facility personnel have the 
following additional tasks:
• train, regularly supervise and oversee the work of community health workers;
• provide them with the required RDT kits and medicines; and
• collect from community health workers the data required for the health information manage-
ment system.
1.3.4 Point of care level: community
Community health workers are an integral part of the health system and provide a link between 
the community and the formal health system; they liaise regularly with health workers in the 
formal health system. Community health workers are especially important in providing care to 
vulnerable groups in remote areas with little access to health facilities. 
In some countries, these workers do not provide patient care and mainly undertake preventive 
activities (health education, distribution of insecticide-treated nets). In countries where they do 
provide patient care, they should:
• refill their RDT and medicine kit orders at appropriate times, to avoid under- and over-stock-
ing;
• receive appropriate stocks in a timely manner and be provided with storage conditions for 
RDTs to avoid exposure to high temperatures;
• perform the tests correctly according to the guidelines;
• refer patients elsewhere when appropriate;
• provide appropriate treatment for malaria and non-malaria cases on the basis of test results 
and guidelines;
• advise patients on adherence to treatment and when to return if still sick;
• record test results and treatment appropriately, and submit the information as part of the 
health information management system;
• follow-up patients after treatment; and
• deliver health education message to the community about prevention, early treatment-seeking 
and the need for a malaria test before taking treatment.
Community leaders and other key people should:
• educate communities about the benefits of testing for malaria before treatment;
• encourage community members to seek early diagnosis and effective treatment without delay 
when they have fever or suspected malaria; and
• ensure that community members are aware of where they can get a malaria diagnostic test and 
receive treatment.
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1Key meSSAgeS of SeCTIoN 1
n each level of the health system has a role in implementing and maintaining the national 
treatment guidelines on fever case management and malaria diagnostic testing, although the 
levels of responsibility will differ.
n A national malaria coordination group on malaria diagnosis should be established that 
includes representatives of the national laboratory services and relevant technical pro-
grammes.
n policies and strategies should be revised on the basis of all available information, includ-
ing the results of a situation analysis.
n technical working groups might be required to address specific tasks, such as policy and 
regulatory review, technical guidelines, supply management, partner coordination and resource 
mobilization.
n monitoring and evaluation and regular feedback are essential components of implementa-
tion and improvement of the programme at all levels.
1. progrAmme plAnning And mAnAgement
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2. policies and technical  
 guidelines
2.1 Update relevant national policies
Several national policies should be updated in order to implement a strategy for universal access 
to malaria diagnosis. The national malaria control programme should either amend the policies 
or ensure that the malaria diagnostic guidelines are included in each relevant policy. The follow-
ing national documents should be reviewed and updated:
• the national malaria strategic plan (often prepared on a 5-year basis);
• the national malaria control policy;
• the national clinical laboratory policy and guidelines;
• the national malaria treatment guidelines; 
• the national laboratory quality management guidelines;
• the national malaria monitoring and evaluation framework and guidelines; and
• other guidelines and regulations, including Integrated Management of Childhood Illness 
(IMCI), Integrated Management of Adolescent and Adult Illness (IMAI), integrated commu-
nity case management, use of blood testing in the private sector, safety and waste management, 
antenatal care guidelines and surveillance guidelines.
The national diagnostic committee should address the following main areas of policy for malaria 
diagnosis:
• national policies and guidelines and the national strategic plan to include universal access to 
malaria diagnostic testing;
• regulations on medical devices, blood safety and waste management;
• quality management requirements at multiple levels (including medical equipment management);
• procurement procedures and regulations;
• human resources strengthening (job descriptions, qualifications at various levels, in-service 
training);
• supervisory support (qualifications, structured checklists and incentives);
• private sector licences (laboratory requirements, reporting, informal sector legislation); and
• the cost of laboratory services to the client. In order to ensure universal access to malaria 
diagnostic testing, services should be provided free of charge, especially in countries where 
antimalarial medicines are provided at no cost to the patient.
National malaria diagnostic and treatment guidelines give standards and norms for use of malar-
ia diagnostic testing and treatment, taking into account the following malaria-specific factors:
• malaria endemicity, epidemic-prone zones and malaria-free areas;
• clear definition of suspected malaria on the basis of signs and symptoms relevant to the 
national context;
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• clear criteria for selecting patients for malaria testing (see sections 2.3.3 and 2.3.4);
• clear criteria for treating patients selected for malaria testing (see sections 2.3.3 and 2.3.4);
• type of health facility in which malaria diagnostic tests (microscopy and RDTs) and supple-
mentary tests are deployed (see section 2.3.5);
• selection of type of microscope, laboratory reagents and related equipment (see section3.1);
• selection of type of RDT (see section 3.1);
• selection of supplementary tests for investigating fever and severe malaria;
• positions of staff and workers who are qualified and allowed to perform each type of test;
• degree of involvement of the not-for-profit private sector (faith-based organizations, nongover-
mental organizations);
• degree of involvement of the formal private sector; and
• degree of involvement (or not) of the informal for-profit private sector.
2.2 Address regulatory issues
2.2.1 Regulation of RDTs
RDTs are blood diagnostic devices and must therefore comply with blood safety procedures (i.e. 
samples must be treated as a potential biohazard); furthermore, they generate blood-contaminated 
waste that must be disposed of and destroyed in the same way as other laboratory infectious waste. 
The national regulations related to blood tests should be reviewed, as they may have major implica-
tions for the deployment of RDTs at points of care and their use by community health workers. 
The use of RDTs in the private sector should be allowed, provided the health worker has been 
trained and performs the test him- or herself. Regarding the sale of RDTs to consumers in the 
private sector (e.g in pharmacies), there is evidence that untrained consumers (e.g. international 
travellers) do not perform the test correctly. The sale of RDTs should therefore be allowed only 
if the provider asks the consumer to demonstrate (after oral and written instructions) his or her 
ability to perform a test and correctly interpret the result.
In countries where diagnostic devices are formally registered, all RDT products used should 
be registered, as a requirement of procurement. Registration of the products may take several 
months, and this should be taken into account in selecting, procuring and planning for the intro-
duction of RDTs. In most procurement processes funded by external funding agencies, national 
registration is a specific requirement, in addition to other requirements such as diagnostic perfor-
mance and quality certification of manufacturing facilities.
2.2.2 Regulation of personnel
National regulations and procedures established by national laboratory services also define the 
minimum requirements for personnel to be eligible or authorized to perform a RDT or micros-
copy, with attention to competence and blood-handling requirements. Specific topics should be 
addressed in such regulations.
For RDTs:
• appropriate level of literacy of users;
• physical (vision) and mental ability;
• minimum training in which patients should be tested, how to perform the test, how to act on 
the result of the test, how to record and report the result and how to dispose of waste safely;
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• motivation and incentives; and
• regularity of supervision, with on-site check of competence.
The regulation should also cover shifting of tasks, by training other personnel to use RDTs when 
there is an inadequate number of health workers, to increase access to parasitological diagnostic 
tests. 
For microscopy: 
• personnel authorized to be trained for microscopy;
• physical (vision) and mental ability;
• minimum training in which patients should be tested, how to perform the test, how to record 
and report the result and how to dispose of waste safely;
• initial accreditation;
• regularity of supervision, with on-site check of competence; and
• incentives and career structure. 
2.2.3 Safety and waste management
Malaria diagnostic tests generate both infectious waste (blood-contaminated sharps and non-
sharps) and general waste. Blood-contaminated sharps include lancets and needles, which should 
be disposed of in sharps boxes. Blood transfer devices for RDTs (loops, straw pipettes, inverted 
cups and calibrated pipettes) are infectious waste but are non-sharps (except glass capillary tubes) 
and should therefore be disposed of separately from sharps, together with used gloves, used cas-
settes, cotton wool and alcohol swabs. The introduction of RDTs will increase the volume of non-
sharps infectious waste substantially: these materials should be handled and destroyed according 
to national guidelines.
2.2.4 Registration of laboratories 
All laboratories in public and private health facilities should be registered or licensed by the 
appropriate regulatory body in the country for malaria testing by microscopy or RDTs. This will 
ensure that the laboratories comply with the basic mandatory requirements for malaria testing. In 
addition to initial licensing, many quality management systems include a requirement for further 
periodic accreditation, although this is not yet done in most highly endemic countries. Addition-
al mechanisms, such as certification (to national norms or international standards such as ISO 
9001) or accreditation (to national standards or international standards such as ISO 15189), may 
be used, usually on a voluntary basis, under the appropriate authority (certification or accredita-
tion body).
2.3 Prepare national guidelines 
2.3.1 Guidelines for managing fever episodes
The incidence of malaria is decreasing in many countries as a result of widescale, effective control 
interventions. In these countries, most fever episodes seen at health facility or community level 
are therefore no longer due to malaria. The commonest cause of fever in malaria-negative chil-
dren is a viral infection. The causes vary from one setting, year or season to another and by age 
group; however, except in epidemic periods, viral causes (especially of respiratory origin) almost 
always predominate. Therefore, only a minority of patients who test negative for malaria need 
antibiotic treatment.
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There is evidence that, when programmes are not managing non-malaria febrile illnesses prop-
erly and only malaria diagnostic tests and treatment are used in the management of fever, health 
workers still tend to treat patients with a negative test result with antimalarial medicines, thereby 
undermining the effectiveness of the malaria diagnosis programme (Figure 1). This is especially 
true in settings where RDTs have been introduced to replace poor-quality microscopy.
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CommoN CAUSeS of ACUTe feveR IN oUTPATIeNT ChIlDReN UNDeR 5 yeARS of Age 
(in approximate descending order of frequency)a
n Upper respiratory tract infections, including otitis media and tonsillitis (viral origin)
n other viral diseases (influenza, human herpesvirus 6, parvovirus b19,  
 epstein-barr virus, cytomegalovirus)
n pneumonia
n malaria
n gastroenteritis
n Urinary tract infection 
n typhoid fever 
n skin infection (abscess, cellulitis)
n sepsis due to bacteraemia
n meningitis
a From the ‘study to investigate the causes of fever in children living in urban dar es salaam and rural ifakara’, dar es salaam 
City Council, ifakara health institute, United republic of tanzania and the swiss tropical and public health institute (2011).
FigUre 1. 
Dilemma of health workers facing a negative malaria test result in a febrile patient
red indicates not recommended actions/behaviours. 
a treatment for cause other than malaria; explanation of result of malaria test and final diagnosis; counselling on when to 
return to health facility.
response by 
heAlth worker
ACtion by 
heAlth worker
pAtient
reACtion
malaria test 
negative
don’t trust result ACt
trust result give ACt anyway
(to keep patient happy)
dissatisfied,
gets anti-malarial 
from somewhere else
tell patient to 
go away…
satisfied but 
still sick
give appropriate 
managementa
satisfied and well
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The minimum diagnostic and treatment requirements for the management of a febrile patient 
should be defined and included in the guidelines and training material. Depending on the dis-
eases prevalent in the area, the availability of appropriate diagnostic tests and medicines should 
be ensured in parallel with malaria diagnostic tests and medicines.
Four WHO guidelines address the management of malaria and non-malaria fevers: one for dis-
trict hospitals (the pocket book of Hospital care for children), one for children under 5 years of age 
[Integrated Management of Childhood Illness (IMCI)], one for adults [Integrated Management of 
Adolescent and Adult Illness (IMAI)] at primary care level and one for community health work-
ers (integrated Community Case Management).
• In the pocket book of Hospital care for children,1 a child referred to the hospital 
with a history of fever for less than 1 week should be tested for malaria as well 
as for urinary tract infection. If the child has cough and fast breathing, he or 
she should be considered as having pneumonia (a chest X-ray is not recom-
mended for the initial diagnosis). The presence of other specific symptoms and 
signs should prompt additional investigations (e.g. lumbar puncture in case of 
neck stiffness or bulging fontanel).
FigUre 2. 
Updated part of the algorithm of the Integrated management of Childhood Illness (ImCI) 
dealing with fever
source: Integrated Management of Childhood Illness, who department of Child and Adolescent health and development, 2010.
1 Pocket book of hospital care for children: Guidelines for the management of common illnesses with limited resources. 
Geneva, World Health Organization, 2005. Available at: 
 http://whqlibdoc.who.int/publications/2005/9241546700.pdf
21
• The updated algorithm for the Integrated Management of Childhood Ill-
ness (IMCI)1 includes the use of malaria diagnostic tests to assess a child 
who presents with fever (Figure 2). In highly endemic areas, all febrile 
children should be tested; in low-endemic areas, only children with no 
obvious cause of fever should be tested for malaria. Only febrile children 
with a positive malaria test or with danger signs of severe illness should receive antimalarial 
treatment. Regardless of the result of the diagnostic test for malaria, the patient should always 
be fully assessed for other conditions.
• In the Integrated Management of Adolescent and Adult Illness (IMAI),2 a 
malaria test should be performed for all patients in a malaria-endemic area 
who complain of fever for less than 7 days. At present, the algorithm does not 
specify whether the different levels of malaria endemicity or the presence of 
an obvious cause of fever should influence the decision to test febrile adults for 
malaria.
• The new WHO/UNICEF strategy for integrated community case manage-
ment3 recommends that community health workers perform a malaria RDT 
for all patients with a history of fever of less than 7 days. In parallel, children 
should be assessed for acute respiratory infection and diarrhoea (Figure 3).
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1 Integrated Management of Childhood Illness for high HIV settings: chart booklet. Geneva, World Health Organiza-
tion/UNICEF, 2008. Available at: 
 http://whqlibdoc.who.int/publications/2008/9789241597289_eng.pdf 
2 Integrated Management of Adolescent and adult Illness: interim guidelines for first-level facility health workers at 
health centre and district outpatient clinic: acute care. Geneva, World Health Organization, 2009. Available at: 
http://www.who.int/hiv/pub/imai/acute_care.pdf
3 Integrated Management of Childhood Illness: Caring for Newborns and Children in the Community. Manual for the 
Community Health Worker. Geneva, World Health Organization, Unicef 2010. In press.
FigUre 3. 
Summary chart of the Who/UNICef strategy for integrated management of childhood illness at 
health facility level
Adapted from Integrated management of childhood illness: caring for the sick child at health facility level, who/UniCeF, 2010
ACt AntibioticsorsAntibioticsno drugsAntibioticsno drug
      ‘watery’  Acute otitis 
 malaria  pneumonia Cold dysentery diarrhoea media
 malaria Fast blood 
 test breathing in stools
 Fever < 7 days Cough diarrhoea earache
nopositive negAtive yes noyes
danger signs Antimalarials and antibiotics refer
yes
no
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2.3.2 RDTs and microscopy
As a general principle, microscopy and RDTs are both adequate for diagnosing malaria in febrile 
patients,1,2 and both are needed in most countries. In situations and settings where both tests can 
be used, countries must decide which test to use where. The decision should be based on the advan-
tages and disadvantages of each test in each location on the basis of its technical characteristics.
Several factors should be considered in choosing whether RDTs or microscopy should be used 
for diagnosis in certain settings and clinical situations, including the existence of a laboratory, 
workload, malaria prevalence, the skill of personnel performing the test and the availability and 
Table 2. Technical strengths and constraints of RDTs and microscopy to be taken into account in selecting  
 the best options for different clinical situations and settings
Criterion Characteristic of diagnostic test Target cases and clinical setting
Recommended diagnostic test
RDT microscopy
Parasite 
density
RDTs give only a positive or a 
negative result,
while
microscopy can also show parasite 
density.
Uncomplicated malaria cases yes yes
severe cases upon admission not alonea yes
Follow-up of admitted patientsb no yes
Antigen 
persistence
RDTs detect persisting antigens 
after parasite clearance,c
while
microscopy gives negative result as 
soon as the parasite is cleared from 
the patient’s blood.
Confirmed malaria cases with persisting 
fever despite antimalarial treatment no yes
Cases of persisting fever  not previously 
tested for malaria yes yes
Cases of persisting fever in people who 
did not receive antimalarial treatment yes yes
electricity 
supply 
RDTs do not require electricity,
while
microscopy requires a reliable 
electricity supply.
health centres and hospitals yes yes
health workers in the community and at 
health posts yes no
Time for test 
completion
RDTs can be performed 
comparatively quickly,
while
microscopy requires more time. 
settings with low work load per health 
worker, e.g. small health facilities and 
facilities in areas of low endemicity
yes yes
settings with high work load per health 
worker, e.g. outpatient departments of 
hospitals or health centres in areas of 
high endemicity
yes not alonea
Competence 
and training 
requirements
RDTs are comparatively easy to 
perform,
while
microscopy is more complex and 
requires the competence of a 
trained microscopist.d
health workers with limited training in 
laboratory skills or settings with limited 
resources for supervisiond
yes no
settings where specific training in 
malaria microscopy is possible and a 
laboratory quality management system is 
functioninge
yes yes
a  this diagnostic test can be used, but not exclusively (the other test is necessary).
b parasite density required to monitor response to treatment.
c rdts to detect pldh may remain positive up to 5–6 days after disappearance of the parasite, while those to detect hrp2 remain positive up 
to 2–3 weeks after disappearance of the parasite.
d both diagnostic techniques require minimum specific training.
e both diagnostic techniques require regular supervision support.
1 Ochola L.B et al. The reliability of diagnostic techniques in the diagnosis and management of malaria in the absence 
of a gold standard. The Lancet Infectious Diseases, 2006, 6:582–588. 
2 WHO technical consultation: Parasitological confirmation of malaria diagnosis, 6–8 October 2009. Geneva, World 
Health Organization, 2009. Available at: 
 http://whqlibdoc.who.int/publications/2010/9789241599412_eng.pdf
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strength of quality management and supervisory activities. When choosing between microscopy 
and RDT, each technical strength and constraint should be taken into consideration in select-
ing the best options for different clinical situations. The list of general considerations in Table 2 
should be taken into account in deciding on the optimal use of RDT and microscopy at different 
levels of the health-care system. 
For example, the microscopy services currently used in health services with a high case load 
per laboratory technician should be reserved for the investigation of treatment failures and 
for the diagnosis and monitoring of patients admitted for severe malaria (see below). This will 
enable each microscopist to perform the correct number of slide examinations per day and 
implementation of a correct quality management system for monitoring laboratory perfor-
mance in malaria diagnosis.
2.3.3 RDTs and microscopy in clinical management of patients
The considerations below take into account the fact that RDTs, unlike microscopy, detect anti-
gens rather than parasites, which is an advantage for detecting malaria in patients with low para-
site densities fluctuating around the level of detection of microscopy (real positive cases), but is a 
disadvantage when patients have cleared all their parasites after effective antimalarial treatment 
and have only remaining antigens (false-positive cases). The duration of persistence of antigens 
after effective treatment depends on the type of antigens detected by the RDT (HRP2 persists 
longer than pLDH and aldolase) and also varies from one patient to another. For practical pur-
poses, patients who reattend a health facility for febrile illness 2 weeks or more after complet-
ing full antimalarial treatment are considered to have a new malaria infection and are managed 
accordingly.1 In most people, persisting antigens are cleared after 2 weeks, and reinfection after a 
malaria episode treated with most antimalarial medicines is plausible after 2 weeks.
Uncomplicated febrile illness 
Who should be tested for malaria?
• In highly endemic areas, all patients presenting with a history of fever or elevated temperature 
should be tested for malaria. In addition, patients under 5 years of age with palmar pallor or 
anyone with a haemoglobin level < 8 g/dl should also be tested for malaria.
• In low-prevalence areas, it is reasonable to limit testing for malaria to febrile patients with no 
obvious cause of illness, as is already done in several countries (e.g. India, the highlands of 
Madagascar and Senegal). The clinical criteria used to restrict testing might be different from 
one country to another and might vary according to the phase of malaria elimination. The 
prevalence threshold (malaria test positivity rate among febrile patients presenting at health 
facilities or parasite prevalence in the general population) at which testing should be restricted 
depends on local circumstances.
• If malaria testing is performed before the patient is seen by a clinician, the health workers 
performing the test should be trained to select patients on the basis of the recommended 
criteria (case definition of a suspected malaria case) in the area or country. This practice is used 
in some settings to improve the efficiency of patient flow in health facilities with high patient 
loads.
• A patient presenting with fever in a highly endemic area may have both malaria and another 
cause of fever. All patients, irrespective of the results of malaria testing, should be fully assessed 
for other potential causes of fever.
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1 Guidelines for the treatment of malaria, second edition. Geneva, World Health Organization, 2010. 
 http://whqlibdoc.who.int/publications/2010/9789241547925_eng.pdf
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CoNSIDeRATIoNS foR DefININg AReAS of hIgh AND loW mAlARIA RISK
in the integrated management of Childhood illness (imCi), the threshold for areas of high 
malaria risk is a positivity rate of malaria tests of 5% among febrile children presenting in 
health facilities. As surveillance of malaria cases is particularly important when the prevalence 
drops, the threshold chosen by some countries is a positivity rate of 1%, i.e. when 1 per 100 
patients or fewer presenting to a health facility with a history of fever is positive by either rdt 
or microscopy. each country might choose a different threshold, depending on the acceptable 
risk of missing a malaria case and on the level of investment in malaria testing they are ready 
to make.
once a threshold is chosen, it implies that some parts of the country or some periods of the 
year (during or between malaria transmission seasons) might have to use a different diagnostic 
algorithm. the feasibility of using different algorithms in different parts of the country or 
different seasons should be carefully considered.
Which malaria test should be used?
• For the management of a new fever episode, quality-assured microscopy and RDTs are equiva-
lent in terms of performance for the diagnosis of uncomplicated malaria.1,2
Who should be treated for malaria?
• In uncomplicated cases, only patients with a positive diagnostic test for malaria should receive 
antimalarial treatment. In addition, the patient should be assessed for other causes of fever, and 
specific treatment should be provided in addition to the antimalarial treatment, if needed.
• In uncomplicated cases, when the diagnostic test for malaria is negative, an antimalarial medi-
cine should not be given. The patient should be assessed for other causes of fever, and specific 
treatment should be given only for those conditions identified. For example, upper respiratory 
tract infections do not require antibiotic treatment and are treated symptomatically. 
• If both an RDT and microscopy are performed in parallel to assess a new episode of fever and 
one of the two tests (or both) is positive, the patient should be considered as having malaria.
• If a combination RDT3 is used, the patient should be treated for P. falciparum malaria in two 
situations: if both test bands appear or if the P. falciparum band appears but not the pan band: 
   positive for P. falciparum and pan-plasmodium positive for P. falciparum 
 (P. falciparum or mixed infection) (P. falciparum infection)
 In both situations, the patient should be treated with an antimalarial medicine active on 
P. falciparum, even if he or she has taken an antimalarial treatment recently. As RDTs are 
1 Ochola L.B et al. The reliability of diagnostic techniques in the diagnosis and management of malaria in the absence 
of a gold standard. The Lancet Infectious Diseases, 2006, 6:582–588. 
2 WHO technical consultation: Parasitological confirmation of malaria diagnosis, 6–8 October 2009. Geneva, World 
Health Organization, 2009. Available at: 
 http://whqlibdoc.who.int/publications/2010/9789241599412_eng.pdf
3 A combination RDT is one with three or more test bands. In most of these tests, one band detects HRP2 specific to 
P. falciparum, one band detects pLDH common to all species and one band is a control.
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slightly more sensitive in detecting HRP2 than p-LDH or aldolate, the result of the test 
shown above on the right side could be due to a real infection that requires treatment. The sole 
appearance of the P. falciparum test line does not mean that the test is detecting only persisting 
antigens.
Who should be referred?
• Any patient with danger signs of severe disease should be referred to an inpatient facility. 
• Patients returning for a follow-up visit in which treatment failure is suspected should be 
referred to a facility where microscopy is performed, if it is not available on site. When referral 
is not feasible and other causes of fever have been ruled out, second-line antimalarial treatment 
should be given.
follow-up of febrile illness
Who should be tested for malaria
• If febrile patients return for a follow-up visit more than 2 weeks after full antimalarial treat-
ment, they should be considered as having a new episode of fever and be tested by RDT or 
microscopy, beside being assessed for other causes of fever.
• Treatment failure might be suspected when the patient has an initial positive malaria test, took 
full, effective antimalarial treatment and has persisting fever in the following 2 weeks.
Which malaria test should be used?
• In cases of suspected treatment failure, microscopy is the preferred test; RDTs are not rec-
ommended because the parasite antigen persists after parasitaemia has cleared (see comment 
above).
• Patients who initially test negative for malaria and have no other identified source of illness 
should be advised to return for repeated testing (by either RDT or microscopy) in 2 days if the 
fever persists or sooner if the symptoms worsen.
Who should be treated for malaria?
• Patients who initially test positive for malaria and still have a positive blood slide for malaria at 
follow-up should receive second-line antimalarial treatment. 
• Patients who initially test positive for malaria and have a negative blood slide for malaria at fol-
low-up should not be given an antimalarial medicine. The patient should be assessed for other 
causes of fever, and specific treatment should be provided for the identified conditions. For 
example, upper respiratory tract infections require symptomatic treatment (to relieve cough 
and soothe the throat) but not antibiotics. 
• Patients with danger signs should be assessed as for a first visit
Who should be referred?
• If the patient is still febrile after 7 days or if the symptoms worsen, he or she should be referred 
for specific assessment. 
Severe febrile illness 
Who should be tested for malaria?
• For patients with danger signs seen at peripheral level where no inpatient facility is available 
(including at community level), priority should be given to immediate administration of pre-
referral treatment rather than losing time by testing the patient for malaria.
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Which test should be used in which clinical situation?
• In severe cases, microscopy is necessary because parasite density must be assessed for monitor-
ing treatment response. If the patient is in hospital, the use of an RDT is helpful to guide initial 
emergency treatment and to document malaria in patients who have received pre-referral anti-
malarial treatment (and might thus have already cleared their parasites). 
• For inpatients with fever, when both microscopy and RDT are negative, the diagnosis of malar-
ia has been excluded and no antimalarial treatment is needed.
Who should be treated for malaria?
• In hospitalized patients with danger signs, antimalarial treatment should be started as soon as 
one malaria test is positive. 
• The treatment should include an antibiotic both in malaria-positive and malaria-negative 
patients, especially children. There is indeed considerable clinical overlap between bacteremia, 
pneumonia and severe malaria, and these conditions may coexist. It is moreover very difficult 
to document bacterial infections in a severely ill patient, especially when blood cultures are 
not available. Even when malaria has been documented, antibiotics should be stopped only if 
blood cultures are negative and other bacterial infections, such as severe pneumonia, have been 
ruled out. 
• In patients with danger signs who must be referred to a higher-level facility, pre-referral treat-
ment should be provided immediately, before any testing is performed. This treatment should 
include an antimalarial medicine and an antibiotic, according to national guidelines.
2.3.4 Algorithms for malaria diagnosis and treatment in febrile patients
The generic clinical algorithms discussed below refer to the management of febrile patients dur-
ing first (Figure 4) and follow-up visits (Figure 5), with regard to malaria diagnosis and treatment 
in areas of high and low malaria risk. These generic algorithms should be adapted to the situa-
tion in each country on the basis of national guidelines for the management of malaria and other 
febrile illnesses. 
2.3.5 Appropriate levels for different diagnostic methods 
microscopy
Microscopy may be introduced or strengthened in all public and private health facilities (see 
Table 3) that have a laboratory which participates in a quality management system for malaria 
microscopy, which should include the following:
• provision of good-quality equipment and supplies (conforming to minimum standards), espe-
cially microscopes, slides and stains;
• access to equipment repair services;
• provision of an alternative power source in areas with no mains electricity or where the power 
supply is unreliable;
• well-organized laboratory with waste disposal facilities;
• microscopists trained and accredited in line with national standards; 
• certification of laboratories in line with national and international standards or at least efforts 
in that direction;
• participation of laboratories in an external quality assessment programme;
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• regular supervision by on-site visits; and
• an effective documentation system.
Before considering expansion of microscopy to new health facilities, a well-functioning quality 
management system should be established in order to strengthen the quality of existing micros-
copy services.
Rapid diagnostic tests
RDTs can be used in all the settings mentioned in Table 3. When using RDTs, the quality man-
agement system should include at least:
• selection of a product that fulfils international standards of diagnostic performance;
• testing of all RDT lots procured;
• recommended transport and storage conditions;
• training of health workers in RDT use and management of febrile illnesses according to 
national guidelines;
• regular supervision by on-site visits; and
• an effective reporting and surveillance system for diagnosis and treatment.
In addition, it is essential that a well functioning supply management system for RDT distribu-
tion is in place.
2.3.6 Appropriate diagnostic tests for different levels of the health-care system 
A few additional points should be taken into account, depending on the level of the health system 
considered.
Community level
Community health workers should be trained for and equipped with RDTs (if the policy permits 
use at this level) and fully supported to confirm malaria before treating patients. Treatment based 
on clinical assessment alone should be considered only when RDTs are not available. 
Use of RDTs should be integrated into a clinical algorithm for the management of common caus-
es of fever, such as integrated Community Case Management. In children, this should include at 
least acute respiratory infection and diarrhoea (see Figure 3).
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Table 3. Appropriate levels of the health system for the use of microscopy and RDTs
level of the health system microscopy RDTs
tertiary health facilities ✓ ✓ a
health facilities with a laboratory service ✓ ✓ a,b
health facilities without a laboratory service ✓
Community level (supervised community health workers) ✓
Formal private sector health facilities ✓ ✓ c
outbreak investigations and follow-up of the progress of an epidemic response ✓ d ✓
population surveys ✓ d ✓
a especially in facilities with high outpatient load
b particularly after working hours of the laboratory
c in a few countries, rdts have also been deployed in the informal private sector 
d microscopy slides are taken in the field for later examination in the laboratory by qualified technicians
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The criteria used by community health workers to select patients for malaria testing should be 
based on those used by health facilities but adapted to the skills of the community health workers 
(see Figure 4).
Primary care level (with no inpatient facility)
At the first visit of patients presenting without danger signs, a qualitative malaria test result (posi-
tive or negative) is enough to decide on treatment. Either RDTs or microscopy can be used.
If the work load of the microscopists is too high and is likely to compromise the quality of the 
results, RDTs are preferable, as long as training, supervision, quality management and full sup-
port are ensured. If available, microscopy should be reserved for investigating treatment failures, 
to distinguish between treatment failure and another cause of febrile illness.
Secondary and tertiary care level (with inpatient facility)
At this level, microscopy is essential for the management of hospitalized patients with suspected 
severe malaria. For inpatients, microscopy is needed to confirm a diagnosis of malaria, for initial 
quantification of parasite density and for follow-up of parasite density until full parasite clear-
ance. Microscopy is also needed for investigating treatment failure in outpatients, especially to 
assess patients referred from health-care facilities that do not have microscopy. 
RDTs are an option for ensuring malaria testing in outpatient departments with a high malaria 
case load. Depending on the workflow and patient load, RDTs may be preferred to microscopy. In 
these settings, support staff might be trained to use RDTs, to avoid tying up busy health workers. 
RDTs are also needed for diagnostic testing for malaria when a laboratory is closed or microscopy 
is not available (after working hours).
formal private sector 
In countries in which a high percentage of patients are seen in private-sector facilities that lack 
good-quality diagnostic services, the widespread practice of treating malaria on the basis of clini-
cal assessment alone jeopardizes the potential benefit of widescale parasitological diagnosis in the 
public sector. The same standards as those set for the public sector should apply to the formal pri-
vate sector in clinics at primary, secondary and tertiary levels, with a proper quality management 
system. Therefore, malaria diagnosis with RDTs and microscopy should be promoted in the formal 
private sector, especially in the context of initiatives for improving access to antimalarial medicines. 
Informal private sector 
Several experiences of use of RDTs in the informal private sector have been conducted, for exam-
ple in Brazil and Cambodia. Operational research is also ongoing in several African countries. 
The informal private sector should be targeted for the strengthening of malaria diagnostic testing 
in a phased approach, after widescale deployment in the public and formal private sectors.
2.4 Prepare an implementation plan
This section defines the components of an implementation plan for achieving universal access to 
diagnostic testing of malaria, after a national diagnostic committee has been established, gaps 
and challenges have been identified on the basis of a situation analysis and policy and technical 
guidelines have been formulated. The operational plan is derived from the plan of action prepared 
earlier, which served for budget approval. This plan gives additional, detailed operational infor-
mation and further elaborates several of the components described in the plan of action. 
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2.4.1 Components of the implementation plan
The implementation plan should include at least the following steps, if not already in place (the 
below activities are described in the corresponding sections of the manual):
Deployment strategy and human resources
• identification of geographical areas and levels of care for phased implementation; 
• criteria for setting priorities on use or strengthening of RDTs and microscopy;
• identification of staff in the national malaria control programme or national reference labora-
tory responsible for programme coordination;
• staffing of health facilities to perform RDTs and microscopy, in line with phased implementation; 
• identification of human resources for training trainers and training of health workers;
• identification of human resources for supervising RDT users outside laboratories; and
• identification of human resources for supervising laboratories, including malaria microsco-
pists and RDT performers.
Procurement of malaria tests and related equipment
• defininition of technical specifications for RDTs, microscopes and related equipment;
• selection of appropriate RDTs, microscopes, Giemsa stain and reagents;
• quantification and forecasting of RDT and microscopy needs;
• quantification and forecasting of commodities for diagnosis and treatment of non-malaria fevers;
• invitations to tender and review of tenders;
• pre-shipment lot-testing for RDTs; and
• transport, port clearance and receipt.
Distribution, storage and maintenance
• definition of national standards for storage of RDTs and maintenance of microscopes;
• definition of standards for storage requirements at central and subnational levels;
• plan for distribution of commodities requiring a cool chain (RDTs, tests and medicines for 
non-malaria fevers);
• plan for distribution of microscopes and related equipment;
• equipment installation and validation;
• guidance for stock management procedures; and
• maintenance of microscopes and related equipment.
Quality management system
• definition of national standards for performance at testing sites and competence of test per-
formers;
• elaboration of standard operating procedures for:
— RDT and blood slide performance,
— RDT transport and storage,
— external quality assessment (slide proficiency testing), 
— validation of routine blood slide results (cross-checking),
2
2. poliCies And teChniCAl gUidelines
32 universal access to malaria diagnostic testing: an operational manual
— laboratory supervisory visits (including checklists) and
— health facility supervisory visits (including checklists);
• strengthening reference laboratory services; 
• training focal people for quality management at subnational levels;
• internal audits;
• supervisory visits to laboratories;
• feedback to laboratories and corrective actions; and
• quality monitoring.
Training
• defining competences and curricula for pre-service and in-service training of laboratory staff 
in microscopy and RDTs; 
• defining criteria for training of other personnel in performing RDTs;
• preparing or updating training manuals for laboratory staff and clinicians (tutor and learner 
guides for microscopy and for RDT);
• updating training manuals for community health workers to include the use of malaria RDTs 
and the management of pneumonia and diarrhoea (integrated community case management);
• training of tutors (master trainers);
• training of laboratory staff for microscopy and RDTs; 
• training of other staff in RDT use, e.g. clinicians, support staff;
• training of clinicians in integrated management of fevers, including use of RDTs in clinical 
management;
• training of community health workers in integrated management of fevers; and
• training of supervisors at all levels in quality management and supervisory techniques and 
requirements.
Supervision
• creating or updating checklists for supervising clinicians managing febrile patients on the 
basis of malaria diagnostic tests; 
• creating checklists for laboratories performing RDTs or microscopy; 
• creating a checklist for RDT performance for facilities with no laboratory;
• if possible, integration of the above checklists into general clinical and laboratory supervision 
of health facilities;
• conducting supervisory visits to health facilities; and
• providing feedback to health facilities and taking corrective actions.
Advocacy, communication and social mobilization
• designing a strategy for communications, behaviour change and social mobilization;
• preparing appropriate materials and messages;
• disseminating key messages to each targeted audience; and
• engagement of the private sector.
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Monitoring and evaluation
• defining or updating core indicators for malaria diagnosis and the data necessary to calculate 
them;
• updating the health information management system and data reporting forms (or, if not pos-
sible immediately, setting up a temporary parallel system) to monitor RDT use;
• distributing reporting forms and training staff in their use;
• designing standardized templates and training appropriate personnel in data entry and analysis;
• analysing collected data to calculate indicators of malaria diagnosis; and
• providing feedback at subnational level and to health facilities and communities.
2.4.2 Defining timelines
Timelines should be defined for all new activities for strengthening both RDT and malaria 
microscopy (see Figure 6). Ideally, introduction of RDTs and strengthening of microscopy should 
be done in parallel, to take advantage of the synergies at each level. Malaria diagnostic tests are 
generally introduced in different geographical areas or extended to different levels of the health 
system in progressive phases. Successful national malaria control programmes that have rapidly 
scaled-up diagnostic testing over a short period (e.g. in Senegal) first used malaria diagnostic tests 
in the public sector only in selected priority districts, before extending their use to all malaria-
endemic areas; subsequently, malaria diagnostic tests were extended to community level. In a few 
countries (e.g. Cambodia), this was then followed by deployment of malaria diagnostic tests in 
the informal private sector.
2.4.3 Budget components
At national level, a full budget should be prepared for all the activities in the implementation 
plan, including initial fixed costs (e.g. microscopes and other laboratory equipment), running 
costs (e.g. staff salaries and incentives) and commodity costs (e.g. RDTs, gloves, sharps boxes, 
slides and laboratory supplies). Costs should be determined for activities specifically related to the 
introduction of RDTs and for strengthening microscopy and also for activities common to both 
microscopy and RDTs, including management of non-malaria fevers.
The components and format of the budget depend on the requirements of the funding agency 
(e.g. government, international and bilateral agencies). Tools for costing in grant proposals to 
major funding agencies are being prepared and are not part of this manual. The distribution of 
costs into different budget components also depends on the requirements of the funding body. 
Generally, the components of the budget listed in Table 4 should be given in detail in the imple-
mentation plan.
Components specifically related to RDT implementation
The major component of the budget for RDT implementation is for procurement of the tests them-
selves. This cost is directly proportional to the quantification of RDT requirements over time. 
One component of the budget is assigned to formulating standard operating procedures and 
training materials and to storage and distribution of RDTs to health facilities. These costs vary 
considerably, and the agencies involved in supply management should be involved in estimating 
the costs for storage and distribution.
At present, quality management for RDTs is based mainly on lot-testing, which has a negligible 
cost (as testing is currently free in WHO reference laboratories), and direct observation of the 
2
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Table 4. Components of the budget for a malaria diagnosis programme
Component Activities specific to microscopy
Activities specific to  
RDTs
Activities for management 
of (malaria and non-malaria) 
fevers
Preparation of technical guidelines, standard operating procedures and checklists
guidelines laboratory supervisiona rdt transport and storage Fever management algorithm
standard operating procedures for 
diagnostic testing microscopy performance rdt performance
other tests used at primary 
care level
other standard operating 
procedures
proficiency testing, 
validation of routine slide 
results
rdt storage
training material training manual for microscopy training manual for rdts
training manuals for 
integrated management of 
fevers
Checklists for supervision laboratory visitsa health facility visits
Procurement and supply of commodities
diagnostic tests microscopes and related supplies rdt kits
Urine dipsticks, 
haemoglobin meter, 
hematocrit meter, 
glucometer
medicines ACts
Antibiotics, zinc, inhaled 
salbutamol, rehydration 
salts
other commodities gloves, lancets, alcohol, cotton wool, timers, sharps boxes
distribution of commodities to the 
field All items listed above
Quality management system 
pre-shipment testing lot-testing
training of focal people Quality management system focal people
monitoring the quality 
management system
Quality monitoring supervision visits and compilation of  
health information management data
Training of health workers
training of tutors expert microscopists tutors for rdt performance outside laboratories and clinical management of fever cases
training of health workers microscopists health workers Clinicians
training of supervisors laboratory supervisorsa Clinical supervisors
Supervision
supervisory visits laboratory visitsa health facility visits
Advocacy, communication and social mobilization 
design of strategies and material Communication on the need for malaria testing Communication on other causes of fever
dissemination of key messages through each delivery channel
Monitoring and evaluation
Updating the health information 
management system 
Add row for rdts in laboratory report and column  
for malaria test results in clinicians’ book
Column for other test 
results in clinicians’ book
train health workers in the new 
health information management 
system 
training of person in charge or focal person for reporting on  
health information management in health facilities
a to simplify, activities specific to laboratories have been mentioned under ‘microscopy’, although both microscopy and rdt are generally per-
formed in laboratories.
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competence of health workers, community health workers and other staff in performing RDTs, 
which is included in the supervision of laboratories, health facilities and community health work-
ers. Transport and per diem costs for the supervisors may be significant. Adequate supervision 
costs must be included in all budget plans submitted for approval.
Training of clinicians to perform RDTs should be part of training in patient management and 
ideally included in training on integrated management of fevers. Training of health workers and 
laboratory technicians in the correct use and interpretation of RDT is important for successful 
implementation of an RDT programme. 
Components specifically related to strengthening microscopy
An important component of the budget for strengthening microscopy is that for quality manage-
ment, in particular accreditation of microscopists, external quality assessment and supervision 
of laboratories. These costs are proportional to the number of laboratories and the number of 
microscopists in the programme rather than the number of tests performed. The most significant 
component of the budget for microscopy activities is recurrent costs for the salaries of laboratory 
technicians involved in malaria microscopy; however, most laboratory technicians do not con-
duct microscopy examinations only for malaria. 
A small part of the budget must be assigned to formulation of standard operating procedures, 
supervisory checklists and effective training material. Such materials have already been devel-
oped for a number of countries, so that the only cost will be for adaptation of these materials to 
the specific country context. The costs of procurement of laboratory equipment, especially new 
microscopes, depends on the requirements for replacing old and obsolete microscopes, as identi-
fied in the situation analysis. As part of recurrent costs, the budget should also include funds for 
regular in-service training of microscopists and refresher training, on the basis of the results of 
microscopists’ performance. Supervisory costs should be included in any detailed budget submit-
ted for approval.
Activities common to both microscopy and RDTs
Financial resources should be available for training clinicians in the use of malaria tests for patient 
management, perhaps as part of broader training on the management of all fevers. Because of 
staff attrition and rotation, the budget should cover refresher training, especially in countries 
with phased implementation of malaria diagnostic tests. 
The largest budget component will be however for setting up or expanding existing supervisory 
activities to include supervision of malaria diagnosis, in particular of clinicians managing febrile 
patients and of health workers performing RDTs. 
Procurement of commodities for the diagnosis and treatment of both malaria and non-malaria 
fevers may represent a considerable part of the overall budget, depending on what is already 
available or planned in other programmes. These commodities (e.g. urine dipsticks, antibiotics, 
rehydration salts, zinc, inhaled salbutamol, …) are nevertheless essential to ensure adherence to 
malaria test results and to decrease the morbidity and mortality of febrile patients. Procurement 
of gloves and sharps boxes should be included as part of the commodity costs. A dedicated budget 
should be allocated for preparing technical guidelines and training materials, for upgrading the 
information system, for monitoring and evaluation and for communication activities. The budget 
should also include funds for conducting operational research as a basis for policies and practices.
2. poliCies And teChniCAl gUidelines
2
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Key meSSAgeS of SeCTIoN 2
n Clear criteria for a ‘suspected malaria case’ should be established to identify patients who 
should be tested for malaria, adapted to the national situation.
n patients with a new non-severe episode of fever can be tested either with an rdt or by 
microscopy.
n patients in whom antimalarial treatment failure is suspected should be tested by micros-
copy.
n treatment of patients with severe febrile illness should be initiated immediately, even 
before diagnostic testing for malaria. microscopy is the preferred diagnostic test for these 
patients. 
n Clinicians should also be trained in the management of non-malaria febrile illness, and 
appropriate medicines and supplies should be provided, including antibiotics for pneumonia 
and oral rehydration salts and zinc for diarrohea.
n in health facilities with microscopy where the workload exceeds laboratory capacity, the 
use of rdts for diagnosis of fever episodes may relieve the burden.
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3. procurement and logistics  
 of malaria tests
3. proCUrement And logistiCs oF mAlAriA tests
3.1 Selection of products for malaria diagnosis 
3.1.1 RDTs
According to the manual on Good practices for selecting and procuring RDTs for 
malaria, which has been published by WHO in 2011,1 the criteria for selecting 
malaria RDTs include:
Target parasite species and antigens
The choice of RDT is based on the prevalence of malaria species in the country. 
Three geographical zones have been defined: 
• Zone 1, in which P. falciparum is predominant and non-falciparum species cause mixed infec-
tion with P. falciparum (most areas of sub-Saharan Africa and lowland Papua New Guinea);
• Zone 2, where P. falciparum and non-falciparum infections occur commonly as single-species 
infections (most endemic areas of Asia and the Americas and isolated areas of Africa, particu-
larly the Ethiopian highlands); and 
• Zone 3, where only non-falciparum infections occur (mainly P. vivax in areas of East Asia, 
central Asia and South America and some highland areas elsewhere).
In Zone 1, RDTs that detect only P. falciparum are generally preferable. In Zone 2, combination 
RDTs that detect all species and distinguish P. falciparum from non-falciparum infections are 
indicated. In Zone 3, RDTs that detect non-falciparum species alone are appropriate (pan-specific 
or P. vivax-specific).
The type of antigen targeted depends on the species to be detected (see Table 5): for detection of 
P. falciparum, tests that detect HRP2 are generally preferred, as they are more sensitive than those 
that detect pLDH; for detection of non-falciparum species, tests targeting pLDH specific to non-
falciparum species or common to all species, or aldolase, are recommended.
1 Good practices for selecting and procuring rapid diagnostic tests for malaria. Geneva, World Health Organization, 
2011. Available at: http://whqlibdoc.who.int/publications/2011/9789241501125_eng.pdf
Table 5. Antigen targets of rapid diagnostic tests for malaria 
Plasmodium species hRP2
plDh
Aldolase
plDh-Pf plDh-pan plDh-Pvom plDh-Pv
P. falciparum X X X X
P. vivax X X X X
P. malariae X X X
P. ovale X X X
hrp2 – histidine-rich protein 2; pldh – Plasmodium lactate dehydrogenase; pf – P. falciparum 
pan – all Plasmodium species; pvom – P. vivax, ovale and malariae; pv – P. vivax
40 universal access to malaria diagnostic testing: an operational manual
RDT performance requirements and WHO recommendations
Each national malaria control programme is responsible for selecting RDTs 
that perform well and reproducibly in the setting of intended use. Rather than 
the results of isolated studies of variable quality (see below) it is strongly rec-
ommended to use of the results of the WHO product testing programme for 
malaria RDTs,1,2 including the most recent results of each product in order to 
prepare a short list of products eligible for procurement. In rounds 1 and 2 of the 
WHO RDT testing programme, a series of tests showed a good correlation 
among the performance parameters (mainly a high panel detection score, 
a low false-positive rate and a low invalid rate).The results of round 3 will 
be available in 2011.
An interactive guide, which allows users to identify RDTs by specific 
thresholds for various parameters of diagnostic performance, is available 
on the internet.3 The user enters the desired parameters and the interactive guide identifies the 
RDTs coresponding to these criteria, on the basis of the results of the WHO RDT product testing 
programme.1,2
In addition, the WHO/GMP website lists RDT products assessed in the product testing programme, 
showing the performance of each in relation to the WHO recommended selection criteria.4
Country experience with RDTs
Field comparisons of different brands of RDTs are difficult and expensive to conduct; they are 
not recommended. Studies to assess the ease of use of different RDT kits can provide useful 
information for a country’s selection of an RDT kit. Procurement should be guided by the needs 
of the national malaria control programme, taking into account previous experience of use and 
training requirements of health personnel, especially if a new type of RDT is to be procured. If 
more than one RDT is to be procured, selection of tests with a similar format, ancillary items and 
testing procedures is recommended to reduce training requirements and errors in performance.
The national health authorities should monitor what RDT products are available in their public 
and private sectors, as many substandard products are available on the market.
Additional considerations
Further criteria essential for selecting appropriate RDTs are: the supplier’s production capacity 
and lead times, storage conditions, delivery schedules, shelf-life as well as registration and budget 
requirements. 
1 Malaria Rapid Diagnostic Test Performance: Results of WHO product testing of malaria RDTs: Round 1 (2008). 
WHO Regional Office for the Western Pacific/FIND/CDC/TDR, 2009. Available at: 
 http://www.wpro.who.int/NR/rdonlyres/ED81BDE9-B812-4B80-8408-3A129A6365C4/0/OMSFINDRapport 
Malaria200900514v25.pdf
2 Malaria Rapid Diagnostic Test Performance: Results of WHO product testing of malaria RDTs: Round 2 (2009). 
WHO WPRO/GMP/FIND/CDC/TDR, 2010. Available at: 
 http://www.wpro.who.int/internet/files/rdt/RDTMalariaRd2_FINAL.pdf 
3 Malaria RDT product testing: Interactive Guide. FIND. Available at:
 http://www.finddiagnostics.org/programs/malaria/find_activities/product_testing/malaria-rdt-product-
testing/index.jsp
4 Information note on recommended selection criteria for procurement of malaria rapid diagnostic tests. Global 
Malaria Programme, WHO. Available at:
 http://www.who.int/malaria/diagnosis_treatment/diagnosis/RDT_selection_criteria.pdf
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3.1.2 Microscopy
Microscopes
The national laboratory services, in collaboration with the national reference 
laboratory, should decide on the specifications of the microscope that is most 
appropriate at intermediate and central facilities on the basis of previous national 
experience and other types of evaluations.1 Manufacturers of all laboratory equip-
ment and supplies should meet national and internationally recognized general 
manufacturing quality standards (ISO 9000). Standard binocular microscopes 
should be used at all times, to simplify both maintenance and the acquisition and 
supply of spare parts (such as lamps, eyepieces and objective lenses). A binocular microscope with 
paired x10 eyepieces and x10, x40 and x100 objectives (the latter as ‘oil immersion’) and a built-
in electrical light source is the ‘gold standard’. Alternative power sources should be established 
where mains electricity is not available or is unreliable. The use of daylight as a light source is not 
recommended for malaria microscopy.
Giemsa stain and buffer solutions
The Romanowsky stains (staining nucleii red and cytoplasm blue), of which 
Giemsa is one, have proved to be the most reliable stains for routine malaria 
microscopy.2 Field stain, which is still used in some programmes, is subop-
timal and generally not recommended. Giemsa is the stain of choice also for 
peripheral laboratories. Giemsa stain powder should be bought from a reputable 
supplier, and, for preparation of Giemsa stock solutions, highly pure methanol 
(high quality, with < 1% water) and glycerol (high quality, with < 1% contami-
nants) must be used. Giemsa stain stock solutions should be prepared within the quality manage-
ment programme in quality-controlled batches and distributed to the users. Alternatively, some 
chemical companies sell ready-made Giemsa stock solutions; these also require quality assess-
ment at central level. 
One of the critical variables in staining is the pH of both the staining solution and the water used 
for washing. Simple hand-held pH meters should be made available to all malaria diagnostic 
laboratories, as pH paper is not satisfactory. Buffer solution is made by combining di-sodium 
hydrogen phosphate and potassium di-hydrogen phosphate salts (both anhydrous) at specific 
concentrations. A precision balance is thus required to weight the salts. Alternatively, for small 
laboratories, buffer tablets to maintain solutions at the correct pH should be purchased. 
Microscope slides
Only high-quality microscope slides, free of surface abrasions, should be used for malaria micros-
copy. Slides with one end frosted for labelling are preferable.
3.2 Quantification and forecasting of requirements for malaria testing
3.2.1 General considerations on the relative needs for microscopy and RDT supplies
As most patients will be tested with only one type of diagnostic test, the needs for microscopy 
and RDTs are interdependent in the precise deployment plan. Quantification of equipment and 
supplies for diagnostic testing of malaria should take into account:
3
3. proCUrement And logistiCs oF mAlAriA tests
1 Manual of basic techniques for a health laboratory, second edition. Geneva, World Health Organization, 2003. Avail-
able at: 
 http://whqlibdoc.who.int/publications/2003/9241545305.pdf
2 Basic malaria microscopy, Part I. Learner’s guide, second edition. Geneva, World Health Organization, 2010; 
section 3.3.1. Available at: 
 http://whqlibdoc.who.int/publications/2010/9789241547826_eng.pdf
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• diagnostic policy, including which test should be used in view of the malaria situation in dif-
ferent parts of the country (what and why); and 
• the deployment plan, i.e. the locations where microscopy will be available and those in which 
only RDTs will be used, and the scale-up strategy (where and when).
The introduction of microscopy into a new facility requires the availability of laboratory services, 
with adequate staffing and infrastructure, including electricity and a water supply. When RDTs 
are introduced into health facilities in which microscopy already exists, account should be taken 
of how a decision is taken on which to use as the first-line test for patients who present with a 
new fever, and also the patient load when the laboratory is closed (when RDTs might be the only 
diagnostic test available). 
In health facilities where outpatients are tested with RDTs, and microscopy is reserved for inpa-
tients and suspected malaria treatment failure, the number of RDTs required is close to the total 
number of suspected malaria cases managed in health facilities (minus the number of suspected 
malaria treatment failures, which is generally low). When outpatients are tested with RDTs at 
certain health-care levels (for example health facilities in which microscopy is not available and 
health posts at the community level) and with microscopy at the other levels, the calculation of 
RDT requirements should be based on the number of suspected cases managed at the level at 
which RDTs will be used as only test. 
For microscopy, the number of microscopes (and related equipment) required depends mainly on 
the number of laboratories in which microscopy will be or is already used and their capacity (i.e. 
trained laboratory technicians). The quantification of microscopes for malaria diagnosis and all 
essential supplies (slides, Giemsa etc) is thus generally not directly linked to the number of sus-
pected malaria cases; however, in countries where microscopy is used widely, it is still necessary to 
estimate the numbers of patients tested by microscopy, so that this number can be subtracted from 
the total number of suspected malaria cases seen in the area in calculating the total RDT require-
ments. This also allows calculation of the number of slides or reagent required for microscopy.
3.2.2 Quantification of the number of suspected malaria cases
The estimation of requirements for RDTs and microscopy is a critical step in the 
procurement cycle. Depending on the availability and reliability of surveillance 
data, one of the following four different approaches should be used.1 In any of the 
four scenarios, the addition of a safety stock needs to be considered.
a. Area with no malaria surveillance data: The estimate of requirements should be 
based on implementation capacity and programme aspects, i.e. the number of 
people performing the tests, the number of tests expected to be performed per day and the num-
ber of working days during which the test will be performed. To this estimate, a certain amount 
(e.g. 20%) should be added for safety stock.
b. Areas with unreliable malaria surveillance data: This situation is prevalent in many countries, 
due either to general underreporting or specific to certain health facilities, often in under-
served geographical areas. In these countries, RDTs are generally introduced as a first-line 
diagnostic tool for outpatients, and microscopy is reserved for severe cases and investigation of 
suspected treatment failures. As the number of suspected severe malaria cases and suspected 
treatment failures is much smaller than the total number of suspected malaria cases, the quan-
1 Good practices for selecting and procuring rapid diagnostic tests for malaria. Geneva, World Health Organization, 
2011; section 2.1.3. Available at: 
 http://whqlibdoc.who.int/publications/2011/9789241501125_eng.pdf
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tities of RDTs required will be close to the total number of suspected malaria cases, and the 
requirements for malaria microscopy will be modest. 
 For these areas, quantification should be based on data from parts of the country with reli-
able surveillance data, similar malaria transmission and similar health-care systems, using the 
method (c) described below. When extrapolating from different areas, however, the following 
might influence the estimate and should be taken into account: differences in the number of 
health facilities and their level of functioning, which affect patient flow at different levels of the 
health-care system; expected variations in patient treatment-seeking behaviour after introduc-
tion of a new malaria treatment policy or differences in pricing of medicines and diagnostic 
testing; and a different scale of deployment of malaria diagnostic services to peripheral health-
care facilities.
c. Areas with reliable malaria surveillance but no reliable data on malaria test consumption: The 
critical variable to be obtained from surveillance data is the number of suspected malaria cas-
es, which is generally not reported as such. This information can, however, be derived from 
other data recorded in the health information system. The malaria reporting system in places 
where RDTs are already in use always contains the following data: 
• the total number of reported malaria cases;
• the number of malaria cases confirmed by microscopy;
• the total number of slides examined for malaria by microscopy;
• the number of malaria cases confirmed by RDTs; and
• the total number of malaria RDTs performed. 
 In some countries, confirmed malaria cases are reported all together, without separating those 
diagnosed with RDTs or microscopy. Ideally, the positivity rates with microscopy and RDTs 
should be reported separately, with the number of slides examined and tests performed. It is 
possible to quantify RDT requirements from malaria surveillance data, on the condition that 
confirmed negative cases are not reported as malaria, as should be the case when the quality 
of routine microscopy or RDTs is high. In order to quantify requirements, it is necessary to do 
some calculations with this routinely recorded data; the relations among these parameters are 
illustrated in Figure 7.
Suspected
Tested
(by microscopy or RDTs)
Not tested
(probable or unconfirmed)
Positive
(confirmed malaria)
Negative
(confirmed non-malaria)
Reported 
malaria cases
FigUre 7. 
Relations between suspected cases tested (by microscopy and RDTs) and those not 
tested (probable or unconfirmed) for malaria
44 universal access to malaria diagnostic testing: an operational manual
 The number of suspected cases, which is the basis for calculating malaria test requirements, 
can be derived from the number of tested patients, the number of positive cases and the num-
ber of reported malaria cases (see section 8.1.1). For detailed information on the calculation, 
refer to the WHO manual Good practices for selecting and procuring RDT for malaria.1
d. Areas with reliable malaria surveillance and reliable data on malaria test consumption: The 
most reliable methods for estimating malaria test requirements are based on consumption 
data, which depend on a functioning logistics management information system. When using 
this quantification method, it is important to consider expected changes in the deployment 
strategy for malaria testing. If malaria tests are introduced in new areas or settings or if the 
type of test used for some groups of patients changes (for example RDTs instead of micros-
copy in uncomplicated cases), the data should be adjusted accordingly. The consumption data 
should also be adjusted by the number of days of stock-outs recorded on the stock record forms 
of the health facilities reporting consumption data. If consumption data are not available for 
all health facilities, it might be acceptable to estimate the requirements on the basis of a repre-
sentative sample of health facilities with reliable consumption data. 
Next steps
• Define the target coverage for quantification by geographical area and by level of the health 
system (e.g. health facility or community level). 
• Consider whether current testing needs are likely to change over time, i.e. to increase or 
decrease, depending on many factors (e.g. the extent of testing by community health workers, 
health sector development plans or changes in the use of health services by the community).
• Consider how the estimates will be affected by the criteria for defining suspected malaria cases 
in the malaria treatment policy in relation to fever assessment (i.e. criteria for selection of 
patients for malaria testing, see section 2.3.4).
• Consider that, over time, large-scale deployment of RDTs will affect the consumption of ACTs; 
therefore the membership of the teams involved in quantifying RDTs and antimalarial medi-
cines sould overlap significantly in competency and scope of work.
• Draw up a realistic plan for completing the quantification on the basis of whether it will be cen-
tralized (managed at central level) or decentralized (each facility compiling its own estimates, 
which are reviewed and consolidated at district and provincial level before submission to the 
procurement office). 
 
3.2.3 Quantification of material needed for malaria testing
RDTs
One RDT kit (or box) generally contains all the material needed for performing 25–30 or more tests, 
including blood collecting devices and buffer solution. Generally, lancets and alcohol swabs are also 
provided, but this should be checked with the supplier. Other general supplies, such as gloves (if 
not already included by the manufacturer), timers and sharps boxes should be procured separately.
1 Good practices for selecting and procuring rapid diagnostic tests for malaria. Geneva, World Health Organization, 
2011; section 2.1.3. Available at: 
 http://whqlibdoc.who.int/publications/2011/9789241501125_eng.pdf
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Microscopy
A list of recommended equipment and supplies for a peripheral 
health laboratory is given in the WHO Manual of basic techniques 
for a health laboratory.1 A list of recommended equipment and 
supplies for a malaria microscopy laboratory in a small clinic is 
given in the WHO Malaria microscopy quality assurance manual.2
Replenishment of defective or obsolete equipment should also 
be considered in quantification of needs, taking into account national capacity for servicing and 
maintenance. 
Material for both malaria microscopy and RDTs
A list of recommended equipment and supplies needed for both microscopy and RDTs is given 
in Table 6, with the corresponding specifications and quantities required. If the RDT kits already 
contain lancets or alcohol swabs, these items should be removed from the procurement list.
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Table 6. list of material common to microscopy and RDTs, with specifications
Description Specifications
general equipment
timers From 1 min to 1 h, fitted with alarm sound
Consumables
Absorbent cotton wool white, non-sterile, in 500-g packages
Alcohola For skin disinfection
gloves examination, latex, disposable, 50 pairs/box, sizes:  large, medium and small
lancets disposable, sterile, standard type, boxes of 200
sharps container For needles and syringes, cardboard for incineration size 15 l
markers dye-, bleach- and water-resistant
a ‘spirits’ generally contain a mixture of ethyl alcohol and methyl alcohol.
1 Manual of basic techniques for a health laboratory, second edition. Geneva, World Health Organization, 2003; Table 
2.2, page 36–39. Available at: 
 http://whqlibdoc.who.int/publications/2003/9241545305.pdf 
2 Malaria microscopy quality assurance manual, version 1. World Health Organization, Regional Office for the West-
ern Pacific, 2009; section 5 and annex 3. Available at: 
 http://www.who.int/malaria/publications/malaria_microscopy_QA_manual.pdf
3 Good practices for selecting and procuring rapid diagnostic tests for malaria. Geneva, World Health Organization, 
2011. Available at: 
 http://whqlibdoc.who.int/publications/2011/9789241501125_eng.pdf 
3.3 Procurement of supplies for malaria testing
All the steps in the procurement of RDTs are described in detail in the WHO 
manual Good practices for the selection and procurement of malaria rapid diag-
nostic tests.3 (Many steps in the procurement of microscopes and related material 
are similar to those for RDTs.) The steps are:
• defining specifications for tenders on the basis of national requirements (see 
section 3.1.1); 
• transforming quantification of needs (see section 3.2) into planned orders, considering the fre-
quency of delivery to each supply point, safety stocks needed at each level of the supply chain, 
foreseen losses, available budget and lead times;
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• procurement by restricted tender, in which only manufacturers with standards (in particular, 
ISO 13485:2003 certification) and the capacity to provide the quantities required within the 
desired timeframe are invited to apply. The tender specification should include RDT perfor-
mance requirements based on WHO recommendation (see section 3.1.1); and
• procurement of other supplies needed for both microscopy and RDT (gloves, timers and sharps 
boxes), which should accompany the procurement of malaria tests.
Specific comments
RDTs: completeness, i.e. RDT kits that contain lancets, alcohol swabs and all other essential mate-
rial should be one of the criteria for procurement. 
Microscopy: Specifications for procuring microscopes and related equipment should be aligned 
against the standards recommended by the national health laboratory system, as microscopes are 
also used and procured for other public health programmes (such as tuberculosis).
3.4 Distribution, transport and storage
RDTs
The performance of RDTs is impaired when they are exposed to high temperatures or humidity. 
The sealed foil packaging protects them from moisture. They should be transported and stored 
under rigorous temperature control to ensure that they are always kept below the maximum tem-
perature recommended by the manufacturer. When air-conditioning is not available, calibrated, 
validated thermometers (for daily recording of minimum–maximum) should be placed in vari-
ous parts of the storeroom to monitor temperature. If the recorded maximum shows that the tem-
perature repeatedly exceeds the limit recommended by the manufacturer, the storage conditions 
should be immediately improved. If there is a strong suspicion that RDTs have been exposed to 
high temperatures for several days, a sample should be sent for lot-testing. 
Community health workers should avoid storing large quantities 
of RDTs; instead, they should obtain supplies more often and in 
smaller quantities to avoid damage to RDTs due to poor storage 
conditions. Further practical guidance on transporting, storing 
and handling of malaria RDTs is provided in two WHO/FIND 
manuals.1,2 
microscopy
Microscopes should always be stored in a dry environment, preferably in their storage boxes, to 
avoid dust and exposure to humidity, which promotes growth of fungus on lens surfaces. Dry 
conditions can be obtained by placing a lighted 25-watt bulb inside a small cupboard, in which 
the microscope is stored at night.
Stock staining solutions should be kept away from direct sunlight, in a cool place, in dark bottles 
with tightly fitting lids, as moisture can affect the quality of the stain. For this reason, it is sug-
gested that the working solution be kept in a small volume in a different container from the main 
solution, and that only dry glassware be used for preparing staining solution daily.
1 Transporting, Storing, and Handling Malaria Rapid Diagnostic Tests at Central and Peripheral Storage Facilities, 
2009. Available at: 
 http://www.wpro.who.int/NR/rdonlyres/1BBCEFC2-46B3-40F5-9898-7455578145E8/0/MalariaRDT_
CENTRAL_2009web.pdf. 
2 Transporting, Storing, and Handling Malaria Rapid Diagnostic Tests in Health Clinics, 2009. Available at: 
 http://www.wpro.who.int/NR/rdonlyres/269BF1DC-BA7C-4422-A16E-F73016DA17B5/0/MalariaRDT_
REMOTE_2009web.pdf
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3.5 Stock management
An efficient transport and distribution system and a reliable logistics management information 
system are vital for coordinating a supply distribution network, whether for medicines, diagnos-
tic devices such as RDTs or supplies for microscopy. Logistics management information system 
record forms are the core of the supply information system, as they contain information on sup-
ply needs, movement and associated financial transactions. The stock record form documents 
all transactions related to an item, with columns and rows for the source of each delivery, the 
quantities received and issued, lot numbers of items dispatched to health facilities, the balance 
available and the expiry date of each lot, if applicable (e.g. for RDTs). The stock record form may 
be different for small health facilities at peripheral levels and for central stores.1 To facilitate stock 
inventory control of RDTs, the stock record form should state the smallest unit of dispatch, i.e. the 
number of boxes, rather than the number of individual tests (cassettes or cards). 
The national policy should state what should be done with overstocks and commodities near their 
expiry date at each level. At point-of-care level, when the consumption is lower than expected (e.g. 
of ACT due to fewer malaria cases than expected), health facilities should be allowed to move 
excess stocks to other facilities that have higher consumption. The medical store unit must make 
regular, periodic counts of the actual stock on hand to ensure that the balance recorded in the 
stock record form is correct and that the minimal safety stocks are available.
A monthly report of stocks of all items should be produced to ensure that reor-
dering is based on consumption, inventory levels, lead times and requirements 
for safety stocks. To calculate quantities for reordering at central level, in addition 
to the above, the estimates should also take into consideration the procurement 
period and the stocks on order but not yet received. For more information, refer 
to the Malaria case management operations manual.2
3.6 maintenance of microscopes and other equipment
Maintenance of microscopes is often neglected; however, maintenance of microscopes and relat-
ed equipment (pH meters, balance and water filter) should be part of general practice for the care 
and maintenance of laboratory equipment by the national laboratory services. Other relevant 
laboratory equipment (e.g. haemoglobin meter, centrifuge, glucometer) should also be included 
in the overall maintenance plan of equipment for all laboratory services.
If possible, a pool of technicians who have been trained in maintenance and know the preventive 
measures for maintaining microscopes should be set up at subnational level. Standard operating 
procedures for the use, care and maintenance of microscopes (see Annex 1) and for other relevant 
equipment, should be prepared.
Basic principles for microscope maintenance are:
• training of biomedical engineers by the manufacturer or agent on the specific maintenance 
requirements for the microscope model adopted by the country;
• existence of a maintenance workshop in the country, including a warehouse of spare parts;
• availability of complete technical information (service and user manuals) for use and mainte-
nance of the microscope model used in the programme;
1 Malaria case management: Operations manual. Geneva, World Health Organization, 2009; appendix 1. Available at: 
http://whqlibdoc.who.int/publications/2009/9789241598088_eng.pdf 
2 Malaria case management: Operations manual. Geneva, World Health Organization, 2009; section 5.2.3. Available at: 
http://whqlibdoc.who.int/publications/2009/9789241598088_eng.pdf
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• training of all laboratory users in the basic care and maintenance of the microscope; and
• availability of spare microscope bulbs in every laboratory.
At laboratory level, a physical inventory of all equipment should be made, and each new item of 
equipment should be added to the list. A specification sheet should be prepared for each item of 
equipment (see example in Annex 2). When an item of equipment is maintained or repaired, a 
sheet recording what has been done should be filled in by the laboratory technician responsible 
for the equipment (see example in Annex 3). A register of all repairs should be maintained in the 
laboratory receiving the repaired equipment (see example in Annex 4).
Key meSSAgeS of SeCTIoN 3
n An rdt product with high diagnostic performance fulfilling the who recommended selec-
tion criteria for procurement should be chosen.
n Quantification of rdt and microscopy supplies and ACt is strongly interdependent and 
should not be done separately.
n rdts should be stored in cool conditions; in hot climates, daily monitoring and recording 
of maximum temperature in storage places is important.
n to avoid stock-outs and wastage of tests, an efficient system of distribution and stock 
management should be put in place.
n maintenance of microscopes and related equipment is often neglected, although it is a 
basic requirement for high-performance malaria microscopy.
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4. Components oF A QUAlity mAnAgement system
4.1 overview of quality management activities at different levels
The quality management system for malaria diagnostic tests includes all the processes necessary 
to ensure that the diagnostic results from both microscopy and RDTs are as accurate as the test is 
designed to be, from the selection of the test to actual use of the results. Many activities that are 
essential to ensure the high quality of the final product (in this case, a correct malaria test result 
in the hands of the clinician) are described in the other sections of this manual (colour-empty 
boxes in Figure 8) and will not be discussed here. The activities that are specific to the quality 
management system (orange boxes in Figure 8) and that have not been discussed elsewhere are 
presented in this section.
4.2 Quality management activities at central level
4.2.1 Preparation of a plan for quality management
What to do
A quality management plan for malaria diagnostic tests should be prepared at central level and 
integrated with, or at least coordinated with, the quality management plans for other, related 
laboratory activities. The plan should describe all the activities discussed below, providing for 
various levels of responsibility (central, subnational and point-of-care) of the people in charge.
When possible, quality management activities should be integrated with other disease pro-
grammes and laboratory service activities. Quality management should be implemented for 
microscopy and RDTs at the same time to benefit from their mutual synergies and reinforcement.
How to do it
Identify key stakeholders, e.g. national malaria quality management system coordinator, person 
in charge of the quality management system at the national laboratory services, person in charge at 
the national malaria reference laboratory, malaria diagnostic coordinator in the national malaria 
control programme, as well as standardization, certification and accreditation bodies. Identify 
the focal person for quality management of malaria microscopy and RDTs. If quality manage-
ment for RDT is handled by a different person than for quality management of microscopy, their 
activities should be carefully coordinated. The focal person is responsible for maintaining quality 
to agreed minimum standards.
A phased approach to quality management with a strong emphasis on monitoring will pro-
vide information on how to improve the system. Monitoring of the quality management system 
is therefore essential for ‘learning by doing’ and adapting the programme to changing needs 
(decreasing malaria endemicity, new diagnostic tools, increasing numbers of subnational refer-
ence laboratories). Feed-back is also an essential component for improvement over time. 
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4.2.2 Quality standards for testing sites and test performance
The diagnostic performance of malaria microscopy depends strongly on the competence of the 
microscopist in preparing, staining, examining and interpreting malaria blood slides. For this 
reason, quality management systems in malaria microscopy have often focused on assessing and 
continuous improvement of the competence of individual microscopists rather than on certifica-
tion of laboratories, which is the standard approach for other laboratory procedures. Both are 
however essential to ensure accuracy of the final test result. A functioning quality management 
system depends on acceptable performance standards, procedures and practices identified for 
organizations and individuals involved in the malaria diagnostic service at various levels of the 
health system. For this, a national standard-setting group should be formed that includes person-
nel from the national malaria control programme and public health laboratory service as well 
other relevant departments of health and educational institutions.
Standards must be defined in five main areas:
Competence of test performers
Peripheral level microscopy: a microscopist at the lowest level of the laboratory 
network should be able to detect the presence or absence of malaria parasites (in 
a slide set of 10 negative and 10 positive slides) with more than 90% accuracy A 
grading system for accreditation of microscopists that can be adapted for country 
settings as appropriate is available in WHO’s Malaria microscopy quality assur-
ance manual.1
RDTs: At present, there is no standardised way to measure the competency level of RDT perform-
ers. The key intervention for quality monitoring is regular supportive on-site supervision (see 
Annex 10). 
Testing site performance (accuracy and timeliness of testing in routine practice) 
The overall performance of a facility in microscopy can be determined by laboratory visits using 
quantitative checklist and by external quality assessment, with proficiency testing in a grading 
system similar to that used for assessment of individual competence. Low laboratory performance 
indicates that the competence of individual microscopists should be investigated.
Supervisor competence
Supervisors should undergo training and accreditation before undertaking supervision. They 
should be given a structured checklist to assess laboratory standards. They should provide on-site 
feedback of their findings, recommendations for improvements and on the spot trouble-shooting, 
when indicated.
Trainer competence
Trainers should have recognized competence in their areas of expertise and be accredited. They 
should be supported by a core group of experts and validators at central level, who have demon-
strated measurable expertise.
Equipment and reagent standards
See section 3.1
4
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1 Malaria microscopy quality assurance manual, version 1. World Health Organization, Regional Office for the West-
ern Pacific, 2009; section 6. Available at: 
 http://www.who.int/malaria/publications/malaria_microscopy_QA_manual.pdf
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4.2.3 Roles of the national malaria reference laboratory
The Ministry of Health should establish a national reference group of expert 
microscopists, generally based at the national reference laboratory,1 set up a 
national blood slide bank and prepare reference slide sets for training,2 reference 
purposes and external quality assessment of testing sites. 
The national reference laboratory should participate in an international exter-
nal quality assessment programme for reference laboratories. WHO has estab-
lished a proficiency testing programme for several diseases, including malaria, 
for national reference laboratories.3
When organizing external quality assessment, priority should be given to important testing sites 
(such as district hospitals, laboratories participating in epidemic surveillance, laboratories work-
ing as references for other testing sites). Once a network of fully quality-assured subnational refer-
ence laboratories is in place, additional testing sites can be included.
At least three external quality assessment activities should be organized by the national reference 
laboratory, first applied to subnational reference laboratories adn then delegated to them to be 
applied to peripheral laboratories, if feasible
Supervision visits of laboratories 
Laboratories at all levels should be monitored by on-site visits with a standard supervisory assess-
ment tool (see Annex 8). During these visits, assessments should be made of microscopists’ com-
petence by direct observation during preparation and staining of blood slides (see Annex 9) and 
of the general quality of the blood slides at the testing site (see section 4.4.3). For more details on 
laboratory supervision, see section 4.4.1. 
Slide proficiency testing (reference blood slide reading at the testing site)
This activity (also called ‘panel testing’) consists of distributing pre-prepared stained blood films 
in a blinded manner to laboratories performing malaria microscopy for examination. This allows 
monitoring of the competence of a microscopist or laboratory to detect, identify and quantify 
malaria parasites on a well-prepared, stained blood film. It is not a measure of the performance of 
malaria microscopy in routine practice. This activity might be focused in priority testing sites (e.g. 
subnational reference laboratories), as it requires a large number of standardized slide sets and is 
complex and time-consuming. On-site visits to these subnational reference laboratories are a good 
opportunity to distribute the reference blood slides and, on a subsequent visit, to collect the results 
of their reading. A standard form should be used to report reading accuracy to laboratories and 
take necessary remedial action in cases of suboptimal performance. 
Validation of routine blood slide results (cross-checking)
The national reference laboratory can set-up a system to perform a second reading (cross-check-
ing) of a sample of routine blood slides prepared at subnational reference laboratories (see section 
4.4.3). Once the results of cross-checking show that the expected level of competence has been 
1 Malaria microscopy quality assurance manual, version 1. World Health Organization, Regional Office for the West-
ern Pacific, 2009; section 5 and annex 3. Available at: 
 http://www.who.int/malaria/publications/malaria_microscopy_QA_manual.pdf
2 Malaria microscopy quality assurance manual, version 1. World Health Organization, Regional Office for the West-
ern Pacific, 2009; section 9 and annexes 8 to 10. Available at: 
 http://www.who.int/malaria/publications/malaria_microscopy_QA_manual.pdf
3 Policy and procedures of the WHO/NICD Microbiology External Quality Assessment Programme in Africa Years 1 to 
4, 2002–2006. Geneva, WHO/CDS/EPR/LYO/2007.3. Available at: 
 http://whqlibdoc.who.int/hq/2007/WHO_CDS_EPR_LYO_2007.3_eng.pdf
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reached at subnational level, a similar system can be put in place between the subnational refer-
ence laboratories and peripheral laboratories. 
Some countries have plans to modify this system to include a third reading of peripheral slides 
by expert microscopists at the national reference laboratory (either a random sample or slides 
with discrepant results after cross-checking), in addition to the second reading at subnational 
level. A third reading of the same slide complicates reliable calculation of the percentage of agree-
ment (see section 4.4.3) and prolongs feedback to the peripheral laboratories. The competence of 
microscopists at subnational level can be evaluated by the national reference laboratory only on 
the basis of slides prepared at the subnational laboratory itself and not from their reading of blood 
slides prepared by others (peripheral laboratories).
For more discussion on different approaches for slide validation, see section 4.4.3.
 
4.2.4 Certification of reference laboratories
Certification is recognition of the performance of a laboratory. It is usually voluntary and comple-
ments mandatory licensing or registration. For example, ISO 15189:2007 accreditation has been 
established for laboratories that meet internationally recognized standards. Intercountry initia-
tives exist or are being set up in some regions. A training toolkit for learning how to implement a 
quality management system in a laboratory on the basis of internationally recognized standards 
is available on the WHO website.1 Certification is, however, expensive to do and to maintain. 
If full certification is not possible, national and subnational reference laboratories should try to 
achieve high standards by participating in a recognized quality management system, which is 
furthermore a prerequisite for accreditation.
4.2.5 Designing standard operating procedures and job aids
A series of standard operating procedures and job aids should be created (preferably at the nation-
al reference laboratory for both microscopy and RDT; sometimes at the national malaria control 
programme for RDTs). The following examples of standard operating procedures can be adapted 
to local contexts:
• RDT performance: job aids based on the WHO validated generic models of job aids and adapt-
ed to the type of RDT available in the country;2
• RDT storage at point-of-care: standard operating procedures (see Annex 4) and the pocket 
guide (see pages 5 to 11 of WHO/FIND Transporting, Storing and Handling Malaria Rapid 
Diagnostic Tests in Health Clinics);3
• use, care and maintenance of microscopes: standard operating procedures (see Annex 5) and 
bench aid (see Plate 5a of WHO Bench aids for malaria microscopy4);
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1 Laboratory Quality Management System Training toolkit. Geneva, World Health Organization/Clinical and Labora-
tory Standards Institute/Centers for Disease Control and Prevention, 2009, Trainer’s guide and handbook. Avail-
able at: 
 http://www.who.int/ihr/training/laboratory_quality/en/
2 Malaria RDT Job-aids and Training Manuals. WHO/FIND. Available at:
 http://www.wpro.who.int/sites/rdt/using_rdts/training
3 Transporting, Storing, and Handling Malaria Rapid Diagnostic Tests in Health Clinics, 2009. Available at: 
http://www.wpro.who.int/NR/rdonlyres/269BF1DC-BA7C-4422-A16E-F73016DA17B5/0/MalariaRDT_
REMOTE_2009web.pdf
4 Bench Aids for Malaria Microscopy. Geneva, World Health Organization, 2010. Available at: 
 http://apps.who.int/bookorders/anglais/detart1.jsp?sesslan=1&codlan=1&codcol=15&codcch=3294
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• preparation of Giemsa stain solution: bench aid (see Plate 7a of WHO Bench aids for malaria 
microscopy1); standard operating procedures (see annex 8 and sections 3.1.3–3.3.5 of the WHO 
Malaria microscopy quality assurance manual2 and learning unit 5 of Basic malaria micros-
copy, Part I3);
• thick and thin blood film preparation for malaria: bench aid (see Plate 3a of WHO Bench 
aids for malaria microscopy)1 and standard operating procedures (see learning unit 4 of Basic 
malaria microscopy, Part I3);
• blood film staining for malaria: bench aid (see Plate 7a of WHO Bench aids for malaria micros-
copy1) and standard operating procedures (see annex 8 and section 4.1.2 of the WHO Malaria 
microscopy quality assurance manual2 and learning unit 5 of Basic malaria microscopy, Part I3);
• routine examination of blood films and parasite density calculation (see Plate 9a of WHO 
Bench aids for malaria microscopy1 and learning unit 5 of Basic malaria microscopy, Part I3);
• waste management of malaria tests: standard operating procedures (see Annex 6) and, for RDT, 
pocket guide (see pages 20 to 29 of WHO/FIND Transporting, storing and handling malaria 
RDT in health clinics4); and
• proficiency testing (external quality assessment) for microscopy: standard operating proce-
dures (see Annex 7).
4.2.6 Accreditation of microscopists
Accreditation of the competence of microscopists can significantly improve the 
accuracy of malaria diagnosis by microscopy and raise the confidence of the 
microscopist.5 It is recommended that national programmes: 
• establish a national malaria microscopy accreditation system;
• give formal recognition to the skills of individual microscopists;
• set up a training programme linked with the accreditation system to improve 
the competence of microscopists working at each level of the laboratory network;
• monitor and record their competence continuously; and
• provide a career path for certified microscopists.
It is recommended that accreditation be time-limited and, for the best-performing microscopists, 
should be valid for no more than 3 years. Earlier reassessment should be available for those who 
are not performing well. 
1 Bench Aids for Malaria Microscopy. Geneva, World Health Organization, 2010. Available at: 
 http://apps.who.int/bookorders/anglais/detart1.jsp?sesslan=1&codlan=1&codcol=15&codcch=3294
2 Malaria microscopy quality assurance manual, version 1. World Health Organization, Regional Office for the West-
ern Pacific, 2009. Available at: 
 http://www.who.int/malaria/publications/malaria_microscopy_QA_manual.pdf
3 Basic malaria microscopy, Part I. Learner’s guide, second edition. Geneva, World Health Organization, 2010. Avail-
able at: 
 http://whqlibdoc.who.int/publications/2010/9789241547826_eng.pdf 
4 Transporting, Storing, and Handling Malaria Rapid Diagnostic Tests in Health Clinics, 2009. Available at: 
http://www.wpro.who.int/NR/rdonlyres/269BF1DC-BA7C-4422-A16E-F73016DA17B5/0/MalariaRDT_
REMOTE_2009web.pdf
5 Malaria microscopy quality assurance manual, version 1. World Health Organization, Regional Office for the West-
ern Pacific, 2009; sections 5 and 6. Available at: 
 http://www.who.int/malaria/publications/malaria_microscopy_QA_manual.pdf
55
4.2.7 RDT lot-testing
Because lot-to-lot variation in diagnostic performance is found for most malaria 
RDTs, it is good practice implemented by a number of funding and procurement 
agencies to test all lots (batches) of RDTs before deployment to the field.1 Lot-
testing can be done: 
• before shipment, directly arranged with the manufacturer and a lot-testing 
centre; 
• after shipment and delivery to the central warehouse and before distribution to the field; or
• after distribution to peripheral health facilities, to investigate reports from the field of unex-
pected test results.
Several funding agencies require pre-shipment lot testing and procure only production lots that 
meet the lot-testing requirement. Procurement agreements should include replacement of failed 
lots. 
During lot-testing, RDTs are evaluated against a small panel of parasites at low densities and 
against negative samples. The RDTs are subsequently incubated at a temperature close to the 
manufacturer’s specified storage temperature and retested at intervals until their expiry date. 
Initial results are available after 5 working days following receipt of the RDTs by the lot testing 
centres.2 
4.2.8 Monitoring the quality management system
Performance indicators (see section 8.1) should be chosen on the basis of data collected by health 
facilities and reported through the national health information management system or, possibly, 
during on-site supervisory visits. In addition to routine data, problems reported from peripheral 
health facilities should prompt additional on-site quality monitoring. To monitor improvements 
over time, it is essential to collect performance indicator data regularly over a long period. The 
main problems identified during supervisory visits should also be reported at secondary or cen-
tral levels.
The main components of monitoring performance in malaria diagnosis are shown in Figure 9.
4
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1 Good practices for selecting and procuring rapid diagnostic tests for malaria. Geneva, World Health Organization, 
2011. Available at: 
 http://whqlibdoc.who.int/publications/2011/9789241501125_eng.pdf
2 Lot testing of Malaria Rapid Diagnostic Tests: Quality benefits all. Geneva, World Health Organization/FIND, 2009. 
Available at: 
 http://www.wpro.who.int/NR/rdonlyres/8DF454F7-1183-4930-8A39-80E225521AB9/0/Lot_testing_
brochure.pdf
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4.3 Quality management activities at subnational level
The subnational (provincial or district) level should organize quality management activities coor-
dinated by the national reference laboratory, such as a microscopy proficiency-testing scheme 
(reading sets of reference slides sent to peripheral laboratories) with slide sets prepared at national 
level. The following activities can also be conducted at points of care (see section 4.3):
Supervision visits of laboratories (see section 4.4.1): The laboratory focal person should supervise 
laboratories at peripheral level by on-site visits using a standard supervisory checklist (see Annex 
8). This should identify problems in performance that may need correction.
Monitoring competence in malaria testing (see section 4.4.2): Direct observation of health workers 
performing RDTs should be integrated into the routine on-site supervision of health facilities 
(see Annex 10). Direct observation of microscopists preparing, staining and reading blood slides 
should be included in supervisory visits to laboratories (see Annex 9).
Validation of routine blood slide results (cross-checking) (see section 4.4.3): Assessment and cross-
checking of routine blood slides at peripheral laboratories should be performed only by the sub-
national reference laboratory or, preferably, during on-site supervision visits. A third reading of 
a sample of slides or of discrepant slides by the national reference laboratory should be avoided.
FigUre 9. 
example of main components for monitoring performance in malaria diagnosis
Adapted from walter reed Army institute of research (2010). malaria microscopy and rapid diagnostic testing quality manage-
ment resource manual. Fort detrick, texas. 
white boxes apply to all health facilities (with or without a laboratory); orange boxes apply only to health facilities with 
laboratory capacity.
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Temperature monitoring of RDT storage in health facilities (see section 3.4): Recording tempera-
ture in storage places should include the daily maximum temperature, which is monitored by the 
supervisor as part of routine on-site supervision of health facilities.
To be effective, it is recommended that the number of supervisors in a province or district be 
based on: the number of people with the necessary skills to be supervisors, the workload of super-
visors, the frequency of supervision required, ease of access to health facilities in terms of dis-
tance and available transport and financial resources for supervision. Reference laboratories at 
subnational level should be closely monitored by the national reference laboratory and participate 
in all quality management activities.
4.4 Quality assessment at points of care
For health facilities with a laboratory facility, the quality management activities for microscopy at 
points of care are generally better handled during on-site visits by laboratory supervisors. These 
visits will also allow evaluation of laboratory technicians’ competence to perform microscopy 
and RDTs. Supervisory visits can be used to assess health workers’ performance in handling 
patients with fever and to assess clinicians’ use of laboratory test results.
For health facilities without a laboratory and for community health workers, all quality assess-
ment activities for RDTs should be integrated into routine supervisory visits that include patient 
management. Therefore, clinical supervisors should be trained in all aspects of RDT performance 
and use.
The activities directly related to the quality management system that can be implemented at 
points of care, with their proposed frequency (to be adapted to the local requirements), are listed 
in Table 7.
4.4.1 Supervision visits of laboratories
A baseline assessment of laboratories’ performance in the diagnosis of malaria 
(and if possible of non-malaria causes of fever) should have been performed dur-
ing the initial gap analysis.1 Supervisory visits to peripheral diagnostic facilities 
are important for monitoring performance and to take or facilitate the appro-
priate corrective actions and strengthen communication between the different 
levels of the quality management programme. 
Supervisory visits should be made routinely, at a minimum of every 6 months 
or, if possible, quarterly. During establishment of the quality management system, more frequent 
visits may be necessary. Special visits may be necessary if problems are identified during external 
proficiency testing or cross-checking of blood slide results by reference laboratories. A follow-up 
supervisory visit shortly after a training session is also useful to correct any bad practices before 
they become fixed or to address any concerns of the health workers.2 These visits should be inte-
grated with supervision of the general health services and laboratory quality assessment of other 
laboratory procedures. Joint visits by clinicians and laboratory staff are recommended. Sufficient 
time must be allotted for the visit to include observation of all aspects of the work associated with 
4
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1 Malaria microscopy quality assurance manual, version 1. World Health Organization, Regional Office for the West-
ern Pacific, 2009; table 3. Available at: 
 http://www.who.int/malaria/publications/malaria_microscopy_QA_manual.pdf
2 Malaria microscopy quality assurance manual, version 1. World Health Organization, Regional Office for the West-
ern Pacific, 2009; section 7. Available at: 
 http://www.who.int/malaria/publications/malaria_microscopy_QA_manual.pdf
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Table 7. Activities directly related to quality management at points of care 
Quality management activity Daily Weekly monthly Quarterly yearly
In the laboratory
Check for damage or malfunction of microscopes. X
remove dust from microscopes with a clean cloth. X
Cover the microscope with a dust cover. X
Cover the lens ports. X
Check the expiry date on giemsa stock solution. X
Check that sharps containers that are three quarters full are disposed of. X
Check that infectious waste (non-sharp) plastic bags that are three 
quarters full are disposed of. X
prepare a report on blood slides prepared in the laboratory. X
prepare a report on all rdts performed in the health facility (both 
in the laboratory and in all other places used when the laboratory is 
closed).
X
Archive blood slides for external slide validation. X
read reference slides received for proficiency testing (if applicable). X
directly observe laboratory technicians performing microscopy and 
rdts. X
Check whether standard operating procedures should be updated (beside 
updates when a change occurs). X
perform internal audit of the laboratory in preparation for a supervisory 
visit from the district. X
In the clinic
Check that sharps containers that are three quarters full are disposed of. X
Check that infectious waste (non-sharp) plastic bags that are three 
quarters full are disposed of. X
Clinicians meet to discuss a few febrile cases they managed recently. X
laboratory technicians, clinicians and nurses meet to solve practical 
problems of diagnosis of malaria and non-malaria fevers. X
directly observe health workers performing rdts. X
directly observe clinicians managing febrile patients. X
Check whether guidelines should be updated (beside updates when a 
change occurs). X
At storage places
Check the expiry dates of rdts and ACts. X
Check the maximum temperature at the rdt storage place. X
Check stock inventories to calculate the number of rdts and microscopy 
supplies that have been used. X
At management team level
Check whether a monthly health information management report has 
been completed.a X
Compare the number of positive malaria tests, the number of malaria 
cases reported by clinicians, the number of ACt issued by the main store 
and the number of ACt dispensed to patients.
X
plan in-service training for clinicians and laboratory technicians. X
perform an internal audit of the health facility (or of parts of its 
activities) in preparation for a supervisory visit from the district. X
a while monthly reporting is the minimum recommended frequency, some countries may report more frequently or even in real time through 
electronic or telephonic reporting systems.
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malaria microscopy and RDT, the adequacy and safety of laboratories, the workload of laboratory 
staff and the adequacy of equipment and supplies. A checklist covering aspects of both micros-
copy and RDT assessment should be used (see Annex 8).
The staff of the facility to be evaluated should be informed in advance of a supervisory visit, 
although unannounced visits may be conducted, depending on the conventions in individual 
countries. The report of the supervisory visit should be sent promptly to the laboratory (i.e. within 
14 days) through the usual channels. 
 
4.4.2 Monitoring the competence of malaria test performers by direct observation
Microscopists
A supervisory visit for laboratory monitoring is an opportunity to observe microscopists directly 
while they are preparing, staining and reading routine blood slides (including cross-checking of 
10 to 20 slides if time allows). Use of a checklist to be filled in for each observation separately (see 
Annex 9) is important in order to document each microscopist’s performance, to give him or her 
feedback, to monitor improvement over time and to decide whether refresher training is neces-
sary when the performance is below the national benchmark.
RDT performers
Direct observation of health workers’ competence in performing an RDT (in or outside the labo-
ratory) on a real patient requires human resources and time to visit each health facility regularly 
and observe each health worker at least once. This activity should be integrated into the over-
all health facility supervisory visit. Supervision of RDT preparation and interpretation with a 
standardized checklist is important. An example is given in Annex 10. When possible, corrective 
action should be taken during the visit, which might include retraining in blood collection and/
or RDT preparation or interpretation of the result.
4.4.3 Quality of routine blood slides for malaria
Besides observing laboratory technicians while they are performing microscopy for malaria, it 
is often considered essential to assess the average quality of preparation and staining and, above 
all, the interpretation of blood slides at testing sites in a more systematic way. Many attempts at 
slide cross-checking have, however, failed, mainly because of lack of transport to bring the slides 
to the reference laboratory, the restricted number of qualified microscopists who can cross-check 
the result properly and the delay and even absence of feedback to the peripheral laboratory. It is 
clearly an activity that consumes time and human resources and is difficult to organize for every 
health facility performing microscopy. The priority should thus be the evaluation of subnational 
reference laboratories by the national reference laboratory. 
For peripheral laboratories, it is often more sustainable to examine the quality of slides and to 
cross-check the results of routine slide examination on-site during a general supervisory visit 
rather than asking laboratories to send samples of slides to a reference laboratory for rechecking. 
The number of slides cross-checked during on-site supervisory visits is expected to be, however, 
limited due to time constraints. Therefore results from several supervisory will need to be aggre-
gated to provide meaningful quantitative data. 
Cross-checking of slides by any of the above methods should not replace internal audits in the 
laboratory (see section 4.4.5), which should remain the priority. If internal quality monitoring is 
well organized, external quality monitoring becomes easier and is needed less often.
4
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Quality of routine preparation and staining of slides
Before a supervisory visit, the laboratory should be informed about the visit and asked to keep 
a predetermined number of blood slides (meeting specific criteria) that were routinely collected 
from patients seen at the facility up to that date. During the visit, a randomly selected sample of 
10 to 20 slides should be evaluated on a standard form, including at least: 
• correct size of films;
• correct volume of blood with correct opacity;
• uniformly spread;
• thick film not fixed with methanol;
• no parts of the film washed off;
• correct staining of thick film; and
• no stain precipitate.
As proposed above, these slides should be analysed on-site so that direct feedback can be given 
and corrective action taken immediately. The evaluation should be kept for monitoring improve-
ment over time.
Validation of routine blood slide results (cross-checking)
Routine blood slide results are cross-checked in a blinded re-examination of a selected sample of 
slides by an expert microscopist from a reference laboratory, either on site during a supervisory 
visit or later at his or her own laboratory. The aim is to detect and quantify the number of false-
positive and, especially, false-negative results given by the laboratory under evaluation.
The slides must be rechecked by an accredited malaria microscopist of proven competence, using 
a microscope of good quality and in good condition. A system should be in place to ensure blind-
ed re-examination (for example, the results of the laboratory under examination in the right 
margin, folded and sealed with adhesive tape). A standard form to give feedback to laboratories 
should always be used. The validator must have a thorough understanding of the sources of errors 
and be trained in compiling a summary report with recommendations, which will eventually be 
returned to the laboratory under evaluation (and to the national malaria control programme).
All schemes for slide cross-checking require a minimum quality of slide preparation and stain-
ing. If the quality of slide preparation and staining is suboptimal, the interpretation of the slide 
result will not be reliable. In addition, all schemes for malaria slide cross-checking require that 
the microscopy reading of the reference laboratory has reached a high level of competence. If a 
system of cross-checking is already in place and the quality of reading at subnational laboratories 
is found to be insufficient, the latter might, for example, give feedback only on the quality of slide 
preparation and staining and not on the reading.
The level of investment required to maintain a cross-checking programme should be carefully 
evaluated. Some ways of cross-checking are more demanding than others in terms of human 
resources and logistics. Many countries have designed programmes that are unrealistic in rela-
tion to the capacity of their health system. For example, it might be decided that routine blood 
slides are read during supervisory visits, the advantage being immediate feedback on the result, 
on top of feedback on the quality of preparation and staining. Such a programme requires, how-
ever, a sufficient number of supervisors who have reached a high level of competence in malaria 
microscopy; it also has major limitations, because only a few slides can be cross-checked during a 
single supervisory visit. It might be rather decided that a certain proportion of routine slides are 
to be taken to the reference laboratory for rechecking, but the logistics of receiving slides from 
every participating laboratory every month and giving rapid feedback to each are often unfea-
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sible. Indeed, experience has shown that this approach can overwhelm the reference laboratory 
and, as a result, feedback to the front-line technician is not given. Collecting slides on a quarterly 
rather than a monthly basis might be a viable alternative, as long as the reference laboratory does 
not receive all the slides to be rechecked at the same time.
The viability of all cross-checking programmes depends on their capacity to detect poor perfor-
mance, identify where the problem lies, provide timely feedback and take the appropriate correc-
tive action. The level of congruence that should be reached by all laboratories should be decided at 
national level; at least 90% congruence is expected for positivity detected by microscopy.
A new protocol for selecting a sample of routine slides to be cross-checked is 
proposed in the WHO.1 This protocol is based on monthly assessment of five 
week positive (< 200 parasites/µl) and five negative randomly selected slides. The 
results are analysed monthly and quarterly as percentage agreement between 
field and expert microscopist, with an expected proportion of agreement > 90% 
for an acceptable level of competence. This method is considered more feasible 
than the standard cross-checking of all positive cases and 10% randomly selected 
negative slides, promoted in the past. The new WHO protocol for slide validation has not yet been 
widely implemented, and its capacity to detect false-negative results in low-transmission settings 
is not fully proven.
Even if a fixed number of positive and negative slides are rechecked, the capacity to detect false-
negative results (lack of sensitivity) depends directly of the slide positivity rate. When this rate 
goes down, the chance of detecting false-negative slides becomes low. For example, the chance of 
detecting a lack of sensitivity (< 80%) when cross-checking five slides reported as negative is about 
one in four in a setting where the positivity rate is 20%. This chance goes down to one in eight 
when the positivity rate is 10%. In areas of low malaria prevalence, the sample of negative slides 
to be cross-checked should therefore be increased. When a small number of slides are tested, the 
percentage congruence will fluctuate widely from month to month by chance rather than because 
of real fluctuations of the laboratory’s competence. Therefore, the absolute number of discrep-
ant results (rather than percentage congruence) should be given as feedback. The results should 
always be analysed as trends over time. 
4.4.4 Monitoring the stability of RDTs in the field 
Evaluating the diagnostic performance of RDTs at a point of care by direct comparison with a 
reference test is more difficult than evaluating blood slides, because there is no standardized test 
with which to compare the end-point of RDTs (parasite antigen concentration). Even when expert 
microscopy is available, the results of an RDT and a blood slide performed on the same patient 
never correlate perfectly, as parasite antigen levels do not necessarily correlate with parasite den-
sity, and parasite antigen persists for some time after parasites have cleared from the blood. Some 
countries have chosen to overcome this problem by using, as a standardized comparison, a ‘refer-
ence RDT’, i.e an RDT of the same manufacturer, stored in controlled conditions at central level 
and performed on site by the supervisor on the same patients. 
In view of these difficulties, it is generally better to focus on other parameters that are determi-
nants of RDT diagnostic performance, i.e. ensuring that health workers are competent to prepare 
and read an RDT (see section 4.3.2) and that the storage conditions for RDTs are correct (in par-
ticular by temperature monitoring, see section 3.4). The maximum daily temperature of storage 
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1 Malaria microscopy quality assurance manual, version 1. World Health Organization, Regional Office for the West-
ern Pacific, 2009; section 8 and annexes 5 to 7. Available at: 
 http://www.who.int/malaria/publications/malaria_microscopy_QA_manual.pdf
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rooms can be monitored with minimum–maximum thermometers, and these should be used to 
detect undue exposure to high temperatures, which can affect the performance of the test devices.
Positive control wells are being developed, which would allow testing of the quality of RDT devic-
es with a lyophilized product containing a standardized amount of parasite antigens correspond-
ing to a low parasite density. Once they are available, they will be a useful option for measuring 
the accuracy of RDTs in clinical use. 
4.4.5 Internal audits for malaria testing
The functioning of the various activities that are required for malaria diagnostic testing should 
be reviewed periodically as part of a good quality management system. When the review is done 
by the staff of a health facility rather than external supervisors, this is called an internal audit.
Laboratory staff should conduct internal audits to check their own performance and to ensure the 
reproducibility and sensitivity of laboratory diagnoses. They should examine the elements of the 
quality management system in their laboratory in order to evaluate how well they comply with 
quality system requirements. Effective internal audits ensure a ‘culture of quality’ in peripheral 
laboratories, with the staff understanding the concepts and need for quality assessment. Organi-
zation of internal audits is the responsibility of the laboratory head, but all personnel must be 
involved and have responsibility for maintaining quality in their work area. 
A technician working in isolation should also conduct internal audits, but the 
number of checks that can be done is more limited, and an independent check 
of his or her work by a second technician is more likely to show up errors than 
self-checking. Checks that are feasible, however, should be carried out routinely.1
A standardized form should be used to follow-up improvements over time, which 
may be similar to that used for supervising laboratories (see section 4.4.1 and 
Annex 8). Internal audits procedures should be checked regularly during visits 
by technical staff from supervisory laboratories. Trouble-shooting guides for equipment, reagents 
and methods are also useful, particularly for the most isolated laboratories, where immediate 
help is not available. 
4.4.6 Quality of RDTs performed at community level
Generally, the RDTs used by community health workers are provided by a nearby health facility 
and have thus undergone quality assessment. To ensure the quality of RDTs, the competence of 
community health workers to perform an RDT and to interpret and correctly use the result is eval-
uated during supervisory visits, by direct observation with a standard check-list (see section 4.4.2) 
The temperature at which RDTs are stored should also be monitored. Community health work-
ers should be allocated limited numbers of RDTs, generally no more than they would use in 1–2 
months. This limits damage of RDTs due to poor storage conditions. Cool boxes (not containing 
ice) or locally adapted cooling boxes should be used for storage of RDTs in the field by validated 
methods. 
1 Malaria microscopy quality assurance manual, version 1. World Health Organization, Regional Office for the West-
ern Pacific, 2009; section 10 and annex 12. Available at: 
 http://www.who.int/malaria/publications/malaria_microscopy_QA_manual.pdf
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4.5 Action to be taken in cases of nonconformity with malaria testing
Reacting to nonconformity is a key component of a good quality management system, and all 
procedures should be documented. Health workers should be trained to be attentive to significant 
deviations from expected results in their facilities. If this occurs, the health worker should report 
the incident to their supervisors and request an unscheduled supervisory visit to assess all pos-
sible sources of the problem.
If the problem appears to be with the RDTs currently in use, the batch of suspected poorly per-
forming RDTs should be replaced, if possible, by those from a different batch. If the problem 
appears to be associated with the quality of the RDT, a rapid initial comparison of the results with 
a “reference RDT” or with expert microscopy, if available, should be organized, keeping in mind 
the limitations described in section 4.4.4. In addition, a sample of the suspected batch can be sent 
to a reference laboratory for lot-testing (at the two WHO/FIND reference laboratories in Philip-
pines and Cambodia, or when available a national reference laboratory for RDT lot-testing). 
The aim of the algorithms in Figure 10 is to identify common problems in the field. Problems 
detected at programme level and the corresponding investigations and responses are described 
in section 8.2.
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FigUre 10.
Actions to take on nonconformity in malaria testing
Adapted from msF-oCA malaria manual, version 1, 2008
10.1 Unexpected low positivity rate of microscopy (not due to a decrease in  
malaria transmission)
microscopists examine thick films too quickly
Unsatisfactory technical skill
microscopist’s fatigue
motivation, workload, work pressure etc
incorrect thick film preparation: too thick, too thin 
(see Figure 10.3)
Centre of thick films washed off during staining (see 
Figure 10.4)
incorrect staining: parasites that are not correctly 
stained are more difficult to detect (see Figure 10.5)
Clerical error
staff-related issues
technical issues
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10.3 thick films for microscopy too thick or too thin
too thicka 
too thina 
poor technique
•	 Poor	technique	during	
preparation
•	 Too	much	blood	added	to	
slide 
•	 Under-spreading:	thick	films	
too small
A standard thick film should be 
available to collection staff
no example of thick film 
available for collection 
staff
•	 Drying	slides	unevenly,	
autofixation
•	 Insufficient	blood	added	to	
slide 
•	 Over-spreading:	thick	films	
too large 
three drops of blood from 
an anaemic patient may be 
insufficient for reading slide
A standard thick film should be 
available to collection staff
poor technique
severely anaemic patients
no example of thick film 
available for collection 
staff
microscopists find it safer to call a result ‘weakly 
positive’ rather than ‘negative’
Unsatisfactory technical skill
microscopist’s fatigue
motivation, workload, work pressure etc
incorrect staining: parasites that cannot be identified 
by either colour or morphology are likely to be 
considered artefacts (see Figure 10.5)
stain precipitate
stain with bacterial growth
Clerical error
staff-related issues
technical issues
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10.2 Unexpected high positivity rate of microscopy (not due to an increase in  
malaria transmission)
a newsprint should be just readable through a wet thick film
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10.4 Centre of thick films washed off during staining
thick films too thicka
inadequate drying before 
staining
microscopy slides are oily
washing is too vigorous
slides not washed in 
water of the same ph 
as the stain
slides not thoroughly 
washed
•	 Poor	technique	during	preparation
•	 Too	much	blood	added	to	slide
•	 Under-spreading:	thick	films	too	small	
slide warmer not used in high humidity
•	 Poor-quality	microscope	slides	
•	 Inadequate	washing	of	oily	slides	before	use
water not added gently, starting at end of slide 
furthest from the thick film
10.5 incorrect staining of blood films
poor-quality stain
incorrect ph
diluted stain filtered
diluted stain used > 6 
hours after preparation
•	 High-quality	stain	
not used 
•	 Stain	of	unknown	
quality (repack-
aged by supplier) 
used 
•	 Stain	precipitates	
excessively 
•	 Incorrectly	stored	
near heat source 
or in direct 
sunlight 
•	 Stain	expired
•	 Incorrectly	
prepared 
•	 Prepared	with	
poor-quality 
methanol or 
glycerol contain-
ing oil or other 
contaminants
•	 Incorrectly	stored	
– not in a dark 
glass bottle, 
stored near a heat 
source or direct 
sunlight
•	 Prepared	more	
than 2 years ago
• ph should be 7.2
• ph should be calibrated for 
each batch of buffer
•	 pH	should	be	measured	with	
a ph meter or lovibond 
comparator
•	 Right	quantity	of	buffer	salts	
(or buffer tablets) should be 
used
the 1:10 diluted geimsa stain 
must not be filtered
diluted geimsa must be prepared 
before use
the optimal staining time should 
be calibrated for each new batch 
of geimsa depending on the 
concentration (3% or 10%)
slides should be washed in water 
adjusted to the same ph as the 
stain
staining period  
too short
staining period  
too long
Commercial stain
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10.6 poor quality microscopy related to laboratory staff
technical skill
•	 Poor	initial	training
•	 Lack	of	periodic	refresher	training
•	 Minimum	workload	to	maintain	skill	(>10	slides/
month)
•	 Lack	of	SOPs,	manuals	and	bench	aids
•	 Limited	supervisor	visits
•	 Poor	working	environment
•	 Poor	equipment,	reagents	and	supplies	
•	 Unmanageable	workload
•	 Poor	support	from	management
•	 Insufficient	feedback,	such	as	results	of	quality	
control and from clinical staff
•	 Insufficient	measuring	and	monitoring	of	workload
•	 Laboratory	staff	are	required	to	do	more	work	than	
they can do accurately
•	 Pressure	from	clinicians	at	end	of	day	to	get	results	
out quickly
•	 Pressure	to	keep	up	with	the	workload	-	patients	
and clinicians waiting
•	 Poor	results	caused	by	microscopist’s	fatigue
motivation
workload
work pressure
Fatigue
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10.7 Unexpected low positivity rate of rdts (not due to an decrease in malaria 
transmission)
poor-quality batch of 
rdts no lot-testing of suspected batches
Check temperature record of storage place to 
determine whether temperature was often > 30 °C
rdts exposed to high 
temperatures
problems in 
performance of rdts by 
health workers
insufficient blood in hole because transfer device is 
defective or too large for the hole or because blood 
cannot exit transfer device
Faint lines wrongly interpreted as negative
insufficient buffer placed in hole
blood or buffer placed in wrong hole (for rdts with 
different holes for blood and buffer)
poor visual acuity of health worker
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4.6 Country scenarios
Three country scenarios reflecting frequently observed settings are represented below and 
describe priority actions that national malaria control programmes may consider to scale up 
access to malaria testing.
Country scenario 1: Country with predominantly areas of high risk for malaria (mainly P. fal-
ciparum; non-falciparum monoinfection is extremely rare) and limited areas of low risk; with 
poor microscopy, no quality management system, no use of RDTs and a high malaria burden 
based mainly on reported clinical cases
Parasite-based malaria diagnosis is virtually absent in the country, wastage of antimalarial medi-
cines is very high, and microscopy results, when available, are generally ignored by health pro-
viders in treatment decisions. In rural high-endemic settings where there are shortages of ACT, 
health providers still select patients for malaria treatment on the basis of the results of poor qual-
ity microscopy, and patients may not receive the appropriate non-malaria treatment they need. 
The first step is to identify a coordinator for RDT use and malaria microscopy strengthening, who 
will plan and manage deployment of RDTs as soon as possible and establish, in collaboration with 
the national reference laboratory, a system for quality management of malaria microscopy. Then, 
phased deployment of RDTs at all levels of the health system, including hospitals, is planned. Pri-
orities are set, e.g. starting with low-endemic regions where overdiagnosis is worst. After selecting 
a RDT that detects P. falciparum only and meeting WHO recommended selection criteria, pro-
curement is started with planned delivery before the malaria transmission season. Pre-shipment 
lot-testing is completed before delivery to the central medical store. Transport to subnational 
warehouses (previously inspected to ensure that cool storage is possible) in the selected provinces 
is organized, in parallel with progressive training of laboratory technicians and clinicians in the 
performance and use of RDTs. RDTs are sent to health facilities immediately after the health 
workers return from training to their workplace. A first supervisory visit is organized in the week 
after use of RDTs has begun, to ensure that the storage conditions (including temperature) and 
health workers’ competence to perform RDTs are in line with standard operating procedures 
and that clinicians are adhering to the results of the test and manage test-negative patients on the 
basis of integrated management of childhood, adolescent and adult illness. If possible, training 
of health workers and distribution of RDTs are planned to start during the malaria transmission 
season, when the proportion of positive cases is highest. Regular supervision, integrated into 
scheduled supervisory visits, is organized, with sensitization of the community about the neces-
sity of testing for malaria before receiving antimalarial treatment.
10.8 Unexpected high positivity rate of rdts (not due to an increase in malaria 
transmission)
poor-quality batch of 
rdts no lot-testing of suspected batches
problems in 
performance of rdts by 
health workers
too much blood put in hole and remaining in test 
window wrongly interpreted as a positive test line
thinking there is a test line when there is none from 
fear of missing a faint lineU
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In collaboration with the reference laboratory, a national core group of microscopists is trained 
and accredited in malaria microscopy. A reference slide bank is created, and the certified expert 
microscopists participate in training other microscopists and in setting up and supervising sub-
national reference laboratories in regional hospitals. A quality coordinator at the national refer-
ence laboratory starts to organize a quality management system for malaria microscopy, with 
slide cross-checking initially in subnational reference laboratories. In addition, quarterly labora-
tory supervisory visits will be started, with a checklist (and a score to follow up performance over 
time), and, if possible, external quality assessment with a proficiency-testing scheme. 
The malaria surveillance programme is adapted to include a diagnostic component, and plans are 
made to report on RDT use in the next update of the health information management system.
Country scenario 2: Country with mainly low-risk areas, predominantly P. falciparum malaria, 
good-quality microscopy with a quality management system in place and no deployment of 
RDTs
Parasite-based malaria diagnosis of good quality is available, but only in health facilities with a 
functioning laboratory. A national reference laboratory with accredited, experienced microsco-
pists is in place. The main aim is to extend access to malaria diagnosis to health facilities without 
laboratory services by introducing RDTs, supported by a quality management system for both 
microscopy and RDTs, and to set up a system to monitor the outcomes of the diagnostic strength-
ening programme (including monitoring of the quality management system).
The priority for phased introduction of RDTs is health facilities without laboratory services. In 
addition, a review of the national standards for equipment, supplies and workload will be com-
pleted to identify gaps and needs. RDTs will be introduced to complement malaria microscopy in 
health facilities where laboratories have a heavy work load and for laboratory work ‘after hours’. 
After selection and procurement of an RDT product that fulfils the WHO recommendations, in 
particular with a high panel detection score (in WHO product testing), the national laboratory 
quality team is updated on the tools for strengthening quality management for microscopy and 
trained in the specificity of quality assessement of RDTs. Phased introduction of both RDTs and 
the quality management system is planned to cover the whole country progressively, maintaining 
good coordination of microscopy and RDT activities at each level.
In parallel, a strong sensitization programme on the equivalent performance of RDTs and 
microscopy for the management of malaria is planned for both health-care providers and the 
community.
Country scenario 3: Country with both P. falciparum and non-falciparum malaria, deploy-
ment of P. falciparum-detecting RDTs in the public sector only, heterogeneous quality of 
microscopy and no effective quality management system
Parasite-based malaria diagnosis of good quality is available, including at community level, but 
only in the public sector. The quality management system is weak, and the malaria test used 
most often (RDT for P. falciparum only) does not detect P. vivax monoinfections. The policy is 
therefore that patients with an RDT-negative result should be treated for a possible P. vivax infec-
tion, obviating most of the potential saving of antimalarial medicines. A programme switch to a 
combination RDT is thus decided.
After selection of a few combination RDT products that fulfil the WHO selection criteria for pro-
curement, the first step is to evaluate the ease of use of each product in order to understand the 
training requirements. Then, policies, guidelines and training materials can be updated for use of 
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the new RDT. The malaria treatment strategy should also be updated; for example, a P. falciparum 
line only (and control line) on the RDT indicates ACT; a pan-Plasmodium line only (and control 
line) indicates chloroquine (or ACT, if chloroquine-resistant P. vivax malaria is present); a P. fal-
ciparum and a pan-Plasmodium line (and control line) indicate ACT; a control line only indicates 
no antimalarial medicine; no control line indicates that the test is invalid.
In parallel, quality management of microscopy is reinforced with an implementation plan and 
timelines for proficiency testing, as well as cross-checking of blood slides in areas where the posi-
tivity rate is still > 20%. Private laboratories are involved, by decree, in this new quality assess-
ment strategy. The formal private sector is involved in deployment of the new RDT, and a quality 
management system based on supervisory visits is organized to ensure adherence to the RDT 
result in the private sector.
Key meSSAgeS of SeCTIoN 4
n A well-performing diagnosis programme requires a well-designed, fully implemented qual-
ity management system.
n high quality standards in malaria diagnosis are needed to ensure that clinicians have faith 
in the results they receive. these take time, commitment and human and financial resources.
n the quality management system should be flexible and cover both malaria microscopy and 
rdts.
n the quality management system should have measurable performance indicators for moni-
toring.
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5. training of health workers  
 and supervisors
5.1 Sensitization 
To ensure successful training, the following groups should be sensitized during meetings for this 
purpose:
• national and subnational (provincial and district levels) health managers from the ministry of 
health and the national malaria control programme;
• people in charge of laboratories and health facilities providing malaria diagnostic services;
• clinicians, laboratory staff and paramedics (nurses, pharmacists, community health workers 
and supervisors) involved in malaria diagnosis and treatment in the public sector;
• health workers in the private sector involved in malaria diagnosis and treatment; and
• representatives of the community.
The sensitization meetings should focus on the importance of parasitological confirmation of 
malaria diagnosis, the equivalence of microscopy and RDTs to detect malaria in symptomatic 
individuals and the safety of treating patients on the basis of the malaria test result. They should 
include a demonstration of the performance of a malaria RDT and group discussions on issues 
such as: the tasks and capacity of the focal person for malaria diagnosis at health facilities with no 
laboratory; where and by whom RDTs should be performed in health facilities; the role of clini-
cal and laboratory supervisors in sites with laboratories; blood safety; waste management; beliefs 
and concerns of community members in relation to blood examination and finger-pricking; and 
patient fees and cost recovery.
5.2 organization of in-service training at all levels
5.2.1 Reference laboratories for malaria microscopy
Groups of expert microscopists should be established at national and subna-
tional (if any) reference laboratories. These microscopists should be selected 
on the basis of an objective evaluation made by the national accreditation sys-
tem (see section 4.2.2). WHO recently introduced standard assessment courses 
designed for accreditation of malaria microscopists already in service (WHO 
malaria microscopy accreditation and certification training). These courses, 
based on practical tests, result in accreditation of microscopists according to 
their level of competence.1 
Malaria microscopy refresher training courses should be provided for staff who do not reach the 
level of competence required for their service. The level of training and the length of the course 
1 Malaria microscopy quality assurance manual, version 1. World Health Organization, Regional Office for the West-
ern Pacific, 2009; section 5 and annexes 2 and 3. Available at: 
 http://www.who.int/malaria/publications/malaria_microscopy_QA_manual.pdf
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will depend on the level of expertise to be reached by the trainee. Training of expert microsco-
pists should also include teaching of training and supervisory skills to give them competence in 
teaching malaria microscopy and in supportive supervision for their role as a national core team 
of malaria microscopists attached to the national programme or the national reference labora-
tory. To include all these aspects, training of previously qualified expert microscopists generally 
requires at least 4 weeks. 
The national microscopy quality management programme should maintain a database of course 
participants and their accreditation levels. It is recommended that microscopists keep an indi-
vidual training and competence logbook, in which relevant certificates and qualifications are 
recorded. This should be kept up to date by each microscopist.
An example of a 4 weeks training course on expert malaria microscopy and quality assurance is 
available on the WHO/EMRO website.1 A section on teaching and assessing RDT performance 
(technical aspects of performing the test) may be added (see section 5.2.2) to the course to allow 
the laboratory supervisor to assess RDT use in health facilities with a laboratory.
5.2.2 Tutors and supervisors
Supervisors and tutors should be identified at appropriate levels (i.e. provincial or district) and 
given training in both test performance and supervisory skills, including use of checklists. 
Laboratory tutors and supervisors
Course tutors in microscopy and laboratory supervisors should be trained by accredited national 
trainers with extensive field experience. The training should include not only microscopy, but 
also comprehensive instruction on performance of RDTs, as a laboratory supervisor should be 
able to assess RDT use and interpretation in laboratories in which RDTs are being deployed. 
The objective of laboratory training tutors and supervisors is to cover the areas listed in section 
5.2.3, as well as organizing quality monitoring and assessment at points of care, supervision of 
RDT and microscopy performance and use, and monitoring of 
malaria diagnoses.
Learners’ and tutors’ guides for malaria microscopy are avail-
able.2,3 These guides follow a timetable for a basic malaria micros-
copy training course of 5 weeks, which, for more qualified staff 
can be reduced to 2 weeks for use as refresher training.
RDTs tutors
A manual for tutors to train health workers in use of RDTs is being prepared. It 
should be used in countries, taking into account the epidemiology of malaria in 
different regions, the national algorithm for malaria diagnosis and treatment of 
febrile cases, the type of RDT that will be used, the organization of supervision 
and monitoring and the local perception of malaria diagnosis. An example of a 
timetable for a RDT tutors’ training course of 3 days is given in Table 8. Topics 4 
and 5 (how to perform a RDT; how to read and report RDT results) in this time-
5. trAining oF heAlth workers And sUpervisors
1 Fourth International course on advanced malaria microscopy and quality assurance. WHO/EMRO and Directo-
rate of Malaria Eradication, Sultanate of Oman, 3 February–2 March 2011. Available at: 
 http://www.emro.who.int/rbm/pdf/malaria_microscopy_course_%20oman_2011.pdf 
2 Basic malaria microscopy, Part I. Learner’s guide, second edition. Geneva, World Health Organization, 2010. Available at: 
http://whqlibdoc.who.int/publications/2010/9789241547826_eng.pdf
3 Basic malaria microscopy, Part II. Tutor’s guide, second edition. Geneva, World Health Organization, 2010. Available at: 
http://whqlibdoc.who.int/publications/2010/9789241547918_eng.pdf
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table are covered by the WHO manual on training health workers in using RDTs.1,2 No generic 
manual covering the other topics is presently available.
Based on practical experience, it appears that the tutors’ competence should not be based on only 
a few days of training in a classroom; they should obtain practical field experience before being 
allowed to train others.
Clinical supervisors
In addition, clinical supervisors should be trained to supervise RDT performance and to oversee 
clinicians using diagnostic test results.
5.2.3 Health workers (laboratory technicians and clinicians)
Who should be trained? 
The training should be planned to ensure that health workers actually performing malaria tests 
are enrolled. Clear criteria for selecting trainees should be established. Everyone who will perform 
malaria tests themselves and all clinicians who will use the results of the tests should be trained to 
ensure good test performance and compliance with test results. Subsequent training sessions tar-
geting new staff should be organized at regular intervals. Training of health workers in the formal 
private system should be considered, ideally in parallel with training in the public system.
Performance of malaria tests: Laboratory technicians (including assistant laboratory technicians 
and health technologists) should be considered for microscopy training, but they should also be 
Table 8. example of a timetable for a tutors’ training course (days 1, 2 and 3) 
 or a health workers’ training course (days 1 and 2) for RDT
Day morning Afternoon
1 opening and administrative issues,  
pre-training knowledge assessment
topic 1: the situation of malaria in the country 
and province
topic 2: importance of malaria diagnosis
topic 3: Algorithm for malaria diagnosis and 
treatment of febrile casesa
topic 4: how to perform a malaria rdt 
(demonstration and return practical)
topic 5: how to read and report malaria rdt 
results
2 topic 6: safety, storage, stock and waste 
management
topic 7: supervision and monitoring of malaria 
diagnosis
topic 8: rdt quality management system, 
problem-solving and trouble-shooting
topic 9: preparation of clinical case studies in 
small groups
topic 10: presentation of group work on clinical 
case studies and discussion
topic 11: Community health education on 
adherence to malaria test result
3 training in training of trainers: effective 
communication and presentation skills 
key messages to be communicated and the 
training mode
practical exercise on how to train (as a tutor) 
health workers in use of rdts, using the rdt field 
manual for health workers
planning and running rdt training workshops, 
with a practical session in small groups
presentation of group work on plans for rdt 
training workshop and discussion
operational aspects of the rdt implementation 
programme, including monitoring and evaluation
post-training knowledge assessment, participants’ evaluation and distribution of certificates
a including detecting danger signs and action to take, selecting patients for malaria testing, managing patients with a positive 
result, managing patients with a negative result.
1 How To Use a Rapid Diagnostic Test (Generic Pf only RDT)? A guide for training at a village and clinic level. Available at: 
http://www.wpro.who.int/NR/rdonlyres/43909BF1-A955-4DA3-9470-0F05E0FBA267/0/Generic_pf_
training_manual_web.pdf
2 How To Use a Rapid Diagnostic Test (Generic Pf-Pan RDT)? A guide for training at a village and clinic level. Available at: 
http://www.wpro.who.int/NR/rdonlyres/23DD7DCB-48C4-4CFF-BD45-332F0BE3DCC7/0/generic_PfPan_
training_manual_web.pdf
73
trained in performing RDTs. In order to make diagnostic testing available in places or at times 
of the day when laboratory technicians are not present, other health workers, such as clinicians, 
nurses and pharmacists, should be trained in RDT use. Community health workers should also 
be trained in RDT performance.
Use of malaria tests results in the context of clinical management of patients: All health workers 
giving care to patients with suspected malaria should be trained in using the results of RDTs and 
microscopy in the clinical management of patients. These will generally include physicians, clini-
cal officers, nurses and community health workers. 
Quality assessment of malaria tests: Health workers involved in quality management of malaria 
testing and also laboratory technicians and clinicians performing the tests should be trained in 
quality management. 
What should be taught?
Some topics are common to both laboratory staff and clinicians, while others are more specific 
to groups of health workers. Laboratory staff should learn how to perform malaria tests (RDTs, 
blood slide preparation, examination and interpretation, recording results and internal audits) 
and also understand which test is most appropriate for which patients, as described in sections 
2.3.3 and 2.3.4. The training should focus not only on techniques and skills but also the rationale 
for strengthening malaria laboratory diagnosis in general and in the local context.
Clinicians and community health workers should be trained in performing RDTs but also to 
include the context of malaria diagnosis (level of malaria transmission in the country and in their 
area, policy for malaria diagnosis and treatment), criteria for selection of patients for malaria test-
ing (see section 2.3.3), action to take on a test result, especially when negative, and integrating 
malaria testing into the overall management of patients with fever.
If possible, clinical and laboratory staff should be trained together (in the shared part of the RDT 
training curriculum) to exchange experiences and increase mutual trust. A successful experience 
with such an approach was reported in Uganda.1
Training objectives
For RDTs, the following learning objectives should be covered:
• Explain the importance of malaria diagnosis in the context of malaria control and elimination, 
the local epidemiological context and the local situation of malaria diagnosis. 
• Recognize the basic differences and similarities between RDTs and microscopy.
• Discuss the algorithm for malaria diagnosis and treatment in febrile cases (selection of patients 
for malaria testing, action to take on malaria test result, search for non-malaria causes of fever, 
criteria for referral, advice to the patient on when to return).
• Describe and demonstrate the precautions required when handling blood.
• Demonstrate performance of a malaria RDT (demonstration and practice).
• Know how to read, record and report RDT results, in line with the revised health information 
management system that includes RDT results. 
• Explain the importance of safety, storage, stock and waste management.
• Understand the RDT quality management system.
• Discuss patient counselling on adherence to malaria test results.
1 JUMP Integrated Management of Malaria Training. Uganda Malaria Surveillance project and Infectious Diseases 
Institute. Available at:
 http://www.muucsf.org/umsp/jump.html
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• Solve clinical case studies.
For microscopy, the training objectives are:1
• Know the basic differences and similarities between RDTs and microscopy.
• Know the clinical criteria for selecting patients for malaria testing and the 
action to take on the test result on the basis of the official algorithm.
• Describe and demonstrate the precautions required when handling blood.
• Prepare acceptable, good-quality thick and thin blood films on the same slide.
• Correctly stain blood films for microscopic examination.
• Accurately record patient details and results in the laboratory register.
• Ensure that clinicians receive the result in a timely manner.
• Understand the correct set up, care and maintenance of a microscope.
• Understand the correct procedures for examining thick and thin blood films.
• Reach the level of competence required for the level targeted by the trainee.
• Understand the quality management system for malaria microscopy.
Teaching methods 
The aim of training is to increase general levels of knowledge and understanding about malaria 
diagnosis and treatment in the management of fever (Why?), not only to improve the trainee’s 
skills in performing a malaria test (How?). If the trainees do not understand the rationale behind 
what they are supposed to do, they will not do it. They must therefore be given the evidence on 
which the guidelines are based and be convinced that they are being taught the best clinical or 
laboratory practices. For clinicians, this training should be integrated (whenever possible) with 
training on management of febrile patients, including non-malaria causes of fever, such as acute 
respiratory infections and diarrhoea.
An interactive approach with both theoretical and practical sessions should be considered, 
including provision of clinical algorithms for malaria diagnosis (see section 2.3.4), case stud-
ies, role-play and frequently asked questions. Trainees should understand the rationale for use 
of quality-assured microscopy and RDTs, especially as experience in many settings is based on 
presumptive treatment or poor-quality microscopy-based diagnosis. Time should be spent on the 
rationale for not giving an antimalarial medicine to patients with a negative malaria test result. 
The teaching should stress the evidence for the safety of this strategy, as it is critical for clinicians 
to change their behaviour (Table 9). The reasons for taking safety precautions when drawing 
blood should be reinforced.
Clear messages should be given at the end of the training sessions, such as:
• Do not ask for a malaria test in the absence of a history of fever or elevated temperature.
• Do not give antimalarial medicines when the result of the malaria test (reliable RDT or reliable 
microscopy) is negative.
• Look for other causes of fever whenever the malaria test result is negative or positive.
• Do not give antibiotics without a clear indication (in children, follow Integrated Management 
of Childhood Illness (IMCI)).
1 Malaria microscopy quality assurance manual, version 1. World Health Organization, Regional Office for the West-
ern Pacific, 2009; section 6. Available at: 
 http://www.who.int/malaria/publications/malaria_microscopy_QA_manual.pdf
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• Tell the patient to return for worsening symptoms or persisting fever.
Training material
Inter-country exchanges and sharing of experiences can be helpful in preparing training material.
RDTs: Generic material is available,1 which should be adapted to the RDT products chosen by 
the country and translated into local languages. For certain commercially available tests, the 
Foundation for Innovative New Diagnostics have issued versions that are ready to use.2
The generic documents depend of the type of RDT that will be used: type 1: P. falciparum-only 
tests; type 2: combination Pf-pan tests in which the P. falciparum band is next to the control band; 
type 3: combination pan tests in which the pan-Plasmodium 
band is next to the control band.
Job aids for performing a malaria RDT (Types 1–3): How to do 
the rapid test for malaria3,4,5
Training manuals on use of RDTs (Types 1–3): How to use a rap-
id diagnostic test (RDT)6,7
Table 9. Published clinical studies supporting the safety of withholding antimalarial treatment 
 for patients with a negative malaria test result
Reference Country Population studied Setting of study 
njama-meya et al. (2007). 
Malaria Journal, 6:7.
Uganda Children under 
5 years
hospital with expert microscopy, 
area highly endemic for 
P. falciparum
ngasala et al. (2008). 
Malaria Journal, 7:199.
United republic of 
tanzania 
(main land)
Children under 
5 years
dispensaries with routine 
microscopy, area highly endemic 
for P. falciparum
msellem et al. (2009). 
PLoS Medicine, 
6:e1000070.
United republic of 
tanzania (Zanzibar)
Children and adults dispensaries with routine rdts, 
area of low endemicity for 
P. falciparum
d’Acremont et al. (2010). 
Clinical Infectious 
Diseases, 51:506–511.
United republic of 
tanzania
Children under 
5 years
dispensaries with routine rdts, 
areas of moderate and high 
endemicity for P. falciparum
1 Malaria RDT Job aids and Training Manuals. WHO/FIND. Available at:
 http://www.wpro.who.int/sites/rdt/using_rdts/training
2 Training material for malaria RDTs. FIND. Available at:
 http://www.finddiagnostics.org/programs/malaria/find_activities/rdt-job-aids
3 Job Aid – How To Do the Rapid Test for Malaria (Generic Pf only RDT)? Modified for training in the use of the 
Generic Pan-Pf Test for falciparum and non-falciparum malaria. Available at: 
 http://www.wpro.who.int/NR/rdonlyres/F8C3BCCE-780B-4182-8166-546005012C83/0/GenericPfJobAid_
lowres.pdf
4 Job Aid – How To Do the Rapid Test for Malaria (Generic Pan Pf RDT)? Modified for training in the use of the 
Generic Pan-Pf Test for falciparum and non-falciparum malaria. Available at: 
 http://www.wpro.who.int/NR/rdonlyres/4EB21BD1-70B4-40FE-8BC5-614B3ED6EBF6/0/GenericPanPf-
JobAid_lowres.pdf
5 Job Aid – How To Do the Rapid Test for Malaria (Generic Pf-Pan RDT)? Modified for training in the use of the 
Generic Pan-Pf Test for falciparum and non-falciparum malaria. Available at: 
 http://www.wpro.who.int/NR/rdonlyres/74C2B789-6B94-4D70-AD70-A6CFA89AFD49/0/GenericPfPan-
jobaid_lowres.pdf
6 How To Use a Rapid Diagnostic Test (Generic Pf only RDT)? A guide for training at a village and clinic level. Available at: 
http://www.wpro.who.int/NR/rdonlyres/43909BF1-A955-4DA3-9470-0F05E0FBA267/0/Generic_pf_
training_manual_web.pdf
7 How To Use a Rapid Diagnostic Test (Generic Pf-Pan RDT)? A guide for training at a village and clinic level. Available at: 
http://www.wpro.who.int/NR/rdonlyres/23DD7DCB-48C4-4CFF-BD45-332F0BE3DCC7/0/generic_PfPan_
training_manual_web.pdf
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Guidance on the interpretation of RDT results using pictures (types 1–3): Malar-
ia generic RDT results guide1
Exercises (questions and answers) for interpretation of RDT results based on 
pictures (types 1–3): Generic quiz examples (quiz 1, quiz 2, quiz 3)1 and Generic 
answer sheets for quizzes1
The aim of this material is to teach the performance and use of 
an RDT. It does not include information on how to use the test in 
the clinical management of febrile patients nor on when to use an 
RDT rather than microscopy. To teach these aspects, case stud-
ies can be prepared and adapted to the national guidelines on 
the management of malaria and non-malaria fevers. Five clinical 
case scenarios used to teach clinicians or to measure their com-
petence at integrating malaria testing into the management of 
fever cases are given in Annex 11 (questions and answers).
Microscopy: The following material is available: 
Bench aids for preparing, staining and interpreting malaria 
blood slides: Bench aids for malaria microscopy2
Training manuals for performing malaria microscopy: Basic 
malaria microscopy, Part I, Learner’s guide3 (This manual comes 
with a CD-ROM on malaria microscopy that can be used in the training sessions and for self-
teaching)
How should the training be organized?
A schedule should be drawn up for administering the training packages (for RDTs and micros-
copy), with details of who, when, where (national, provincial, district or community levels) and 
what will be taught. The relevant authorities should be involved in planning and conducting the 
training (e.g. ministry of health, provincial managers, nongovermental organizations). 
Training should be conducted in anticipation of the malaria transmission season, to avoid sud-
denly confronting health workers with the low positivity rate of the dry season, which they may 
not believe. In addition, training should be timed to coincide with distribution of the necessary 
equipment and supplies, including gloves and sharps boxes. These should arrive immediately 
after the training has been completed, so that the health workers can apply what they have learnt.
The length of the training sessions for microscopy depends on the target audience: for novice 
microscopists, WHO recommends 4–5 weeks; for already trained laboratory technicians requir-
ing refresher training, WHO recommends 2 weeks with the training materials listed above. For 
RDTs, the training course with the presently available manual1 can be completed in one half day 
(3.5 h). Based on practical experience, in places where changing treatment practices on the basis 
of test results is the main focus, a 2-day training workshop is required, of which half a day is gen-
erally dedicated to performance of the test itself and the rest on the other topics described under 
‘What should be taught’ (see Table 8). 
1 Malaria RDT Job aids and Training Manuals. WHO/FIND. Available at: 
 http://www.wpro.who.int/sites/rdt/using_rdts/training/
2 Bench Aids for Malaria Microscopy. Geneva, World Health Organization, 2010. Available at http://apps.who.int/
bookorders/anglais/detart1.jsp?sesslan=1&codlan=1&codcol=15&codcch=3294
3 Basic malaria microscopy, Part I. Learner’s guide, second edition. Geneva, World Health Organization, 2010. Avail-
able at: http://whqlibdoc.who.int/publications/2010/9789241547826_eng.pdf
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The maximum number of participants at a training session should also be defined: for RDTs, a 
training session usually involves 20–30 participants supervised by two main tutors who have full 
theoretical knowledge and field experience, and one or two assistants mainly with field experience. 
For microscopy, the number of participants depends on the number of microscopes available, but 
one experienced tutor assisted by one or two microscopists can generally train 20 participants.
The training material should be based on the training objectives and might be adapted from the 
generic material proposed above. The modules for laboratories, health facilities and the com-
munity should be evaluated to ensure their effectiveness for training (learning skills). For RDT 
training, sensitization of health managers and training sessions for national trainers, tutors and 
supervisors should be planned. If feasible, plan for delayed rather than immediate training of 
RDT performers, to leave time for tutors to gain experience in using RDTs in the field.
Organize accreditation of microscopists and training of RDT performers. Whether refresher 
training is necessary to maintain competence in RDT use is controversial. For RDTs, experience 
in the United Republic of Tanzania and Zambia showed that performance was maintained with-
out formal retraining for 18 and 12 months, respectively. Maintenance of skills requires however 
effective routine supervision and a working quality management system. If refresher training 
is planned, the learning objectives should be clarified, and they should be different (focused on 
trouble-shooting) from that of the initial training. 
Plan for earlier supervision if performance is considered to be poor on the basis of the results of 
quality monitoring and supervisory visits. Additional supervisory visits should be arranged, and, 
if the problem persists, the health workers might benefit from corrective training. If, after sup-
portive supervision and corrective training, malaria test performers fail to improve, they should 
not be permitted to perform RDT or microscopy and report on a malaria test result.
5.2.4 Community health workers
Community health workers should be trained in the performance of RDTs and to interpret and 
use the result. The topics to be covered in the training sessions are the same as for facility-based 
clinicians (see section 5.2.3). Integrated community case management for both malaria and non-
malaria diseases is now recommended instead of home-based management of malaria, which 
addressed only malaria and not the frequent diseases that can be safely managed by community 
health workers. Therefore, training in malaria diagnosis should be integrated into broader train-
ing on the management of the main causes of illnesses (for children aged less than 5 years, to 
include malaria, acute respiratory infections and diarrhoea, see Figure 3), depending on national 
policy. This integrated approach will also reduce the temptation of community health workers to 
treat RDT-negative patients with an antimalarial medicine, as they will be able to identify and 
treat other common diseases.
Community health workers tend to adhere to malaria test results better than formal clinicians. 
They nevertheless need to be taught how to educate the community on the utility of malaria testing 
before treatment rather than requesting treatment on the basis of a clinical diagnosis alone. Train-
ing should include how to identify the danger signs that require immediate referral and adminis-
tration of pre-referral treatment (for example, rectal artesunate and antibiotics for children).
5.3 Integration into pre-service training
Paradigms in medicine, particularly on how to manage patients, are changing rapidly with the 
accumulation of new scientific knowledge. These changes must be integrated as quickly as pos-
sible at points of care and also at pre-service levels. For example, the new policy on diagnostic 
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testing for malaria before treatment should be included immediately in pre-service training cur-
ricula.
To ensure proper use of malaria tests (and of diagnostics in general), students should learn to 
recognize the patient’s probability of having a certain disease, the useful clinical predictors for 
those diseases, and which laboratory test(s) should be performed to support the diagnosis, or, if 
no laboratory test is available, whether presumptive treatment should be given. Evidence-based 
practice guidelines are constructed from this approach and should be the core of in-service train-
ing on the management of malaria and non-malaria fevers, rather than the classical description of 
all possible symptoms, signs, tests or treatments for each disease. This will prepare health work-
ers, once in service, to quickly understand why a recommendation or policy has been changed.
5.4 Training in integrated management of fever
To improve clinicians’ adherence to malaria test results when deciding whether to prescribe an 
antimalarial treatment, they must be trained not only on malaria diagnosis but also on the man-
agement of fevers in general. Clinicians should be trained on the epidemiology of non-malaria 
causes of fever, the clinical predictors of these alternative diagnoses (e.g. ‘cough and fast breath-
ing’ for pneumonia in children under 5 years of age), the laboratory tests for confirming these 
diagnoses, when available (e.g. urine dipstick or microscopy for suspected urinary tract infection) 
and how to treat these conditions (e.g. no antibiotic for upper respiratory tract infections or other 
viral causes of fever).
In the same way that reliable laboratory tests are essential for the rational use of medicines, reli-
able clinical assessments of patients are essential for the rational use of laboratory tests. Because 
malaria tests have high diagnostic performance (in comparison with diagnostic tests for most 
other infectious diseases), the decision to treat malaria is based on the test result only and not on 
the symptoms or signs presented by the patient. For this reason, clinicians often consider that pre-
cise history-taking and physical examination are no longer necessary if a reliable test for malaria 
is available. During training, it is therefore essential to correct this misconception by explain-
ing the poor specificity of multiple signs and symptoms in the diagnosis of malaria (see section 
5.3). Clinical elements are, however, essential for deciding whether to test the patient (e.g. fever 
or palmar pallor: test for malaria; fever in child aged < 2 years or urinary complaints: test with 
urine dipstick) and whether to give treatment on the basis only of clinical manifestations (e.g. 
cough and fast breathing: give antibiotics). Clinicians should spend the necessary time to assess 
the patient clinically in order to avoid missing non-malaria causes of fever and indiscriminately 
using a broad range of laboratory tests. 
Evidence-based decision charts should be given to clinicians and community health workers to 
improve the management of patients and the rational use of antimalarial and antibiotic treat-
ments. This will help to protect both categories of medicines against rapid development of resist-
ance. The Integrated Management of Childhood Illness (IMCI) algorithm has been now updated 
to include a diagnostic test for malaria in the ‘fever box’ (see Figure 2). The appropriate decision 
charts (for example, Integrated Management of Childhood Illness (IMCI) for primary care, blue 
pocket book for district hospital) should be included in the training of all type of clinicians, 
including senior clinical officers and physicians, adapting the way of explaining the scientific 
evidence to their level of knowledge. 
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n if possible, clinicians and laboratory technicians should be trained together in rdt perfor-
mance and use, to allow exchanges and reinforcement of mutual trust.
n Clinicians should be trained not only on how to perform an rdt but also on who should be 
tested and how to use the test result for the clinical management of patients.
n Clinicians should be reassured about the safety of withholding antimalarial treatment from 
patients with a negative malaria test result.
n Clinicians should be trained on how to advice patients on when to return to the health 
facility
n to increase adherence to malaria test results, clinicians should be given decision charts 
and appropriate tools for managing both malaria and non-malaria febrile illness.
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6. supervision at points of  
 care (health facilities and  
 the community)
Supervision is conducted to assess the quality and performance of diagnostic testing on site by 
qualitative surveys at all levels of service delivery. Supervision involves:
• observation of procedures;
• verification of recorded and collected data; 
• identification of constraints and causes of deficiencies;
• identification of corrective measures;
• provision of on-site reorientation, training and mentoring; and 
• formulation of recommendations for improvement.
When possible, supervision of malaria diagnosis should be integrated with that of the clinical 
management of malaria and of febrile patients in general. Some countries have begun to inte-
grate supervisory programmes for malaria into those for HIV, tuberculosis and other vertical 
programmes.
All health facilities and communities in which malaria diagnostic services are provided should 
undergo regular supervision. The recommended frequency is at least once every 6 months, but 
this can be adapted to country specific needs. Integration of supervisory activities for efficient use 
of resources must be encouraged, but not at the cost of incomplete supervision. 
Supervision includes direct observation of clinicians during patient assessment 
and care,1 (see Annex 13) assessment of laboratory services (see section 4.4) and, 
if possible, interviews with patients.
To avoid duplicating visits, health facilities supervision should also include com-
ponents of quality management for malaria diagnostics, such as:
• the availability and regular use of standard operating procedures and bench 
aids;
• competence in performing RDTs, by direct observation of health workers performing an RDT 
and interpreting the result (see Annex 10);
• quality of microscopy for malaria (and if possible for non-malaria testing), including: 
 — monitoring microscopists’ competence by direct observation of preparing and staining 
blood slides (see Annex 9); and 
— validation of routine slide results (cross-checking), by re-reading a selection of slides to 
review and giving feedback on blood film preparation and staining, accuracy of diagnosis 
and reporting (if reading of the same slide by an expert microscopist is possible on site), (see 
section 4.4.3);
1 Malaria case management: Operations manual. Geneva, World Health Organization, 2009; annex 8. Available at: 
http://whqlibdoc.who.int/publications/2009/9789241598088_eng.pdf
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• RDT storage (general conditions and temperature) (see section 3.4);
• stock management (see section 3.5);
• waste management (see section 4.2.5);
• internal audits (see section 4.4.5); and
• equipment (including calibration) and its maintenance (see section 3.6).
Standardized supervisory checklists should be drawn up for each country, all of which should 
include: 
Laboratory (see section 4.4.1 and Annex 8):
• prior training of staff;
• availability of reference documentation and training tools;
• water and power supply;
• working environment (bench space, lighting, ventilation) and furniture;
• laboratory equipment and supply (system, functionality, maintenance);
• slide preparation and labelling (see Annex 9);
• slide staining (see Annex 9);     
• slide reading and storage (see Annex 9);
• performance of non-malaria tests (e.g, urine dipstick, microscopy of urine or stools, haemo-
globinometer, glucometer);
• blood safety and waste management;
• compliance with all standard operating procedures, including slide validation, if operational; 
and
• recording and reporting results.
RDTs (see Annex 12):
• prior training of staff;
• availability of reference documentation and training tools; 
• stock management (including expiry date);
• storage conditions;
• RDT preparation and reading (see Annex 10);
• safety and waste management (see Annex 6);
• compliance with all standard operating procedures; and
• recording and reporting results.
Clinicians and health facility staff in general (see Annex 12):
• existence of a quality management system; 
• prior training of staff;
• observation of fever diagnostic procedures (see Annex 13);
• availability of reference documentation and training tools;
• specimen collection;
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• safety and waste management  (see Annex 6);
• compliance with test results;
• recording, reporting and transmitting results to the appropriate health authorities;
• compliance with all standard operating procedures; and
• appropriate timing of consultations (not too short, reasonable waiting time, covering the 
expected time slot).
The level of adherence of health workers to the criteria for patient selection for malaria testing 
and prescription of antimalarial medicine on the basis of the test result should be a central part 
of clinical supervision. In addition to direct observation of clinicians (whose behaviour might 
be different from usual, knowing that they are observed), such information can be obtained by 
comparing, for a defined period (e.g. the past 3 months), the following data from the available 
registries:
• number of patient attendances;
• number of malaria tests performed (RDTs and blood slides); 
• number of positive malaria tests (microscopy and RDTs); 
• number of malaria cases reported; and
• number of courses of antimalarial medicines issued by the main store or dispensed to patients.
The number of malaria tests performed should be lower than the number of attendances, the 
ratio depending on the criteria for suspecting malaria and on the type of patient (mostly acutely 
ill, or also with chronic or special medical conditions) attending the health facility. The number 
of confirmed positive malaria cases (by microscopy and RDTs) should be close to the number of 
antimalarial courses issued by the main store. Moreover, the number of positive malaria cases 
(confirmed by microscopy and RDTs) should be close to the number of malaria cases reported, if 
all suspected malaria cases are tested, as per the recommendations.
Obtaining these data during supervision allows immediate corrective action if the numbers do 
not tally. For example, if the monthly number of antimalarial courses recorded in the prescription 
book is much higher than the number of positive malaria tests recorded in the laboratory, clini-
cians should be asked why they do not adhere to the test results.
The outcomes of supervision can be compared over time for each health facility. They should not 
be aggregated, because outcomes are specific to each health facility and indicate further specific, 
focused technical support. 
Key meSSAgeS of SeCTIoN 6
n regular supervision is the mainstay of a successful malaria diagnostics programme.
n during supervision, health workers must be observed directly while performing an rdt or 
microscopy to ensure strict adherence to standard operating procedures.
n supervision should also include observation of clinicians attending patients to ensure 
their adherence to malaria test results, their ability to manage malaria-negative patients and 
their ability to advise patients on when to return.
n the observations and corrective actions taken during supervisory visits should be docu-
mented on checklists, to give prompt feedback and to monitor changes over time.
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7. information, education  
 and communication
7. inFormAtion, edUCAtion And CommUniCAtion
7.1 Preparing a communication plan
Universal access to malaria diagnostic testing requires a major shift, from presumptive treatment 
of febrile episodes to treatment based on test results. This change in behaviour requires a change 
in health workers’ and patients’ attitudes and habits with regard to fever. This should be the focus 
of an information, education and communication campaign.
Communication for behavioural change is a specialized intervention, which requires the involve-
ment of technical groups from the ministry of health and specialized international and national 
nongovermental organizations or agencies. All the stakeholders – policy-makers, government, 
multilateral and bilateral agencies, medical and pharmacy societies and associations, nongover-
mental organizations, community-based organizations, hospital organizations and community 
and private sector representatives – should be brought together to determine what changes in 
behaviour should be achieved with the communication activities. The main outcomes should be:
• rational use of medicines by patients: active demand for proper diagnoses; no demand for 
antimalarial medicines when a malaria test is negative or for antibiotics in the case of upper 
respiratory tract infections; and no demand for injections for uncomplicated illnesses; and
• correct diagnostic and medicine-dispensing practices by health-care providers: confirmation 
of a malaria diagnosis by microscopy or RDT, reliability of test results, compliance with posi-
tive and negative test results, and prescription of antibiotics when, and only when, indicated.
The behavioural objectives and results should be specific, measurable, achievable, relevant and 
time-bound (Table 10). 
Once the behavioural outcomes have been defined, the roles and responsibilities and the time-
frame for communication activities of different partners should be stated. Then, determine how 
the communication plans will be funded, implemented, coordinated, monitored, documented 
and reported. Once the target audience has been chosen (e.g. population at-risk or by age, gender 
or geographical area), the messages to be communicated should be designed, with the communi-
cation delivery channels (Table 11). 
Monitor the communication plan and strategy in the field and evaluate and revise the plan 
accordingly.
7.2 Roles and responsibilities
A sustainable change can be brought about in a population only if people at all levels actively 
promote malaria diagnostics and rational use of medicines: 
• Central level: Prepare and finance a plan for advocacy, communication and social mobilization.
• Intermediate level: Diffuse the messages as widely as possible.
• Peripheral level and community: Adopt the messages and transmit them through the agreed 
delivery channels, e.g. during routine interactions with patients and community members, 
particularly those with influence, such as teachers and village leaders.
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Table 11. Type of communication for urban and rural target audiences
Target audience Urban Rural
men radio, television, places of worship, 
announcements, newspapers
places of worship, radio, community 
health workers, announcements
women health clinics, television, radio, antenatal 
clinics, community health workers, newspapers, 
places of worship, announcements
Community health workers, antenatal 
clinic, husbands, places of worship, 
announcements 
young people schools, university, television, radio, 
newspapers, places of worship, announcements
schools, radio, places of worship
returnees radio, television, places of worship, 
announcements, newspapers
places of worship, radio, community 
health workers
nomads radio, vaccination programmes radio, vaccination programmes
the above communications channels are given as example only, and appropriate communication channels for each of the target 
audiences should be identified and will vary in countries for different population groups.
Adapted from Communication for behaviour impact strategic plan for Afghanistan, 2008–12.
Table 10. example of behaviour objectives of a communication strategy for malaria 
 diagnostics: Priority problem: adherence to test results (health professionals and 
 the general public)
Communication challenge or 
behaviour problem
Clients and health professionals disregard laboratory results, especially a 
negative rdt result, and treat for malaria anyway. they believe that the 
symptoms indicate malaria and do not believe the test result.
target audience primary: patients, service providers
secondary: community leaders, community owned resource persons
Communication objective increase the percentage of clients and health professionals who act in 
accordance with laboratory test results for malaria.
main messages 1.  malaria laboratory tests are accurate and should be believed.
2.  disregarding laboratory results delays proper treatment and results in 
more harm than good.
3.  laboratory testing techniques and equipment have been improved.
message delivery channels television and radio spots, print media, health facilities
key promises treating malaria on the basis of laboratory results will lead to rational 
use of antimalarial medicines.
Following the results of laboratory tests will reduce exposure to multiple 
treatments and adverse drug reactions.
desired actions and responses patients and health workers follow the guidelines for treating or not 
treating on the basis of the result of the laboratory test.
source: Communication strategy for malaria control interventions, United republic of tanzania 2008–2013.
Key meSSAgeS of SeCTIoN 7
n the main focus of a communication plan is to shift behaviour from presumptive treatment 
to treatment based on test result.
n messages specific to the type of diagnostic test intended for use should be pre-tested in 
the field.
n Communication and education activities should be synchronized with training and distri-
bution of the diagnostic test.
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8. monitoring and evaluating  
 the programme 
8.1 establishing indicators and monitoring 
8.1.1 General indicators 
The framework for measuring the performance of a malaria control programme includes infor-
mation about the programme, such as inputs, activities and outputs (for example, number of 
RDTs delivered in one year), and information from populations and health facilities, such as 
outputs and outcomes.1 This section on monitoring and evaluation covers the output and income 
measures, while section  9 covers the impact on malaria surveillance.
Monitoring is based on assessments of monthly data collected through the routine health infor-
mation management system. A small set of key indicators can be analysed continuously at dif-
ferent levels of the health system. Monitoring and evaluation of malaria diagnostic testing are 
important, as parasitological confirmation of malaria diagnoses is essential for a robust surveil-
lance system, which in turn is used for planning and decision-making. As treatment and diag-
nostic testing are interdependent, monitoring and evaluation should always include at least these 
two components as a continuous activity. Monitoring and evaluation of treatment and diagnostic 
testing should also, if possible, be integrated with that of other diseases that cause fever, such as 
pneumonia. A good monitoring and evaluation system should include:
• a defined list of indicators for tracking implementation of malaria diagnostic testing; 
• reliable methods of data collection, analysis and use; and
• a system for providing regular feedback to testing centres.
All indicators should be integrated into the health information management system. If the sys-
tem cannot be updated immediately, a temporary, parallel system for retrieving this information 
should be put in place.
A clear clinical definition should be established for a ‘suspected malaria case’, to guide a decision 
to perform a malaria diagnostic test. Each country should prepare clinical criteria for a suspected 
malaria case on the basis of the probability that the fever is due to malaria. The same definition 
should be used in areas with similar epidemiological patterns of malaria, taking into account 
population movement, and included in the algorithm for diagnosis and treatment used by clini-
cians (see section 2.3.4). 
Health facility registers should be standardized to include at least the age, malaria (and other) test 
results, final diagnosis(es) (uncomplicated or severe) and treatment prescribed to each patient. 
Cases should be classified as ‘suspected’, ‘tested’, ‘confirmed’ (test positive) and ‘treated’, as shown 
in Figure 11. If possible, cases should be stratified by age (children under 5 years, children over 5 
years and adults). 
1 Malaria programme reviews: a manual for reviewing the performance of malaria control and elimination pro-
grammes, trial edition, March 2010. Geneva, World Health Organization, 2010; Table 2. Available at: 
 http://www.who.int/malaria/publications/atoz/whomprmalariaprogramperformancemanual.pdf
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If the data element ‘number of suspected malaria cases’ cannot be obtained from the registry, it 
can be deduced from the number of reported cases as follows (see Figure 11):
Suspected malaria cases = tested cases + not tested cases
Not tested cases = treated cases – positive cases
If the number of patients receiving first-line antimalarial treatment is not available, it can be 
replaced by the total number of malaria cases reported, because clinicians tend to report patients 
whom they have treated for malaria as malaria cases. The assumption behind this formula is that 
malaria-negative patients are not treated with antimalarial medicines (i.e the dotted line in Figure 
11 does not exist). The number of suspected malaria cases obtained will correspond to all patients 
considered by clinicians as possibly having malaria but not necessarily to the number of patients 
who meet the national definition of a suspected case.
This information will form the basis for calculating the core data elements (Table 12), from which 
the indicators for monitoring malaria diagnoses can be calculated (Table 13). The indicators can 
be calculated at various levels (health facility, district, subnational or national).
The main outcome of a programme for strengthening diagnostic services is the ‘percentage of 
suspected malaria cases tested for malaria’. Universal access to malaria diagnostics is reached 
when this indicator is close to 100%. If it is < 100%, there is under-testing of patients, and more 
effort should be made to achieve universal access; if it is > 100%, there is over-testing of patients 
and thus wastage of malaria tests. The latter can be calculated only if the number of suspected 
malaria cases is based on data available in the registry rather than deduced from the other data 
as shown above.
The second main indicator is the ‘percentage of confirmed positive malaria cases receiving first-
line antimalarial treatment (ACT)’. This indicator reflects effective malaria case management. It 
should also be close to 100% in order to promote a decrease in morbidity and mortality due to 
malaria. 
FigUre 11. 
Relations among classifications of malaria cases
Cases treated for malaria
 (any case receiving
first-line antimalarial 
treatment)
Suspected
Tested
(by microscopy or RDTs)
Not tested
(probable or unconfirmed)
Positive
(confirmed malaria)
Negative
(confirmed non-malaria)
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The third main indicator for rational use of antimalarial medicines (at least of first-line treatment) 
is the ‘percentage of first-line antimalarial treatment (ACT) used for confirmed malaria cases’. It 
should be close to 100%. When this is the case, there is no wastage of ACTs to treat unconfirmed 
or even negative malaria cases.
The positivity rate of RDTs or malaria blood films (slide positivity rate) is an important indicator 
in malaria surveillance; however, it may also indicate a local problem in the accuracy of RDTs or 
microscopy if a sudden, unexpected change (not explained by the seasonality of malaria trans-
mission or by an epidemic) is noted in a certain geographical area (see Figures 10.1, 10.2, 10.7 and 
10.8).
Indicators based on data provided by sources other than the health information management 
system can also be used, such as the quantities of RDTs and ACTs ordered by health facilities or 
8
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Table 12. Core data elements for calculating indicators for malaria diagnosis and treatment
data element Comments 
number of suspected malaria casesa Fulfilling the national definition
number of patients tested by rdtb
number of patients positive by rdtb For countries with a significant prevalence of different 
species of Plasmodium, this number should be stratified 
by species.
number of patients tested by microscopy
number of patients positive by microscopy For countries with a significant prevalence of different 
species of Plasmodium, this number should be stratified 
by species.
number of patients tested for malaria equal to the number of patients tested by rdt and/or 
microscopy
patients tested by both rdt and microscopy should be 
counted once.
number of people tested by rdtb and/or 
microscopy per yearc
everyone, whether symptomatic or not, thus including 
both patients and the healthy community
number of confirmed malaria cases equal to the number of patients positive by rdt and/or 
microscopy
For countries with a significant prevalence of different 
species of Plasmodium, this number should be stratified 
by species.
total number of patients receiving first-line 
antimalarial treatment (ACt)b
number of confirmed malaria cases receiving first-
line antimalarial treatment (ACt)b
this requires that the diagnosis and treatment of a given 
patient are not recorded separately.
stock-outd of rdts this month on the form for a health facility or community, the 
response would be yes/no.
on the summary form for the district, the number of 
health facilities or communities reporting no stock-out 
would be recorded.
stock-outd of key microscopy consumables this 
month
stock-outd of first-line antimalarial drugs (ACt) 
this month
number of health workers trained to perform rdts 
for malaria per health facility
For community programmes, per village
number of technicians accredited for malaria 
microscopy per targeted laboratory
a if the number of suspected cases is not directly available, it should be calculated from the number of tested cases plus the 
number of treated cases minus the number of positive cases, provided that negative cases are not treated. 
b when rdts are performed and ACt provided at community level, the data should be added to those given by health facilities.
c this element is often used in low-endemic countries, where a significant part of individuals are tested through active case 
detection, in addition to the core element ‘number of patients tested for malaria’.
d generally defined as 7 days or more (not necessarily consecutive) of stock-out. this may depend on the strength of the supply 
system.
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issued by central medical stores at national and subnational levels. All efforts should be made to 
link these data to those of the health information management system in order to measure the 
real impact of the malaria diagnosis strengthening programme.
8.1.2 Monitoring testing capacity over time
In order to understand rapidly why one or more indicators of the malaria diagnosis programme 
show poor results, a system is needed to monitor testing capacity. This generally corresponds to 
the indicators used to monitor the quality management system described in section 4.2.8, which 
show the evolution over time of the quality of malaria testing in laboratories and health facilities. 
For laboratories, this system should be integrated into global monitoring of all laboratory proce-
dures and not organized for malaria testing only. To avoid duplication of visits and efforts, these 
indicators should be based on data collected on checklists during supervision (see Annex 8 for 
laboratories and Annex 12 for health facilities). 
8.2 Trouble-shooting, investigation and response
The indicators listed in Table 13 can reveal a variety of problems in malaria diagnosis and treat-
ment at different levels. Each indicator should have a specific threshold for corrective action. 
Usually, an investigation at the health facility by an on-site visit will show the reasons why the 
indicators did not reach the target. After discussion with supervisors at district level, it might be 
necessary to extend the investigation and discuss any action needed with the community. An 
adequate response should be given and understood by everyone involved. Risk prevention strate-
gies should be also put in place (see Table 14).
Key meSSAgeS of SeCTIoN 8
n Feasible, reliable indicators should be chosen to monitor a malaria diagnostic testing pro-
gramme.
n the data necessary for calculating the indicators should be in the health information man-
agement system.
n the main outcome indicator of a programme for strengthening malaria diagnostic services 
is the ‘percentage of suspected malaria cases tested for malaria’.
n A strategy for investigating and responding to problems identified in the monitoring pro-
gramme should be prepared in advance.
8
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9. expected impact  
 on malaria surveillance
Accurate measurement of the burden of malaria has direct implications for the selection and 
planning of interventions at national or international level. Reliable data on the incidence of 
malaria also influence the requirements for ACT, RDTs and microscopy supplies, which in turn 
can minimize the risks of stock-outs or over-stocks of these life-saving commodities; therefore, 
reliable figures are needed at all levels. With the decreasing transmission of malaria in Africa and 
elsewhere, the geographical heterogeneity of malaria distribution is increasing. 
In countries with poor malaria diagnostic services, an increase in RDT testing could greatly 
improve the reliability of surveillance data. If malaria test results are properly recorded in health 
facilities and properly transmitted to the central level, the number of malaria cases can be deter-
mined precisely and trends followed over time.
With progressive deployment of high-quality malaria diagnostics, the picture of reported malaria 
incidence will change drastically. For instance, in places where overdiagnosis of malaria was the 
rule, an apparent decrease in malaria transmission (besides the real decrease due to malaria con-
trol) is simply due to the introduction of accurate malaria diagnostic testing. In these circum-
stances, trends in the numbers of cases of anaemia and blood transfusions in children under 
5 years could be used to monitor impact, as these figures are unlikely to be affected by malaria 
testing. As soon as a large percentage of outpatient suspected cases (> 80%) are tested, indicators 
of the success of malaria control at national scale1 can be calculated precisely from surveillance 
data, as long as data are accurately reported (Table 15).
1 Guidelines for malaria disease surveillance and core indicators for control and elimination, draft version. Geneva, 
World Health Organization, 2011.
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Table 15. National indicators used in malaria surveillance
Indicator Numerator, denominator Interpretation
Confirmed malaria 
casesa 
number of cases positive for malaria (by rdt and/
or microscopy) reported by health facilities
Can be presented as cases per week, month or year 
in countries in the malaria elimination phase and 
in some low-transmission countries in the control 
phase, any person, whether symptomatic or not, 
with a positive result (microscopy or rdt) would 
be considered to be a confirmed case of malaria.
Confirmed malaria 
incidence ratea 
(number per 1000 
people)
Numerator: number of malaria-positive cases 
reported by health facilities per year x 1000
Denominator for rate: population living in areas at 
risk for malaria
should be stratified by age (< 5, all ages)
incidence rate of < 1 confirmed case per 1000 
people per year indicates readiness for elimination 
phase
percentage of 
suspected malaria 
cases tested for 
malaria
Numerator: number of suspected malaria cases 
tested (by rdt and/or microscopy) × 100
Denominator: total number of suspected malaria 
cases reported by health facilities 
A suspected case fulfils the national definition.
Annual malaria 
parasite incidence 
rate (number per 
1000 people)
Numerator: number of people positive by rdt and/
or microscopy per year x 1000
Denominator for rate: population living in areas at 
risk for malaria
this indicator is used mainly in low-incidence 
countries and if the annual blood examination 
rate is > 10%
inpatient confirmed 
malaria casesa
number of hospitalized malaria-positive cases 
(by rdt and/or microscopy) reported by health 
facilities
Can be presented as cases per week, month or year
inpatient confirmed 
malaria incidence 
ratea (number per 
1000 people)
Numerator: number of hospitalized malaria-
positive cases reported by health facilities per 
year x 1000
Denominator for rate: population living in areas at 
risk for malaria
should be stratified by age (< 5, all ages)
Confirmed malaria 
deaths 
number of malaria-positive (by microscopy and 
rdt) deaths reported by health facilities
Confirmed malaria 
mortality rate 
(number per 1000 
people)
Numerator: number of malaria-positive deaths 
reported by health facilities per year x 1000
Denominator for rate: population living in areas at 
risk for malaria
malaria rdt 
positivity ratea
Numerator: number of malaria-positive cases by 
rdt × 100
Denominator: total number of suspected malaria 
cases tested with an rdt
Annual rates should be used, not only the rate 
during the peak season
malaria slide 
positivity ratea
Numerator: number of malaria-positive cases by 
microscopy × 100
Denominator: total number of suspected malaria 
cases examined by microscopy
test or slide positivity rate < 5% throughout the 
year indicates readiness for pre-elimination phase
malaria test 
positivity ratea
Numerator: number of malaria-positive cases by 
rdt and/or microscopy × 100
Denominator: total number of suspected malaria 
cases examined by rdt and/or microscopy
malaria parasite 
prevalence ratea
Numerator: number of people tested positive by 
rdt and/or microscopy 
Denominator for rate: number of people tested by 
rdt and/or microscopy
people are tested during a community survey 
(healthy population).
percentage of 
confirmed malaria 
cases treated with 
ACt
Numerator: number of confirmed malaria cases 
treated with ACt × 100
Denominator: total number of confirmed malaria 
cases reported by health facilities 
if the information system does not collect the 
number of patients treated, the number of ACts 
received or dispensed can be used as a surrogate 
numerator.
a For countries with significant prevalence of different species of plasmodium, this number should be stratified by species.
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10. diagnostic strategies 
in particular settings 
10.1 Advanced malaria control and pre-elimination 
Programmes that have achieved an advanced stage of malaria control and are progressing towards 
pre-elimination should maximize efforts to ensure universal access to malaria diagnostic testing. 
Further, the distribution of malaria transmission is often highly heterogeneous within a country, so 
that a good malaria surveillance system is necessary to guide subnational malaria control strategies. 
When malaria incidence falls, the great majority of febrile illnesses are not due to malaria, and 
treatment of each fever episode with antimalarial medicines is not only ineffective but is harm-
ful in most cases, because the correct treatment for the cause of the fever is not given. In these 
conditions, diagnostic capability for other causes of the presenting illness is needed, in addi-
tion to malaria. When the outpatient malaria positivity rate in health facilities is below a certain 
threshold (e.g. 1%), malaria testing should be restricted to those patients with a high probability 
of having malaria (see section 2.3.4). This restriction should be extended to all levels of the health 
system, including communities using simple criteria (for example, ‘fever and no pneumonia and 
no diarrhoea’). In such settings, the strategy of active case detection is used to find and treat all 
positive febrile cases among people living in the area in which an index case (detected at the 
health facility) lives. This strategy is easier to implement if there are community health workers 
who are fully integrated into the health system. It requires the use of sensitive diagnostic tools 
(RDTs with a high panel detection score or quality assured expert microscopy). RDTs have the 
advantage of permitting immediate treatment on site. 
In focused screening and treatment (screening all people living in a defined geographical area) or 
mass screening and treatment (screening of an entire community in a broad geographical area), 
the people to be detected, and treated if positive, are asymptomatic and generally have a low 
malaria parasite density. The sensitivity of the malaria tests presently available are insufficient, 
and alternative assays of high sensitivity are needed that are reasonably specific and minimally 
invasive. High-throughput PCR is a promising tool, which is being evaluated for this use. Mass 
screening and treatment strategies are currently being evaluated for use in certain malaria con-
tainment projects. Strategies similar to focused screening and treatment, based on active case 
detection with microscopy or RDTs, were used in Taiwan (China) and Venezuela in the 1950s 
and in China, India, Oman and the Philippines in the 1990s and possibly contributed to reducing 
malaria transmission.
When malaria transmission falls, it is important to map individual malaria cases to the household 
level in order to determine the effectiveness of various control policies. New reporting systems 
(for example mobile phones and global positioning systems) are being developed to record the 
results of accurate malaria testing in health facilities and even villages. Strategies based on sur-
veys in which serology for malaria is coupled with geospatial analyses are also being evaluated.
10.2 Areas in which malaria has been eliminated 
Once malaria has been eliminated in an area, considerable resources are required to sustain 
surveillance in order to detect possible reintroduction as early as possible and to maintain the 
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capacity for rapid investigation and containment of reintroduced cases if they are found. The 
requirements for surveillance and screening in areas in which malaria has been eliminated but 
which are still vulnerable to malaria transmission are similar to those of programmes in coun-
tries in the elimination phase. 
The diagnostic strategy might involve screening migrant populations, investigating large popula-
tions around detected cases and devising criteria for screening suspected patients, such as recent 
travellers to malaria-endemic areas. RDTs with high panel detection scores must be readily avail-
able in places where technicians are not skilled in malaria microscopy. As expert microscopy 
might still be required for confirmatory diagnosis and specific surveys, centres of excellence for 
microcopy must be maintained, even in this situation. 
When malaria is rare and no longer perceived by local health services and the community to be a 
significant public health concern, ways must be found to maintain high-quality malaria diagnosis 
in order to continue screening for suspected malaria cases and to target malaria diagnostic test-
ing to cases that are likely to be malaria.
10.3 Non-endemic areas
In non-endemic areas, highly sensitive malaria diagnostic testing (RDTs with a high panel detec-
tion score and expert malaria microscopy) is needed to investigate non-immune febrile patients 
(who can develop fever even before patent parasitaemia) who travelled to an endemic area within 
the past 3 months. In non-endemic areas, there are generally too few patients to be tested to jus-
tify malaria diagnostic services at all levels of the health system. They should, however, be avail-
able at least at secondary care level, and a system should be in place to refer suspected malaria 
cases (or their blood sample) rapidly to these centres with malaria diagnostic capacity. In these 
centres, the test positivity rate tends to increase because of restricted criteria for malaria testing to 
travellers from endemic areas. In this situation, microscopists generally see enough positive slides 
to maintain their skills.
10.4 epidemic-prone zones
In epidemic-prone zones, good quality malaria diagnosis must be available, not only for case 
management but also for surveillance, i.e. investigation of an unexpected increase in cases of 
fever. During outbreak investigations and field surveys, RDTs have the advantage of allowing 
both detection and immediate treatment of malaria-positive cases. When the positivity rate is 
very low, it becomes difficult to maintain the interest and skills of microscopists and their capac-
ity to implement an effective quality management system based on slide cross-checking (because 
of problems of sensitivity).
10.5 Complex emergencies
In emergencies and complex situations, there are several logistic and practical 
advantages to using RDTs rather than microscopy: rapid deployment in the 
field, less training needed than for microscopy, no need for an electricity supply, 
immediate availability of results for treatment of positive cases in the field, and 
potential for testing more cases.1 
1 Malaria control in complex emergencies: an inter-agency field handbook. Geneva, World Health Organization, 2005. 
Available at: 
 http://whqlibdoc.who.int/publications/2005/924159389X_eng.pdf
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resource documents
National guidelines for malaria diagnosis from sub-Saharan countries
1. Politique de prise en charge du Paludisme. Programa Nacional De Luta Contra O Paludismo, Minis-
tério da Saúde,Republica da Guiné-Bissau, 2008
2. Guidelines on the implementation of rapid diagnostic tests including quality assurance and control in 
Rwanda. National Malaria Control Programme, Ministry of Health, Rwanda 2009
3. Directives nationales pour le traitement du paludisme. Programme national de lutte contre le palud-
isme, Ministère de la Santé, République du Sénégal 2006
4. Swaziland National Malaria Diagnosis and Treatment Guidelines. National Malaria Control Pro-
gramme, Ministry of Health, Kingdom of Swaziland, 2009
5. National Guidelines for the use of Malaria Rapid Diagnostic Tests in Tanzania. National Malaria Con-
trol Programme, Ministry of Health and Social Welfare, United Republic of Tanzania, draft version 
2007
Who technical documents, manuals & training materials
1. Guidelines for the treatment of malaria, second edition. Geneva, World Health Organization, 2010. 
Available at: 
http://whqlibdoc.who.int/publications/2010/9789241547925_eng.pdf
2. World malaria report 2010. Geneva, World Health Organization, 2010. Available at: 
http://www.who.int/malaria/world_malaria_report_2010/worldmalariareport2010.pdf
3. Malaria control in complex emergencies: an inter-agency field handbook. Geneva, World Health Organ-
ization, 2005. Available at: 
http://whqlibdoc.who.int/publications/2005/924159389X_eng.pdf
4. Safe Management of Wastes from Health-Care Activities. Geneva, World Health Organization, 1999. 
Available at: 
http://www.healthcarewaste.org/en/documents.html?id=1
5. Manual of basic techniques for a health laboratory, second edition. Geneva, World Health Organiza-
tion, 2003. Available at: 
http://whqlibdoc.who.int/publications/2003/9241545305.pdf
6. Malaria programme reviews: a manual for reviewing the performance of malaria control and elimina-
tion programmes, trial edition, March 2010. Geneva, World Health Organization, 2010. Available at: 
http://www.who.int/malaria/publications/atoz/whomprmalariaprogramperformancemanual.pdf
7. Malaria case management: Operations manual. Geneva, World Health Organization, 2009. Available at: 
http://whqlibdoc.who.int/publications/2009/9789241598088_eng.pdf
8. WHO technical consultation: Parasitological confirmation of malaria diagnosis, 6–8 October 2009. 
Geneva, World Health Organization, 2009. Available at: 
http://whqlibdoc.who.int/publications/2010/9789241599412_eng.pdf
9. Good procurement practices for artemisinin-based antimalarial medicines. Geneva, World Health 
Organization, 2010. Available at: 
http://whqlibdoc.who.int/publications/2010/9789241598927_eng.pdf
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10. Good practices for selecting and procuring rapid diagnostic tests for malaria. Geneva, World Health 
Organization, 2011. Available at: 
http://whqlibdoc.who.int/publications/2011/9789241501125_eng.pdf
11. Malaria microscopy quality assurance manual, version 1. World Health Organization, Regional Office 
for the Western Pacific, 2009. Available at: 
http://www.who.int/malaria/publications/malaria_microscopy_QA_manual.pdf
12. Basic malaria microscopy, Part I. Learner’s guide, second edition. Geneva, World Health Organization, 
2010. Available at: 
http://whqlibdoc.who.int/publications/2010/9789241547826_eng.pdf
13. Basic malaria microscopy, Part II. Tutor’s guide, second edition. Geneva, World Health Organization, 
2010. Available at: 
http://whqlibdoc.who.int/publications/2010/9789241547918_eng.pdf
14. Bench Aids for Malaria Microscopy. Geneva, World Health Organization, 2010. Available at 
http://apps.who.int/bookorders/anglais/detart1.jsp?sesslan=1&codlan=1&codcol=15&codc
ch=3294
15. Pocket book of hospital care for children: Guidelines for the management of common illnesses with lim-
ited resources. Geneva, World Health Organization, 2005. Available at: 
http://whqlibdoc.who.int/publications/2005/9241546700.pdf
16. Integrated Management of Childhood Illness for high HIV settings: chart booklet. Geneva, World Health 
Organization/UNICEF, 2008. Available at: 
http://whqlibdoc.who.int/publications/2008/9789241597388_eng.pdf
17. Integrated Management of Adolescent and adult Illness: interim guidelines for first-level facility health 
workers at health centre and district outpatient clinic: acute care. Geneva, World Health Organization, 
2009. Available at: 
 http://www.who.int/hiv/pub/imai/acute_care.pdf
18. Integrated Management of Childhood Illness: Caring for Newborns and Children in the Community. 
Manual for the Community Health Worker. Geneva, World Health Organization, Unicef 2010. In press.
19. Technical Guidelines for Integrated Disease Surveillance and Response in the African Region, second 
edition. World Health Organization, Regional Office for Africa/Centers for Disease Control and Pre-
vention, 2010. Available at: 
http://www.afro.who.int/clusters-a-programmes/dpc/integrated-disease-surveillance/
features/2775-technical-guidelines-for-integrated-disease-surveillance-and-response-in-the-
african-region.html?lang=en.
20. Laboratory Quality Management System Training toolkit. Geneva, World Health Organization/Clini-
cal and Laboratory Standards Institute/Centers for Disease Control and Prevention, 2009, Trainer’s 
guide and handbook. Available at: 
http://www.who.int/ihr/training/laboratory_quality/en/.
21. Guidelines for Malaria Disease Surveillance and Core Indicators for Control and Elimination, draft ver-
sion 17, Nov 2010, unpublished document. Geneva, World Health Organization,.
22. Quality Standards in Health Laboratories: Implementation in Thailand: A Novel Approach. World 
Health Organization, Regional Office for South-East Asia New Delhi, 2005. Available at: 
http://www.who.int/ihr/training/laboratory_quality/11_cd_rom_quality_standards_in_health_
laboratories_thailand.pdf
23. Proposal for a dual strategy for the development of malaria Microscopy and Rapid Diagnostic Testing 
in the Republic of Yemen. World Health Organization, Regional Office for the Eastern Mediterranean, 
unpublished document, 2010.
24. Regional course on training of trainers on use of malaria Rapid Diagnostic Tests (RDTs), Sana’a, Yemen, 
17–19 May 2009. World Health Organization, Regional Office for the Eastern Mediterranean, 2009. 
Available at: 
http://www.emro.who.int/rbm/pdf/yem_5_09_prog.pdf
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25. Policy and procedures of the WHO/NICD Microbiology External Quality Assessment Programme in 
Africa Years 1 to 4, 2002–2006. Geneva, WHO/CDS/EPR/LYO/2007.3. Available at: 
http://whqlibdoc.who.int/hq/2007/WHO_CDS_EPR_LYO_2007.3_eng.pdf
26. Consideration of mass drug administration for the containment of artemisinin-resistant malaria in the 
Greater Mekong subregion, Report of a consensus meeting, 27–28 September 2010, Geneva, Switzerland. 
Geneva, World Health Organization, 2011. Available at: 
http://whqlibdoc.who.int/publications/2011/9789241501644_eng.pdf
27. Consultation on Technical and Operational Recommendations for Clinical Laboratory Testing Har-
monization and Standardization, Maputo, Mozambique, 22–24 January 2008. Geneva, WHO/AFRO/
CDC/ASCP/USAID/B&MGF/ClintonF/GF, 2008. Available at: 
http://www.who.int/hiv/amds/amds_cons_tech_oper_lab_test.pdf
Who/fIND technical reports, manuals & training materials
1. Lot testing of Malaria Rapid Diagnostic Tests: Quality benefits all. Geneva, World Health Organiza-
tion/FIND, 2009. available at: 
http://www.wpro.who.int/NR/rdonlyres/8DF454F7-1183-4930-8A39-80E225521AB9/0/Lot_
testing_brochure.pdf
2. Malaria Rapid Diagnostic Test Performance: Results of WHO product testing of malaria RDTs: Round 
1 (2008). WHO Regional Office for the Western Pacific/FIND/CDC/TDR, 2009. Available at: 
http://www.wpro.who.int/NR/rdonlyres/ED81BDE9-B812-4B80-8408-3A129A6365C4/0/
OMSFINDRapportMalaria200900514v25.pdf
3. Malaria Rapid Diagnostic Test Performance: Results of WHO product testing of malaria RDTs: Round 
2 (2009). WHO WPRO/GMP/FIND/CDC/TDR, 2010. Available at: 
http://www.wpro.who.int/internet/files/rdt/RDTMalariaRd2_FINAL.pdf
4. How To Use a Rapid Diagnostic Test (Generic Pf only RDT)? A guide for training at a village and clinic 
level. Available at: 
http://www.wpro.who.int/NR/rdonlyres/43909BF1-A955-4DA3-9470-0F05E0FBA267/0/
Generic_pf_training_manual_web.pdf
5. How To Use a Rapid Diagnostic Test (Generic Pf-Pan RDT)? A guide for training at a village and clinic 
level. Available at: 
http://www.wpro.who.int/NR/rdonlyres/23DD7DCB-48C4-4CFF-BD45-332F0BE3DCC7/0/
generic_PfPan_training_manual_web.pdf
6. Job Aid – How To Do the Rapid Test for Malaria (Generic Pf only RDT)? Modified for training in the 
use of the Generic Pan-Pf Test for falciparum and non-falciparum malaria. Available at: 
http://www.wpro.who.int/NR/rdonlyres/F8C3BCCE-780B-4182-8166-546005012C83/0/
GenericPfJobAid_lowres.pdf
7. Job Aid – How To Do the Rapid Test for Malaria (Generic Pan Pf RDT)? Modified for training in the use 
of the Generic Pan-Pf Test for falciparum and non-falciparum malaria. Available at: 
http://www.wpro.who.int/NR/rdonlyres/4EB21BD1-70B4-40FE-8BC5-614B3ED6EBF6/0/
GenericPanPfJobAid_lowres.pdf
8. Job Aid – How To Do the Rapid Test for Malaria (Generic Pf-Pan RDT)? Modified for training in the 
use of the Generic Pan-Pf Test for falciparum and non-falciparum malaria. Available at: Available at: 
http://www.wpro.who.int/NR/rdonlyres/74C2B789-6B94-4D70-AD70-A6CFA89AFD49/0/
GenericPfPanjobaid_lowres.pdf
9. Transporting, Storing, and Handling Malaria Rapid Diagnostic Tests at Central and Peripheral Stor-
age Facilities, 2009. Available at: 
http://www.wpro.who.int/NR/rdonlyres/1BBCEFC2-46B3-40F5-9898-7455578145E8/0/
MalariaRDT_CENTRAL_2009web.pdf
10. Transporting, Storing, and Handling Malaria Rapid Diagnostic Tests in Health Clinics, 2009. Avail-
able at: 
http://www.wpro.who.int/NR/rdonlyres/269BF1DC-BA7C-4422-A16E-F73016DA17B5/0/
MalariaRDT_REMOTE_2009web.pdf
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Working documents, SoPs, eQA guidelines from ministries of health of 
endemic countries, international Ngos and academic institutions
1. IMALDIA algorithm for the use of RDT in clinical management. Swiss TPH, Switzerland and Dar es 
Salaam City council, Republic of Tanzania 2007
2. IMALDIA QC performance checklist point of use RDT. Swiss TPH, Switzerland and Dar es Salaam 
City council, Republic of Tanzania 2007
3. IMALDIA QC storage checklist point of use RDT. Swiss TPH, Switzerland and Dar es Salaam City 
council, Republic of Tanzania 2007
4. IMALDIA Implementation and supervision checklists for health facility visits. Swiss TPH, Switzer-
land and Dar es Salaam City council, Republic of Tanzania 2007
5. IMALDIA General document and general presentation for health workers’ training on RDT. Swiss 
TPH, Switzerland and Dar es Salaam City council, Republic of Tanzania 2007
6. IMALDIA Clinical case studies for training on RDT. Swiss TPH, Switzerland and Dar es Salaam City 
council, Republic of Tanzania 2007
7. Walter Reed Army Institute of Research. Pilot Project (United Republic of Tanzania) Malaria Micros-
copy and Rapid Diagnostic Testing Quality Management Resource Manual, draft version 2010
8. IMaD Supervision Checklist RDT microscopy health facilities, Ghana
9. IMaD Improving malaria diagnostics outreach: training and support supervision manual, Ghana 2010
10. IMaD Scores and guidelines for observation performance microscopy and RDT, Ghana
11. MSF-OCA Malaria Microscopy Manual, Version 1 2008
12. MSF Supervision Checklist for RDTs – General Site Supervision
13. MSF Supervision Checklist for RDTs – Operator Supervision
14. MSF Problem Recording Form – RDTs
15. MSF-OCA Laboratory & Rapid Diagnostic Testing Quality Control Protocol for Malaria, Tuberculo-
sis, Leishmaniasis and HIV Rapid Diagnostic Testing (RDT) Version 2 2008
16. Malaria Laboratory Diagnosis External Quality Assessment Scheme Guidelines. Ethiopian Health 
and Nutrition Research Institute (EHNRI), Federal Ministry of Health, Ethiopia 2009
17. MANUTENÇÃO CONCEITO. Fundação de Vigilância em Saúde, Laboratório Central de Saúde 
Pública, Govierno do Estado do Amazonas, Brazil
18. Checklist for Supervisory / Monitoring Visits to RDT Sites, Philippines
19. Malaria Diagnosis Quality Assurance Programme Manual with Malaria Diagnosis Standard Operat-
ing Procedures, version 1.1 Swaziland 2009
20. Supervision checklists. Programme National d’Assurance de Qualité dans le diagnostic biologique du 
Paludisme, Laboratoire National de Santé Publique, Haïti 2010
21. Malaria Diagnostics Quality Assurance: Supervisors Guide. Programme National d’Assurance de 
Qualité dans le diagnostic biologique du Paludisme, Laboratoire National de Santé Publique, Haïti 2010
22. Manuel de formation au diagnostic biologique du paludisme, pour le participant. Service des Labora-
toires, Programme National de Lutte contre le Paludisme (PNLP), Madagascar 2011
23. Manuel de formation des dispensateurs de soins a domicile. Programme National de Lutte contre le 
Paludisme, République du Sénégal 2009
24. Training guide & facilitator’s manual for malaria Rapid Diagnostic Test. National Malaria Control 
Programme, United Republic of Tanzania 2010
25. Learners’ manual for malaria Rapid Diagnostic Test. National Malaria Control Programme, United 
Republic of Tanzania 2010
26. Microscopy Maintenance Program – Solomon Islands, Pacific Malaria Initiative Support Centre (Pac-
MISC), draft version 2011
27. National Strategy for Community-based Management of Malaria (CBMM) in Afghanistan, draft ver-
sion 2011
28. The Global Fund. Monitoring and Evaluation Toolkit HIV, Tuberculosis and Malaria and Health Sys-
tems Strengthening, third edition 2009
29. Mantenimiento preventivo y correctivo de equipos de laboratorio. Instituto Nacional de Salud, Min-
isterio de Salud, Peru 2005
30. Control de equipos de laboratorio. Instituto Nacional de Salud, Ministerio de Salud, Peru 2007
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standard operating procedures for the use, 
care and maintenance of microscopes
Adapted from Walter Reed Army Institute of Research Malaria (2010). Microscopy and rapid 
diagnostic testing quality management resource manual, Fort Detrick, Texas.
Standard operating procedure No. xxx: Use, care and maintenance  
of microscopes 
Last update on: ........................... , by ...............................................................................................................
Purpose: to provide the protocol for the use, care and maintenance of microscopes 
Application: sites where malaria microscopy is performed
Principle: The accuracy of malaria microscopy depends on the correct functioning and use of 
the microscope. Microscopes should be set up for optimal performance, protected from damage, 
used ergonomically, regularly maintained and, if required, repaired by qualified personnel. 
Maximum depth of field can be achieved only if the microscope light source has sufficient lumi-
nosity to allow the iris diaphragm to be closed optimally without loss of brightness. It is generally 
not possible to achieve maximum depth of field when using a mirror as a light source, and an 
artificial light source from a substage lamp with a substage condenser is required. 
Precautions and safety:
Electrical connections to the microscope and the internal circuitry can be potentially hazardous.
The power source and connections to the microscope should be secure and not expose staff to a 
risk for electrocution. 
The microscope and electrical connections should not be exposed to water. 
Repairs to a microscope, other than the replacement of bulbs and fuses, should be performed by 
qualified service engineers or technicians. 
Care should be taken to prevent damage to the eyes by exposure to the high light-intensity halo-
gen lamp. 
The microscope should not be cleaned with xylene, as it damages the microscope. 
The microscope should be used ergonomically to prevent back and neck strain. 
Reagents, chemicals and materials:
Commercial microscope cleaning solution 
Dust cover 
Lens-cleaning tissue 
Soft cloth 
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equipment and instruments:
Microscope and electrical connections 
Procedures 
Transporting and moving the microscope:
Transport microscopes in the original container with the internal packing materials to prevent 
the microscope from moving within the container. 
If the original packaging is not available, use a specifically designed microscope transport box 
supplied by the manufacturer or a fabricated container containing foam or similar packing mate-
rials to prevent the microscope from moving within the container during transport. 
During transport, protect the microscope from excessive movement or vibration: pack the micro-
scope so that it does not move around in the transport vehicle and cannot fall from the top 
of other items being transported; protect the microscope from exposure to water (such as rain, 
flooding, falling into water), excessive heat, direct sunlight and rodents. 
Carry a microscope with two hands, supporting the base and the arm. 
Placement:
Place the microscope on a firm bench, free from vibration. Because of the high magnification, 
very small movements of the bench will cause large movements in the image being viewed by the 
microscopist. 
Place the microscope in a position where there is space for the microscopist to place his or her legs 
fully under the bench. 
Do not place the microscope in front of a brightly lit window. Place the microscope in front of a 
wall or a darkened window. 
Microscope set-up:
Follow the manufacturer’s directions for optimal set-up of the optical system and general use. 
Adjust the iris aperture to the setting recommended by the manufacturer to achieve maximum 
depth of field. 
If the manufacturer provides an iris diaphragm setting on the condenser, set this to the x100 
objective lens setting. 
Use the following method if the eyepiece of the microscope can be removed: fully raise the con-
denser; set the lamp to ‘low’; select the x40 objective; close the iris diaphragm; remove one eye-
piece; look down the tube, then adjust the condenser until the edge of the diaphragm is in sharp 
focus without showing an outer fringe ring in green or in red; open the iris diaphragm until the 
objective lens completely fills with light; the shape of the light is usually octagonal; when the 
points of the octagon touch the outside of the objective lens, open the iris diaphragm until the 
light appears circular; replace the eyepiece. 
Prevent damage to the x40 objective:
Immediately remove any immersion oil that accidentally comes into contact with the x40 objec-
tive. Because the x40 lens is located next to the x100 lens and because it is also a long lens, it is easy 
for it to come into contact with immersion oil accidentally. The x40 objective is not sealed against 
oil penetration, and any immersion oil left in contact with the x40 objective will penetrate the lens 
and be deposited on the inside of the lower lens. This can be repaired only by the manufacturer 
by dismantling the objective lens. 
Lower the stage before removing a slide. 
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Daily maintenance:
Inspect the microscope for damage or malfunction. 
Record any damage or malfunction in the register for ‘Maintenance of laboratory equipment’. 
Use a clean cloth to remove dust from the surfaces of the microscope. 
Clean the parts of the microscope with a clean cloth and commercial microscope cleaning solu-
tion. Ensure that immersion oil residues are removed. Do not clean any part of the microscope 
with xylene. 
Clean the objective lens with a lens cleaning tissue only. Never clean lenses with alcohol, ordinary 
tissues, cleaning paper, toilet paper, cotton wool or hand towels, as they scratch the lens surface. 
Cover the microscope with a dust cover. 
Do not leave lens ports uncovered; use the port cover or sealing tape.
Repairs:
Site staff can replace a broken bulb or replace a blown fuse (with caution). Other repairs must be 
performed by a qualified service engineer or technician. 
Do not exchange lenses and ports with those of other microscopes.
Routine servicing, such as realignment of the optics, replacement of lens and maintenance and 
lubrication of the stage, should be performed by a qualified service technician. 
Bulb replacement:
Strictly follow the manufacturer’s instructions. 
Fuse replacement:
Extreme caution should be exercised in attempting to replace a blown fuse. Fuses are fitted by the 
manufacturer to protect the microscope from electrical damage, and if there is an electrical fault 
the replacement fuse could be destroyed. This could expose the site staff to danger of electrocution. 
Fuses should be replaced only if there is reasonable evidence that the fuse was damaged by a 
power surge that is not likely to recur. 
Strictly follow the manufacturer’s instructions. Disconnect the microscope fully from the power 
source. Do not perform the repair alone. 
After replacing the fuse, ensure that the microscope ‘on/off’ switch is off. Connect the microscope 
to the power supply and switch the power supply on. Switch on the microscope, wearing heavy 
rubber gloves to provide as much insulation protection as possible. 
If the replacement fuse fails again, do not attempt to replace the fuse a second time. Decommis-
sion the microscope, and have it repaired by a qualified service technician. 
After all repairs, whether successful or not, complete the register for ‘Maintenance of laboratory 
equipment’. 
Quality assessment procedures 
The set-up and maintenance of the microscope(s) should be inspected during routine supervisory 
visits. The register for ‘Maintenance of laboratory equipment’ should also be inspected. 
Causes of error
Unskilled repairs attempted on malfunctioning microscopes
Removing eyepieces unless they are designed to slide in and out of the tube
Removing eyepieces from sealed microscopes, which exposes the internal optics to dust and fungi
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ANNex 2. 
specification sheet for  
laboratory equipment
Adapted from Mantenimiento preventivo y correctivo de equipos de laboratorio. Instituto Nacional 
de Salud, Ministerio de Salud, Peru 2005.
name of health facility: technical sheet number:
laboratory/area: date:
DeSCRIPTIoN 
1. name of equipment
2. brand:  model: 3. serial number:
4. location:
5. warranty period: 6. end of warranty (date):
7. date of receipt in central warehouse: 8. date of receipt at the laboratory:
9. person responsible for installation: 10. date of installation:
11. date put into service: 
ACQUISITIoN
12. Financing or donation source: 13. Approval number: 
14. purchase order number: 15. Cost:
16. Condition in which the device was received: new n   Used n   rehabilitated n 
17. name of manufacturer: 18. phone:  Fax:
19. Address of manufacturer: 20. e-mail:
21. name of distributor in the country: 22. phone:  Fax:
23. Address of distributor: 24. e-mail:
TeChNICAl INfoRmATIoN
25. operational manual: yes n  no n  26. warranty certificate: yes n  no n
27. installation manual: yes n  no n 28. production certificate: yes n  no n
29. service manual: yes n  no n 30. other certificate (describe):
31. manual of accessories: yes n  no n
32. other manual (indicate which):
TeChNICAl SPeCIfICATIoNS
33. general: mechanical n  electrical n  electronic Automatic n  semi-automatic n
34. power supply: 110-120 v / 50-60 hz n  210-240 v / 50-60 hz n
35. display: Analogue n  digital n 36. Capacity: 
37. specifications (describe):
38. Accessories:
person responsible for the equipment: person in charge of the laboratory:
signature:  signature: 
date: date:
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ANNex 3. 
maintenance service report  
for laboratory equipment
Adapted from Mantenimiento preventivo y correctivo de equipos de laboratorio. Instituto Nacional 
de Salud, Ministerio de Salud, Peru 2005
name of health facility: report number:
laboratory/area: date:
DeSCRIPTIoN of The eQUIPmeNT
1. name of equipment:
2. brand:  model: 3. serial number: 
4. location:
PeRSoN ReSPoNSIble foR mAINTeNANCe
5. name: 6. position or area of activity: 
7. name of institution/company: 8. phone: Fax:
9. Address of manufacturer: 10. e-mail:
DATeS of mAINTeNANCe SeRvICe
11. period 1: from  to 12. period 2: from  to
mAINTeNANCe SeRvICe CARRIeD oUT
13. description: ………………………………………………………………………………………………………
……………………………………………………………………………………………………………………
……………………………………………………………………………………………………………….......
14. Findings and actions taken: ……………………………………………………………………………….……
………………………………………………………………………………………………………………...……
…………………………………………………………………………………………………...................….
15. types of equipment used for maintenance: ……………………………………………………..………………
……………………………………………………………………………………………………………………
……………………………………………………………………………………………………………………
WARRANTy PeRIoD of The mAINTeNANCe SeRvICe (If APPlICAble)
16. the warranty for the maintenance service for the above-mentioned equipment is valid from ..................
until ....................
ComPlIANCe WITh The ReQUIRemeNTS of The mAINTeNANCe SeRvICe
17. we declare that the equipment described above has been tested for a period of ……………. days, 
during which it has not shown any failure in functioning. we therefore confirm compliance of the 
maintenance service with service order number ………. , by the technician cited above.
person responsible for the equipment: person in charge of the laboratory or maintenance 
coordinator:
signature:  signature: 
date: date:
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ANNex 4. 
register for maintenance of  
laboratory equipment
Adapted from Mantenimiento preventivo y correctivo de equipos de laboratorio. Instituto Nacional 
de Salud, Ministerio de Salud, Peru 2005.
A list of all existing laboratory equipment and a schedule for maintenance (and calibration when 
appropriate) should be attached to this register.
name of health facility: page number:
report 
number
date of 
maintenance
name of 
equipment
Findings of 
maintenance
maintenance 
technician or 
company
signature
next 
maintenance 
(month/year)
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ANNex 5. 
standard operating procedures for storage 
of rapid diagnostic tests at points of care
Adapted from Walter Reed Army Institute of Research Malaria (2010). Microscopy and rapid 
diagnostic testing quality management resource manual, Fort Detrick, Texas and from WHO/
FIND Transporting, Storing, and Handling Malaria Rapid Diagnostic Tests in Health Clinics, 2009.
Standard operating procedure No. xxx: RDT storage at points of care 
Last update on: ........................... , by ...............................................................................................................
Purpose: To provide guidelines for storage of malaria rapid diagnostic tests
Application: Sites performing malaria diagnostic testing (not supply warehouses before distribu-
tion to sites) 
Principle: Malaria RDTs must be stored correctly within the temperature range stipulated by the 
manufacturer. 
Equipment and instruments: Maximum–minimum thermometer 
Procedures: 
Storage conditions:
• Store malaria RDTs in cartons rather than as individual items. This helps to insulate the sup-
plies and provides protection against moisture damage. 
• Do not expose malaria RDTs to direct sunlight. 
• Do not store malaria RDTs in a freezer.
• Limit access to the storage area as much as possible: constantly opening the door of a cooled or 
semi-cooled storage room allows access of hot air from the outside. 
• RDTs should be kept cool. Ideally, in hot or humid places, malaria RDTs are stored in an air-
conditioned room.
• If air-conditioning is not available, to prevent from exposure to high temperatures, store 
malaria RDTs by one or more of the following methods:
— Storage room selected and adapted to achieve as cool an ambient temperature as possible
— Located in coolest part of the building (eastern side of the building or part of the building 
shaded by a tree)
— Protected from direct sunlight
— Awnings fitted over windows, if possible
— Windows shaded with blinds or curtains or covered with solid material (e.g. cardboard)
— Room with as high a ceiling as possible
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— Prevent high ceiling temperatures: rooms with thatched roofs are significantly cooler than 
those with metal roofs; insulate the inside of the roof if possible; provide air vents in the 
ceiling to allow hot air to escape; a roof ventilation turbine is an inexpensive, efficient cool-
ing mechanism; install a ceiling fan or standing fan if possible; create as much natural ven-
tilation as possible, but avoid allowing hot breezes into the room; ensure that rain cannot 
penetrate the air vents. 
• Store supplies at least 30 cm away from the walls of the room and at least 1 m from the ceiling 
to avoid exposure to heat radiated from the walls and ceiling. 
• Store supplies as close to the floor as possible (but at least 10 cm above the floor), as this is the 
coolest part of the room. 
Temperature monitoring:
• Store supplies according to the manufacturer’s specifications: check the specified temperature 
range for each new lot of malaria RDTs (temperature specifications may change). 
• Storage temperature must be monitored with a maximum–minimum thermometer. The ther-
mometer should be attached to an internal dividing wall at the same height as the highest 
stored carton. Temperature must be monitored and recorded daily, except on weekends if 
nobody is on site. The minimum and maximum daily temperature readings must be recorded. 
Reset the thermometer after each reading.
• Reduce the storage time if it is not feasible to store the malaria RDTs continuously within the 
temperature range specified by the manufacturer. Inform the focal person on malaria diag-
nostics at a higher level if the correct storage conditions cannot be achieved for a maximum 
storage period for the conditions of the site.
Moisture control:
• Supplies can be damaged rapidly by moisture, particularly malaria RDTs removed from their 
primary packaging. 
• Ensure that the storage area is dry: there are no leaks in the roof; the floor is sealed; the area is 
not vulnerable to flooding by groundwater. 
• Store the supplies on pallets or by other means so that they are stored at least 10 cm above the 
floor to avoid any moisture being absorbed from the floor. 
• Do not store supplies in an area where there is fungal growth on the walls or floor. 
Rodent control: 
• Protect the supplies from rats and mice. 
Causes of error:
• Using a defective thermometer
• Inaccurate use of the maximum–minimum thermometer; not resetting the thermometer after 
recording results 
• Inaccurate reading of the thermometer
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ANNex 6. 
standard operating procedures  
for management of wastes from  
malaria diagnostic tests
Adapted from Walter Reed Army Institute of Research Malaria (2010). Microscopy and rapid 
diagnostic testing quality management resource manual, Fort Detrick, Texas and from WHO/
FIND Transporting, Storing, and Handling Malaria Rapid Diagnostic Tests in Health Clinics, 2009.
Standard operating procedure No. xxx: Waste management of  
malaria tests 
Last update on: ........................... , by ...............................................................................................................
Purpose: To provide guidelines for waste management at sites performing malaria diagnostic 
testing. This standard operating procedure provides general recommendations for handling 
infectious waste. National guidelines and policies, if available, supersede this standard operating 
procedure. 
Application: Sites performing malaria diagnostic testing
Principle: 
Waste materials resulting from malaria diagnostic testing can be infectious or environmental-
ly damaging. Sites should have organized waste management systems to protect the staff, other 
people and the environment. It is efficient and cost-effective to manage different types of waste 
products separately. This standard operating procedure is intended to supplement existing waste 
management programmes by categorizing malaria diagnostic testing waste as sharps, infectious 
and non-infectious.
Precautions and safety: 
Blood samples and blood-contaminated materials are potentially infectious. Follow the safety 
precautions prescribed in the national biohazard protocol for avoiding blood safety risks. 
Specimen and sample requirements: 
Waste materials produced during malaria diagnostic testing 
Reagents, chemicals and materials: 
• Sharps boxes 
• Sharps pit 
• Waste bins 
• Wastebin liners 
• Disposable gloves 
• Penetration-resistant gloves
114 universal access to malaria diagnostic testing: an operational manual
Procedures: 
Types of waste materials:
• Waste is categorized as sharps; infectious, non-sharps; and non-infectious, non-sharps 
• The different types of waste are handled differently. Sites should use a colour-coding system, 
if possible, to identify waste receptacles, in order to minimize the chances of the waste being 
accidentally placed in the wrong container: e.g. sharps, red; infectious non-sharps, yellow; 
non-infectious non-sharps, green 
Waste management during testing: 
Sharps 
• Correctly designed commercial sharps boxes should be used whenever possible. 
• Sharps should be placed in puncture-resistant plastic.
• Cardboard containers fitted with covers could be used as sharps containers if commercial 
sharps boxes are not available. 
• The use of glass jars for sharps should be avoided because accidental breakage of a glass con-
tainer containing sharps presents a significant danger to staff. 
• When the sharps container is three quarters full, dispose of the entire container into a cor-
rectly designed sharps pit or incinerate the entire container. Do not overfill sharps containers 
or attempt to force sharps through a blocked entry hole.
• Do not reuse sharps containers. Attempting to empty and clean a sharps box is extremely haz-
ardous. 
• Do not place sharps or sharps containers in the general waste. 
• Refer to national guidelines for the proper use and construction of a sharps pit. 
Infectious non-sharps waste
• Infectious non-sharps waste should be placed in a strong, leak-resistant plastic bag placed in a 
metal or plastic bin with a secure lid. 
• The wastebin should be clearly labelled ‘hazardous materials’ or similar. 
• Store the wastebin in a safe place, where it is protected from accidentally being knocked over 
and is out of reach of children and stray animals. 
• When the plastic bag is three quarters full, seal the bag by tying the open end into a knot and 
remove the bag from the wastebin. 
• Dispose of the bag either by placing it in a burial pit or by incineration. 
• Wearing gloves, disinfect the wastebin with household bleach before putting in a new plastic bag. 
• Refer to national guidelines for appropriate waste disposal methods. 
Non-Infectious non-sharps waste 
• Non-infectious non-sharps waste can be managed according to the usual practice at the site. 
Storage of sharps and infectious non-sharps waste before final disposal:
• Do not mix sharps, infectious non-sharps and non-infectious non-sharps waste. 
• Clearly mark the storage area for sharps and infectious non-sharps waste with a warning sign, 
such as ‘Caution: infectious and sharps waste. Unauthorized persons keep out’. 
• Do not store sharps and infectious non-sharps waste in patients’ rooms or in public areas. 
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Disposal of sharps and infectious non-sharps waste:
Sites should comply with national guidelines. 
Disposal of sharps
• Avoid incineration of sharps whenever possible. Metals (lancets) and glass cannot be burnt 
and should be discarded after incineration. Sharps should not be placed in the infectious non-
sharps waste disposal system. Cardboard sharps boxes produce a considerable amount of 
harmful smoke. Plastic sharps containers produce toxic smoke. 
• If burning is unavoidable: burn only in areas separated from public spaces, as burning pro-
duces harmful smoke and airborne particles; bury the residual ashes and unburnt glass and 
metals in an isolated location well covered with soil. 
• People disposing of sharps into a sharps pit or by incineration should wear heavy-duty pen-
etration-resistant gloves (such as leather gloves). Disposable gloves do not provide sufficient 
protection. Disposable gloves may be worn underneath penetration-resistant gloves. 
• A simple, safe method is to use a large solid plastic or metal drum (or barrel, such as a 44-gallon 
drum) in a secure location and drop the full sharps containers through a hole in the top. When 
the barrel is three quarters full, fill with concrete and dispose of in a deep burial pit. 
• Alternatively, dig a deep hole in the ground and line the floor and sides with clay, bricks or 
cement, or use a hole constructed with large cement pipes. Make sure that the pit has a concrete 
cover with a narrow cylinder, so that sharps containers can be dropped into the pit. When the 
pit is full, fill it with concrete and seal it. Keep the pit fenced off or secured. 
Disposal of infectious non-sharps 
• People working with infectious waste should wear gloves, including cleaning, maintenance 
and ground staff. 
• Infectious non-sharps waste can be buried in a pit 2–5 m deep, with the bottom at least 1.5 m 
above the water table. 
• Do not locate the pit near water supplies such as water courses or wells. The pit should be 
lined with low-permeability material, such as clay. The pit should be protected from rain with 
an appropriate cover (e.g., tarpaulin or a constructed roof) and protected from flooding with 
groundwater (e.g. construct a trench or a ridge around the perimeter to divert groundwater). 
• Add a layer of soil or sawdust after each layer of waste. 
• Clearly mark the storage area for infectious non-sharps waste with a warning sign such as 
‘Caution: infectious waste. Unauthorized persons keep out’. 
• Avoid burning waste if possible, as waste may contain a considerable amount of plastic that 
will pollute the environment. If burning is unavoidable, burn in areas separated from public 
spaces, as burning produces harmful smoke and airborne particles; bury the residual ashes and 
unburnt glass and metals in an isolated well covered with soil. 
Causes of error: 
Insufficient care and diligence in safely disposing of waste materials
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ANNex 7. 
testing for proficiency in reading blood 
slides against reference slides
Adapted from Walter Reed Army Institute of Research Malaria (2010). Microscopy and rapid 
diagnostic testing quality management resource manual, Fort Detrick, Texas.
Standard operating procedure No. xxx: Slide proficiency testing 
Last update on: ........................... , by ...............................................................................................................
Purpose: External quality assessment of malaria microscopy by reading reference blood slides at 
testing sites
Principle: 
• Thick and thin blood films are prepared and stained by the national reference laboratory and 
sent to field laboratories performing malaria microscopy for examination in a blinded manner. 
The results are analysed centrally and used as an indicator of performance.
• This type of external quality assessment is a measure of competence to examine well-prepared 
and stained blood films. The reference blood films are used internally by laboratories to monitor 
the competence of individual microscopists. At programme level, external quality assessment 
addresses the overall competence of a laboratory, as the blood films may have been examined 
by more than one microscopist. 
• External quality assessment monitors partially the accuracy of routine blood film examina-
tion, as this depends on many factors in addition to reading skill, such as blood film prepara-
tion, staining and workload. 
Specimen and sample requirements: Five external quality assessment blood films prepared and 
distributed quarterly to all participating laboratories.
Procedures: 
National reference laboratory
• A set of five1 external quality assessment blood films should be prepared and distributed quar-
terly1 in secure slide boxes to each laboratory.
• Prepare a sufficient number of blood films so that each laboratory receives the same set. They 
should be prepared by the standard operating procedures for preparation of thick and thin 
blood films and stained by the standard operating procedures for Giemsa staining. They should 
be protected with coverslips. They can be prepared in advance and stored in slide storage boxes, 
protected from heat and humidity. 
• Specific reporting instructions should be prepared for each set of external quality assessment 
blood films, including reporting the blood films as positive or negative for malaria parasites; 
reporting the presence of P. falciparum; reporting the presence of a mixed infection; reporting 
the presence of schizonts or gametocytes.2 
1 Other programmes are sending 10 slides per survey three times a year, to reduce logistic constrains.
2 Other programmes are also evaluating the parasite count for P. falciparum positive slides.
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• The participating laboratories should retain the external quality assessment blood films as part 
of a laboratory slide bank for teaching and self-instruction. 
• The external quality assessment set should consist of negative blood films, weakly positive 
blood films (80–200 parasites/μl) and moderately-to-strongly positive (> 500 parasites/μl) 
blood film illustrating a diagnostic feature (e.g. schizonts, mixed infection).
• The composition of the positive blood films should vary each month. The type of slides selected 
should take into account the target national competency levels of microscopists. 
• The external quality assessment results reported by the laboratories should be analysed against 
the reporting instructions issued with each set of blood films. A report should be prepared and 
distributed to the laboratories within 6 weeks of the distribution of blood films. The results 
should be checked for cheating by laboratories that shared results before reporting (for exam-
ple, two or more laboratories reporting similar errors). 
Participating laboratories
• The laboratory supervisor should ensure that each malaria microscopist in the laboratory has 
the opportunity to examine the external quality assessment blood films at least once a year.
• The laboratory supervisor should send the completed report form to the national reference 
laboratory within 1 week of receipt of the external quality assessment blood films. This time 
does not include the transport or postage time for sending the results. 
• On receipt of the report from the national reference laboratory, if there are discrepancies 
between the overall laboratory and the national reference laboratory results, the blood film(s) 
should be re-examined as a training exercise; if one or more microscopists reported incorrect 
findings, the laboratory supervisor should take appropriate corrective action. 
Quality assessment procedures:
Before distribution to the participating laboratories, 5% of the external quality assessment blood 
films should be examined for staining quality. Blood film sets with unsatisfactory staining quality 
(as defined in standard operating procedures for Giemsa staining) should be rejected. 
Before distribution to the participating laboratories, five blood films from each external quality 
assessment set should be examined in a blinded manner by at least three expert microscopists to 
confirm the correct result for the blood film. 
Reporting of results: The results should be reported to the participating laboratories within 6 
weeks of distributing the blood films. 
Causes of error:
• Poor preparation and staining of the external quality assessment blood films
• Incorrect reading of the external quality assessment blood films by the national reference 
laboratory
• Participating laboratories sharing findings before reporting results
• Participating laboratories examining external quality assessment blood films under unsatis-
factory microscopes
limitations and procedure notes:
This type of external quality assessment by panel testing monitors partially the routine accuracy 
of malaria microscopy, which also depends on the quality of blood film preparation and staining 
and on the workload. It can be complemented or combined by other types of quality management 
activities such as crosschecking (validation) of blood slides.
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ANNex 8. 
Checklist for supervision of laboratories 
performing malaria testing
Adapted from WHO (2009). Malaria microscopy quality assurance manual; Walter Reed Army 
Institute of Research Malaria (2010). Microscopy and rapid diagnostic testing quality management 
resource manual, Fort Detrick, Texas; and Consultation on technical and operational recommen-
dations for clinical laboratory testing harmonization and standardization, Maputo, Mozambique 
2008.
All laboratories should add the checklist for direct observation of laboratory technicians per-
forming malaria microscopy (Annex 9) and the checklist for direct observation of health workers 
performing RDTs for malaria (Annex 10) to this checklist.
The score for each item should be chosen on the basis of the relative importance that the pro-
gramme gives to it.
I. general Information
name of laboratory/Facility: date of visit (mm/dd/yyyy)
type of facility: n rural n Clinic n district hospital n provincial hospital n private hospital n other
Address of the laboratory:
municipality: province:
telephone/Fax
e-mail:
name of head of laboratory:
name of facility head/director:
names of laboratory technicians trained for malaria microscopy and rdt
 
1. .............................................................................................................................................................
 date of last training  ....–....–....      no. of months in the laboratory ................... 
  dd mm yyyy
2. ............................................................................................................................................................. 
 date of last training  ....–....–....      no. of months in the laboratory ................... 
  dd mm yyyy
3. ............................................................................................................................................................. 
 date of last training  ....–....–....      no. of months in the laboratory ................... 
  dd mm yyyy
4. ............................................................................................................................................................. 
 date of last training  ....–....–....      no. of months in the laboratory ................... 
  dd mm yyyy
5. .................................................................................................................................................
 date of last training  ....–....–....      no. of months in the laboratory ................... 
  dd mm yyyy
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routine working hours of the laboratory monday–Friday ..............................
 saturday ..............................
 sunday ..............................
is malaria rdt testing available out of the working hours of the laboratory n yes n no
II. Procedures
 Score laboratory 
 if good score
A. Archiving of slides
number of slides read in the previous month ……..
slide positivity rate in the previous month …….. %
b. Review of quality of slide preparation (randomly selected)
 nUmber perCentAge1
total number of slides reviewed ……….  —  
number of slides fully and clearly labelled ………. ……%
number of slides without surface abrasions ………. ……%
number of slides without a blue background coloration ………. ……%
number of slides without fungal contamination ………. ……%
number of slides where giemsa stain was used ………. ……%
number of slides with a correct size of films ………. ……%
number of slides with correct blood volume and opacity ………. ……%
number of thick films that are uniformly spread ………. ……%
number of thick films not fixed with methanol ………. ……%
number of slides without washed off parts ………. ……%
number of slides with pink to light purple background coloration2 ………. ……%
number of slides without stain precipitate2 ………. ……%
number of slides without bacterial contamination2 ………. ……%
C. Direct observation of malaria microscopy performance  
 (use checklist for the direct observation of laboratory technicians,  
 Annex 9)
 nUmber oF steps 
 perFormed CorreCtly
name of technician ……………………….. ……/24 
name of technician ……………………….. ……/24  
name of technician ……………………….. ……/24  
name of technician ……………………….. ……/24 
Correct each technician 
for the steps performed 
wrongly and watch 
him/her again while 
performing a new test
1 Number of slides fulfilling the criteria times 100, divided by the total number of slides reviewed. The target is 100%.
2 This can only be assessed microscopically.
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 Score laboratory 
 if good score
D. blood slide validation (cross-checking of routine slides)
total number of slides cross-checked by validator  …….
 of which ……. are weak positive,1
 and of which ……. are negative.1
number of false positive slides ……
number of false negative slides ……
percentage of agreement2 ……%
e. Direct observation of RDT performance (use checklist for the  
 direct observation of health workers, Annex 10)
 nUmber oF steps 
 perFormed CorreCtly
name of technician ……………………….. ……/14 
name of technician ……………………….. ……/14  
name of technician ……………………….. ……/14  
name of technician ……………………….. ……/14 
f. Direct observation of urine dipstick performance  
 (use specific checklist)
 nUmber oF steps 
 perFormed CorreCtly
name of health worker ……………………….. ……/xx 
name of health worker ……………………….. ……/xx  
name of health worker ……………………….. ……/xx  
name of health worker ……………………….. ……/xx 
g. Direct observation of acid-fast bacillus performance  
 (use specific checklist)
 nUmber oF steps 
 perFormed CorreCtly
name of technician ……………………….. ……/xx 
name of technician ……………………….. ……/xx  
name of technician ……………………….. ……/xx  
name of technician ……………………….. ……/xx 
h. Direct observation of other (non-malaria) RDT performance  
 (use specific checklist)
 nUmber oF steps 
 perFormed CorreCtly
name of technician ……………………….. ……/xx 
name of technician ……………………….. ……/xx  
name of technician ……………………….. ……/xx  
name of technician ……………………….. ……/xx  
1 Based on the reading of the assessed laboratory.
2 (Number of real positive slides + Number of real negative slides) / total number of slides cross-checked.
Correct each technician 
for the steps performed 
wrongly and watch 
him/her again while 
performing a new test
Correct each technician 
for the steps performed 
wrongly and watch 
him/her again while 
performing a new test
Correct each technician 
for the steps performed 
wrongly and watch 
him/her again while 
performing a new test
Correct each technician 
for the steps performed 
wrongly and watch 
him/her again while 
performing a new test
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 Score laboratory 
 if good score
III. laboratory set-up
 good poor remArks
bench space   
sink/washing area/staining area
Access to clean water supply
natural lighting
power source
ventilation
storage space for supplies and materials
waste management system
post exposure prophylaxis in case of injury available within 24h
Iv. RDT kits (malaria, hIv, syphilis and pregnancy) and urine dipsticks  
 kept in the laboratory
specify which rdt has been inspected:
1. ....................................................................
2. ....................................................................
3. ....................................................................
4. ....................................................................
 yes no remArks
rdt kits are protected from direct  
sunlight
rdt kits are protected from humidity,  
rain or water
rdt kits are not expired
v. microscopes
 yes no remArks
the microscope(s) is binocular
the microscope lamp(s) has sufficient  
power to provide good illumination  
when the condenser aperture is set at  
the correct setting for the x100  
objective
blood films can be brought into sharp  
focus at x100 oil immersion  
magnification
the stage movement mechanism is  
precise and stable
the microscope(s) is regularly serviced
the microscope(s) is protected with a  
cover when not in use
Xylene is never used to clean the  
nicroscope(s), objectives or eye pieces
spare bulbs are stored in the laboratory
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 Score laboratory 
 if good score
vI. microscope slides
 yes no remArks
microscope slides are of good quality  
and are thoroughly cleaned before use
microscope slides do not have scratches  
or surface aberrations
microscope slides do not give a blue  
background colour after staining
microscope slides do not have fungal  
contamination
microscope slides that have been  
damaged by fungus are discarded and  
not used again
in settingss with high humidity,  
microscope slides are protected against  
fungal contamination 
vII. Stain solutions
 yes no remArks
stock staining solutions are stored in  
the dark and far from a heat source
Commercial stain solutions are within  
the manufacturer’s expiry date
Commercial stain solutions do not  
contain excessive stain precipitate
the cap of the reagent bottle is always  
tightly sealed except when stain is  
being removed for use
stain is always removed from the  
reagent bottle using a clean pipette or  
something similar
water is never added to the stock stain  
solution
Unused stain is never returned to the  
stock bottle
vIII. other laboratory tests available at peripheral level laboratories
 yes no remArks
glucometer properly stored
haemoglobinometer properly stored
…
123
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 if good score
Ix. general laboratory supplies
 yes no remArks
Alcohol and cotton (or similar) for  
cleaning skin prior to blood collection
lancets
methanol
buffer salts or buffer tablets
ph meter that reads to two decimal  
places
ph calibration solutions
staining jar
staining rack
drying rack
graduated cylinders of the correct size
wash bottles
timers – sufficient number for staining  
and for each microscopist
immersion oil
tally counters – sufficient number for  
the number of staff
lens paper
slide boxes for storage
For laboratories that prepare stain from  
powder – sufficient glycerol, methanol,  
powder, beakers, measuring cylinders,  
filter paper, funnels, stirring rods,  
scales, spatulas and storage bottles
x. Documentation 
 yes no remArks
logbook or record book located in the  
laboratory
logbook or record book for all rdt  
performed out of laboratory working  
hours available
blood slides and malaria rdt  
information recorded separately
patient’s name and details recorded in  
an organized and legible manner
date malaria test was performed  
recorded 
species identification performed
parasite counting performed (if yes,  
specify method used under remarks  
column)
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 Score laboratory 
 if good score
forms
pathology request forms used
result/report forms completed correctly
referral forms used
Analysis
monthly analysis prepared including:
Malaria:  
number of slides examined, the  
number of rdt performed, positivity  
rates for each type of test and, for  
slides, percentage of species identified  
(as appropriate) and quantification
Other tests:
number of tests performed, positivity  
rate for each test
maintenance of laboratory equipment
register for maintenance of laboratory  
equipment is up-to-date
specification sheet available for every  
laboratory equipment
All maintenance service reports  
available
Availability of up-to-date standard operation procedures and/or bench aids
malaria rdt performance
Use, care and maintenance of  
microscopes
preparation of stock giemsa
thick and thin film preparation
blood staining for malaria
waste management of malaria tests
Urine dipstick performance
measurement of glycaemia
measurement of haemoglobin and  
haematocrit
hiv rdt performance
syphilis rdt performance
pregnancy test performance
internal audit of laboratory
 yes no remArks
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ANNex 9. 
Checklist for direct observation  
of laboratory technicians performing 
malaria microscopy
Adapted from Improving Malaria Diagnostics (IMaD). Improving malaria diagnostics outreach: 
training and support supervision manual, Ghana 2010.
name of health facility: position of health worker performing test: .........
number of days during which health  
worker performed microscopy in the past month: 
...../...../.....
name of observer:
date of observation:
No. Steps observed yes No Comment
PRePARATIoN of STAIN
1. giemsa stain stock solution labelled with time and 
date
2. giemsa stain stock solution kept well-stoppered
3. giemsa stock diluted to 10% (or 3%)
4. ph of buffer used for dilution is 7.2.
5. diluted giemsa discarded after a maximum of 6 h
SlIDe STAININg
6. slides are clean and not scratched.
7. only thin films are fixed with methanol (2–3 s) or 
ethanol (20 min) and dried before staining.
8. slide stained for 8–10 min (if 10% dilution) or 
45–60 min (if 3% dilution)
9. slide rinsed with clean water
10. slide drained and dried on rack
11. no heating used to dry films
SlIDe exAmINATIoN
12. immersion oil placed on slide
13. stage of microscope racked down before placing 
slide
14. Focus with x40 objective before focus with x100 oil 
immersion objective
15. ≥ 100 fields examined before declaring slide 
negative
SlIDe ReADINg
16. negative result differentiated from positive result
17. species identified
18. parasite density quantified by counting ≥ 200 
white blood cells
19. if parasite density is high, thin film used for 
counting
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No. Steps observed yes No Comment
ReSUlT RePoRTINg
20. result reported as negative or positive for parasites
21. species of parasite reported
22. parasite density reported as number of parasites 
per 200 white blood cells or converted to number 
of parasites per microlitre
23. date and time of result recorded
24. result properly delivered back to clinician or 
patient and recorded in the laboratory register
SlIDe CleANINg AND SlIDe AND mICRoSCoPe SToRAge
25. slides placed on tissue to remove oil
26. slides for quality management system stored 
according to protocol
27. microscope cleaned appropriately (manufacturer’s 
instructions)
28. microscope stored properly to avoid fungus and 
covered to avoid dust
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ANNex 10. 
Checklist for direct observation  
of health workers performing rapid 
diagnostic tests (rdt) for malaria
Adapted from ‘Improving Malaria Diagnosis in health facilities’ (IMALDIA) project. Dar es 
Salaam City Medical Office of Health, United Republic of Tanzania, and the Swiss Tropical and 
Public Health Institute, Basel, Switzerland 2006–2008.
name of health facility: position of health worker performing test: .........
number of days during which health worker 
performed rdts in the past month: ...../...../.....
name of observer:
date of observation:
No. Steps observed yes No Comment
 1. procedure explained to the patient or caregiver
 2. expiry date checked
 3. device labelled with patient’s name
 4. gloves worn
 5. Finger disinfected and allowed to dry before 
pricking
 6. new sterile lancet used for each patient and 
disposed of immediately in appropriate sharps 
container
 7. right amount of blood collected with the blood 
transfer device
 8. All collected blood deposited in right well
 9. Correct number of buffer drops deposited in right 
well
 10. proper timing observed before reading test result
 11. proper interpretation of test result
 12. Used test, capillary tube and alcohol swab disposed 
of in appropriate container
 13. result recorded accurately in the register
 14. result recorded accurately on the patient’s card
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ANNex 11. 
Case scenarios for training in  
use of rapid diagnostic tests (rdt)  
in clinical management
Adapted from ‘Improving Malaria Diagnosis in health facilities’ (IMALDIA) project. Dar es 
Salaam City Medical Office of Health, United Republic of Tanzania, and the Swiss Tropical and 
Public Health Institute, Basel, Switzerland 2006–2008.
Questions
Case study 1:
A child aged 3 years is brought in for fever over the past 24 h. The father reports no cough or 
diarrhoea.
Physical examination shows a temperature of 38.6 °C but no other major sign.
RDT is negative.
(1) What is your diagnosis?
(2) What advice do you give to the father, and what treatment do you prescribe?
Case study 2:
An infant aged 11 months is brought to a dispensary for fever over the past 48 h. The mother 
reports difficulty in breastfeeding since the previous day and one episode of convulsion.
Physical examination shows a temperature of 38.6 °C and slight drowsiness but no other major 
sign.
Explain the actions you would take, one by one.
Case study 3:
A boy aged 4 years is brought to a health centre by his brother because he has been ‘hot’ for 3 days 
and has been coughing since the previous day. There are no other major signs.
On examination, the boy is found to have a temperature of 38.3 °C and a respiratory rate of 45/
min. Chest auscultation gives normal results. 
(1) What is your diagnosis?
(2) Which test(s) do you ask for?
(3) For each possible test result, which treatment(s) would you give?
Case study 4:
A girl aged 12 years is brought to a dispensary for fever and headache since the previous week. 
She reports having had malaria (documented by a malaria test) 1 week previously and taking an 
artemisinin-based antimalarial medicine. The fever abated within 1 day but recurred after 3 days.
(1) What do you ask her?
(2) What do you do (a) if microscopy is available and (b) if microscopy is not available at all?
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Case study 5:
A boy aged 10 years presents at a dispensary with joint pain and cough for the past week. He has 
no fever and no other symptoms. His temperature is 37.3 °C, and a physical examination shows 
normal findings.
What do you do?
Answers
Case study 1: non-specific fever (without danger signs)
1) Diagnosis: non-specific fever or non-malaria fever or flu-like syndrome
2) Reassure the father that his child does not have malaria. Tell him to bring the child again if the 
fever persists or if a new problem appears. Treat the child with an antipyretic only.
Take home message: RDT is negative   no malaria   no antimalarial treatment
Case study 2: severe febrile illness at dispensary level
— Difficulty to suck, convulsion, drowsiness = Danger signs
— Do not lose time by asking for malaria tests; they will be done at the hospital.
— Immediately prescribe an antimalarial and an antibiotic treatment (and antipyretic)
— Refer the infant urgently to hospital
Take home message: Danger signs antimalarial + antibiotic + immediate referral
Case study 3: pneumonia with or without malaria
In the presence of cough, measure the respiratory rate:
If it is ≥ 50/min for infants aged 2–12 months or if it is ≥ 40/min for children aged 12 months– 
5 years, there is fast breathing, which is a sign of pneumonia.
1) Diagnoses:  Pneumonia (because of fast breathing) with or without malaria
2) Tests:  RDT
3) Result: if RDT is positive, give an antimalarial and an antibiotic
  if RDT is negative, give an antibiotic only
Take home message: Fast breathing   pneumonia (whatever the result of RDT)   antibiotic
  No fast breathing   no pneumonia   no antibiotic
Case study 4: persisting fever after antimalarial treatment
1) Ask the patient if she took full ACT treatment (all tablets without vomiting thereafter) or only 
partial treatment
2) If she took full treatment:  
a) If microscopy is available: ask for a blood slide AND look for other causes of fever
 If the blood slide result is positive, give second-line antimalarial treatment
 If the blood slide result is negative, do not give antimalarial treatment at all
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b) If microscopy is NOT available: perform RDT AND look for other causes of fever
 If the RDT result is positive, give second-line antimalarial treatment (even if the patient 
might be already cured)1
 If the RDT result is negative, do not give antimalarial treatment at all
If she took only partial treatment:  
 Give (or complete) first-line antimalarial treatment, look for other causes of fever and 
advice her to come back if fever persists (malaria tests are not needed at this stage)
Take home message: Persisting fever after antimalarial   ask if patient took full treatment:
  If yes   ask for microscopy (if available)
  If no   give (or complete) the first-line antimalarial treatment
  In any case   look for other causes of fever
Case study 5: cough and joint pain without fever
In absence of fever, the child does not suffer from a malaria episode. He probably has an upper 
respiratory tract infection.
To exclude pneumonia, measure the respiratory rate and give an antibiotic only if fast breathing 
is present. 
Reassure the caretaker that the child has no serious illness and give an analgesic.
Take home message: No history of fever and no elevated temperature  
   do not ask for any malaria test
   do not give antimalarial treatment
Conclusion: avoid mis-management of patients with no danger signs:
— Do not ask for a malaria test if there is no history of fever and no elevated temperature.
— Do not give antimalarials when the malaria test (RDT or reliable microscopy) is negative.
— Do not forget to look for other causes of fever, whatever the result of the malaria test.
— Do not give antibiotics without a clear indication: follow the recommendations of Inte-
grated Management of Childhood Illness (IMCI).
1 In this situation, the RDT result might be positive either because of the presence of parasites due to treatment fail-
ure (the patient is not cured), or because of persisting antigens despite clearance of parasites (the patient is cured). 
In the absence of microscopy, it is impossible to distinguish between these 2 situations and second-line antimalarial 
treatment should be given.
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Checklist for supervision of malaria 
diagnostic testing in health facilities
Adapted from WHO (2009). Malaria microscopy quality assurance manual; Walter Reed Army 
Institute of Research Malaria (2010). Microscopy and rapid diagnostic testing quality management 
resource manual, Fort Detrick, Texas; WHO (2009). Malaria case management operations manu-
al; and ‘Improving Malaria Diagnosis in health facilities’ (IMALDIA) project. Dar es Salaam City 
Medical Office of Health, United Republic of Tanzania, and the Swiss Tropical and Public Health 
Institute, Basel, Switzerland 2006–2008.
All health facilities should add the checklist for supervision of clinical management of febrile 
children at health facility level (Annex 13) and the checklist for direct observation of health work-
ers performing RDTs for malaria (Annex 10) to this checklist.
Health facilities with a laboratory should add the checklist for supervision of laboratories per-
forming malaria testing (Annex 8) and the checklist for direct observation of laboratory techni-
cians performing malaria microscopy (Annex 9) to this checklist.
I. general Information
name of laboratory/Facility: date of visit (mm/dd/yyyy)
type of facility: n rural n Clinic n district hospital n provincial hospital n private hospital n other
Address of the laboratory:
municipality: province:
telephone/Fax
e-mail:
name of person in charge of the health facility:
name of focal person for all rapid diagnostic tests:
name of health workers performing rdt for malaria or for other diseases (e.g. hiv)
1. .............................................................................................................................................................
 Formal training received n yes n no      no. of months in health facility n n 
2. .............................................................................................................................................................
 Formal training received n yes n no      no. of months in health facility n n 
3. .............................................................................................................................................................
 Formal training received n yes n no      no. of months in health facility n n
4. .............................................................................................................................................................
 Formal training received n yes n no      no. of months in health facility n n 
5. .............................................................................................................................................................
 Formal training received n yes n no      no. of months in health facility n n
is rdt testing available at any time during the working hours of the health facility n yes n no
post exposure prophylaxis for hiv available within 24 hours in case of injury n yes n no
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1. examination area? n yes n no 
2. lighting of examination area? n yes n no
3. space to see patient? n yes n no 
4. Chair and table for health worker? n yes n no 
5. Functioning weighing scale? n yes n no 
6. thermometer? n yes n no 
7. watch or other timing device? n yes n no 
8. patient record cards? n yes n no 
9. malaria patient register? n yes n no 
10. supplies for assessing patient? n yes n no 
Iv. Clinic and referral services
•	 Reorganize	space	and	help	health	workers	
 set up examination area
•	 Identify	minimal	requirements	for	furniture	
 that could be moved to the examination 
 area
•	 Report	needs	to	district	level	(scale,	timing	
 device, thermometers, guidelines, charts, 
 patient record cards)
if other solution, please describe: 
…………….................................................
solve problems that interfere with case 
management of fever, e.g.:
•	 Help	trained	worker	to	train	other	staff
•	 Organize	patient	flow
•	 Identify	ways	to	make	case	management	
 more efficient, less time-consuming
help trained/untrained staff to determine 
how to ensure case management tasks can 
be carried out.
reconfirm scheduled clinic hours for services 
offered
discuss difficulties encountered in providing 
essential services every day and identify 
possible solutions
review what to do when referral is not 
possible
report unsolved problems to district level
1. Clinic opens during all scheduled  
 hours? n yes n no
2. reasonable waiting time for  
 patients? n yes n no
3. is patient load balanced by staff  
 distribution during clinic hours? n yes n no
4. pharmacy services available during  
 open hours? n yes n no
5. diagnostic services available? n yes n no
6. preventive and control services  
 provided? n yes n no
7. immunization services available  
 every day? n yes n no
8. referral care possible within  
 reasonable time? n yes n no
II. Space and equipment
III. organization of case management tasks
1. register patients, manages triage/ 
 patient flow? n yes n no
2. weigh patient? n yes n no
3. take body temperature? n yes n no
4. enough time spent to assess patient? n yes n no
5. Are rapid tests performed? n yes n no
6. Are drugs dispensed? n yes n no
7. instructions on how medication  
 should be given? n yes n no
8. give first dose of drug? n yes n no
9. Complete patient records? n yes n no
Tasks not routinely carried out well by trained workers:
•	 Find	out	why	tasks	are	not	carried	out	well
•	 Determine	whether	the	task	is	carried	out	by	other	 
staff
•	 Determine	whether	the	way	in	which	the	task	is	 
carried out by other staff interferes with work of 
trained heath worker
Assess conditions Solve identified problems
 Score health 
  if good facility score
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v. malaria RDT performance
number 
of steps 
performed 
correctly 
......... /14
......... /14
......... /14
Correct the steps performed wrongly by 
each health worker and watch him or her 
performing a new rdt on a real patient.
identify appropriate solution, e.g.:
•	 Review	and	give	practice	in	using	drug	
stock card or book
•	 Review	rational	use	of	drugs	with	persons	
responsible for prescribing
•	 Identify	ways	to	combine	use	of	transport
report stock shortages to district level.
AnneX 12
ANNex
12
Assess conditions Solve identified problems
 Score health 
  if good facility score
(Use checklist for the direct observation  
of RDT performers, Annex 10)
name of health worker
.........................................................
name of health worker
.........................................................
name of health worker
.........................................................
number 
of steps 
performed 
correctly 
......... /XX
......... /XX
......... /XX
vI. Performance of other rapid tests
Urine dipstick (use the corresponding 
checklist)
name of health worker
.........................................................
name of health worker
.........................................................
name of health worker
.........................................................
hiv rdt (use the corresponding checklist)
name of health worker
.........................................................
name of health worker
.........................................................
name of health worker
.........................................................
Correct the steps performed wrongly by 
each health worker and watch him or her 
performing a new test on a real patient.
number 
of steps 
performed 
correctly 
......... /XX
......... /XX
......... /XX
vII. Availability of drugs and other supplies in stock on day of visit
1. First-line antimalarial drug n yes n no 
2. second-line antimalarial drug n yes n no 
3. First-line antibiotic for pneumonia n yes n no 
4. First-line antibiotic for dysentery n yes n no 
5. First-line antibiotic for skin 
 infections n yes n no 
6. inhaled salbutamol n yes n no 
7. Zinc n yes n no 
8. oral rehydration salts n yes n no 
9. iron n yes n no 
10. vitamin A n yes n no 
11. mebendazole n yes n no 
12. tetracycline eye ointment n yes n no
13. spacer for inhaled salbutamol n yes n no
14. malaria rdts n yes n no
15. Urine dipsticks n yes n no
16. glucometer n yes n no
17. haemoglobin or haematocrit meter n yes n no
18. hiv rdts n yes n no
Correct the steps performed wrongly by 
each health worker and watch him or her 
performing a new test on a real patient.
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19. syphilis rdts n yes n no
20. pregnancy rdts n yes n no
21. First-line parenteral antibiotics  
 for severe illness n yes n no
22. Quinine injection n yes n no 
23. sterile syringes n yes n no 
24. sterile needles n yes n no 
25. butterfly needles and cannulae n yes n no 
26. Antipyretics n yes n no 
27. Cotton swabs n yes n no 
28. skin disinfectant n yes n no 
29. intravenous administration sets n yes n no 
30. nasogastric tubes n yes n no
31. dextrose 5%, 10% and 50% n yes n no
32. normal saline n yes n no
33. intravenous and rectal diazepam n yes n no
Determine problem in availability of drugs and other 
supplies, e.g.:
•	 needs	not	adequately	assessed
•	 inadequate	records	and	ordering
•	 drugs	not	used	rationally
•	 not	enough	drugs	available	in	central	store
•	 high	seasonal	demand
•	 no	transport
ensure expired medicines and rdts are 
discarded.
report need for medicine and tests stock 
control to district level.
Assess conditions Solve identified problems
 Score health 
  if good facility score
vIII. Storage and stock management
1 organization of stocks according to  
 expiry date? n yes n no 
2. medicines and tests stock control  
 in place? n yes n no 
3. medicines or rdts expired? n yes n no 
4. medicines, tests and supplies stored  
 securely? n yes n no 
5. medicines and tests protected from  
 direct sunlight? n yes n no 
6. medicines and tests protected from  
 humidity, rain or water? n yes n no 
7. daily monitoring of temperature in  
 place? n yes n no
Compare storage conditions with corresponding standard 
operating procedure and correct discordances.
Compare stock management with corresponding standard 
operating procedure and correct discordances.
Which items have expired and how much?
......................................................................... 
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Ix. Quality of records
1. Are individual patient records or  
 registers maintained? n yes n no
2. if yes, assess whether most include:
 — rdt (for malaria, hiv) or urine  
  dipstick or other laboratory test  
  result n yes n no
 — final diagnosis(ses) n yes n no
 — treatment prescribed n yes n no
 — treatment given n yes n no
 — follow-up, indicating date n yes n no
3. logbook or record book for all rdts,  
 with date, name and test result n yes n no
Assess conditions Solve identified problems
 Score health 
  if good facility score
teach health workers how to fill in registers.
propose ordering or creating missing 
registers.
in health facilities with laboratory: ensure 
records of all rdts performed outside the 
laboratory are merged with records of rdts 
performed in the laboratory.
provide latest versions of missing standard 
operating procedures and/or bench aids.
x. monthly analysis
1. Correct number of attendances n yes n no
2. Correct number of malaria tests  
 performed n yes n no
3. Correct malaria test positivity rate n yes n no
4. Correct number of malaria cases n yes n no
5. Correct number of first-line anti- 
 malarials prescribed n yes n no
6. Correct total number of patients  
 receiving first-line antimalarial  
 treatment (ACt) n yes n no
7. Correct number of confirmed  
 malaria cases receiving first-line  
 antimalarial treatment (ACt) n yes n no
teach health workers how to count and report 
each indicator correctly.
Selection of patients for RDT testing:
Compare monthly number of attendances with 
monthly number of rdts performed during the 
past 3 months.
Accuracy of malaria diagnosis:
Compare monthly number of rdt-positive 
results with monthly number of malaria cases 
during the past 3 months.
Appropriateness of malaria treatment:
Compare monthly number of first-line 
antimalarials prescribed and the monthly 
number of malaria cases during the past 3 
months.
xI. Availability of standard operating procedures and/or bench aids (latest versions)
1. integrated management of Childhood  
 illness (imCi) n yes n no
2. treatment guidelines n yes n no
3. malaria rdt performance n yes n no
4. Urine dipstick performance n yes n no
5. performance of other rapid tests  
 (e.g. hiv) n yes n no
6. storage of medicines and tests n yes n no
7. stock management of medicines,  
 tests and supplies n yes n no
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ANNex 13. 
Checklist for supervision of clinical 
management of febrile children  
at health facility level 
Adapted from WHO (2009). Malaria case management operations manual and WHO (2003). 
Health facility survey, tool to evaluate the quality of care delivered to sick children attending outpa-
tient health facilities.
A similar checklist for febrile children can be developed, taking into account that the differential 
diagnosis is much wider in adults than in children.
name of health facility: position of health worker attending patient:  
.........................................................................
number of days during which health worker 
attended patients in the past month: ...../...../.....
name of observer:
date of observation:
No Steps observed yes No Comment
hISToRy-TAKINg
1. does the health worker ask about the age of the 
child?
2. does the health worker ask if the child is able to 
drink or breastfeed?
3. does the health worker ask if the child vomits 
everything?
4. does the health worker ask if the child has 
convulsions?
If not spontaneously mentioned by the caregiver:
5. does the health worker ask about fever?
6. in case of fever, does the health worker ask for 
how long?
7. does the health worker ask about cough or 
difficult breathing?
8. does the health worker ask about diarrhoea?
9. does the health worker ask about ear problems?
10. does the health worker ask about possible other 
problems?
11. does the health worker ask if the child or the 
mother has had an hiv test?
12. does the health worker check the child’s 
vaccination card?
PhySICAl exAmINATIoN
13. if the child is not visibly awake, does the health 
worker try to wake him or her up?
14. does the health worker (or other staff) check the 
child’s temperature?
15. does the health worker (or other staff) weigh and 
record the weight of the child?
16. does the health worker check the child’s weight 
against a growth chart?
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17. does the health worker look for severe wasting or 
oedema of both feet?
18. does the health worker look for palmar pallor?
19. in case of cough or difficult breathing, does the 
health worker measure the respiratory rate?
20. does the health worker look for dehydration?
ClASSIfICATIoN
21. in case of danger signs, does the health worker 
refer or admit the child?
22. in case of fever, does the health worker ask for a 
malaria test?
23. does the health worker appropriately classify the 
illness?
TReATmeNT
24. in case of danger signs or severe malnutrition, 
does the health worker give treatment to prevent 
low blood sugar?
25. in case of convulsions, does the health worker 
immediately give diazepam?
26. in case of wheezing, does the health worker 
immediately give inhaled salbutamol using a 
spacer and prescribe salbutamol for home use?
27. in case of severe dehydration, does the health 
worker immediately give intravenous fluids or oral 
rehydration salts?
28. in case of referral, does the health worker give an 
antimalarial medicine and an antibiotic as pre-
referral treatment?
29. does the health worker prescribe an antimalarial 
medicine if, and only if, the malaria test is 
positive?
30. does the health worker prescribe an antibiotic 
if, and only if, the clinical classification is 
pneumonia, dysentery, mastoiditis or significant 
skin infection?a
31. in case of diarrhoea, does the health worker 
prescribe zinc?
32. in case of dehydration, does the health worker 
prescribe oral rehydration salts?
CommUNICATIoN AND ADvICe
33. does the health worker tell the caregiver what is 
wrong with the child?
34. does the health worker give the caregiver advice 
on how the child should take the prescribed 
medicines?
35. does the health worker check whether the 
caregiver has correctly understood the 
prescription?
36. does the health worker give the caregiver advice 
on when the child should return?
37. does the health worker give the caregiver advice 
on hiv testing?
38. does the health worker ask the caregiver if he or 
she has any questions?
a if a urine dipstick is performed and is positive for leukocytes or nitrites, an antibiotic should be given to treat urinary tract 
infection.
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 regulation  18
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